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Abstract
Given an aging population, shortage of nursing staff and a continuously increasing workload,
automation in the medical sector is an important aspect of future intensive care. Although
automation and machine learning are current research topics, progress is still very limited
in comparison to other application areas. Probably one of the most serious problems is
data shortage in a heterogeneous landscape of medical devices with limited interfaces and
various protocols. In addition, the recording of data or, even more so, the evaluation of
automation is limited by a complex legal framework. Given these complications and the
sensitive legal nature of medical records, only very limited data is accessible for further
analysis and development of automated systems.
For this reason, within the context of this thesis various solutions for data acquisition and
automation were developed and evaluated concomitant to two clinical studies utilizing a
large animal model in a realistic intensive care setting at the University Hospital Tübingen.
Foremost, to overcome the problems of data availability and interconnection of medical
devices, a software framework for data collection and remote control using a client-server
architecture was developed and significant amounts of research data could be collected in a
central database. Furthermore, a closed-loop controller based on fuzzy logic was developed
and used for management of end-tital CO2, glucose, and other parameters to stabilize the
animal subjects during therapy and reduce caregivers’ workload.
In addition to the fuzzy controller, closed-loop management for temperature and anti-
coagulation could be established by developing hardware interfaces for a forced-air warm-
ing unit and a point-of-care analysis device, respectively. Besides further reduction of care-
givers’ workload, such systems can provide additional patient safety and allow management
in settings where human supervision may not be present at all times.
One general and encountered problem for closed-loop control in a medical setting is limited
availability of measurements, especially if manual blood withdrawals are required. As an
initial step to address this problem, measured parameters from other devices as potential
surrogates were evaluated in a comparison between different regression approaches. The
required training data, a matched set of blood gas and monitoring parameters, was obtained
by utilizing a developed algorithm for automated detection of withdrawal events.
Yet, besides any specific implementations and analysis, many general aspects regarding the
physical implementation of such a system and interaction with caregivers could be evaluated
in the experimental setting and might guide further development of clinical automation.
v

Kurzfassung
Angesichts der alternden Bevölkerung, des Mangels an Pflegekräften und der ständig
steigenden Arbeitsbelastung ist Automatisierung ein wichtiger Aspekt zukünftiger Inten-
sivmedizin. Obwohl Automatisierung und maschinelles Lernen aktuelle Forschungsthemen
sind, ist der Fortschritt im Vergleich zu anderen Anwendungsbereichen jedoch noch sehr be-
grenzt. Eines der größten Probleme ist wohl die Datenknappheit in einer heterogenen Medi-
zinproduktelandschaft mit begrenzten Schnittstellen und zahlreichen unterschiedlichen
Protokollen. Darüber hinaus sind die Datenerfassung und erst recht die Erprobung einer
Automatisierung durch ein komplexes rechtliches Rahmenwerk eingeschränkt. Aufgrund
dieser Komplikationen und der sensiblen Rechtslage für Patientendaten sind diese nur sehr
begrenzt für weitere Analysen und die Entwicklung automatisierter Systeme zugänglich.
Im Rahmen dieser Dissertation wurden daher verschiedene Lösungen zur Datenerfas-
sung und Automatisierung begleitend zu zwei klinischen Studien des Universitäts-
klinikums Tübingen am Großtiermodell in einer realitätsnahen Intensivstation entwickelt
und evaluiert.
Um die Probleme der Datenverfügbarkeit und Vernetzung medizinischer Geräte zu lösen,
wurde vorrangig ein Software-Framework für die Datenerfassung und Steuerung mittels
einer Client-Server-Architektur entwickelt und umfangreiche Forschungsdaten in einer zen-
tralen Datenbank gesammelt. Darüber hinaus wurde ein auf Fuzzy-Logik basierender Regler
entwickelt, welcher zur Stabilisierung des endtitalen CO2, Glukose und anderen Parametern
verwendet wurde und damit die Arbeitsbelastung der Pflegekräfte reduzieren konnte.
Zusätzlich zum Fuzzy-Regler konnten durch die Entwicklung von Hardware-Schnittstellen
für Geräte zum Temperaturmanagement mittels luftbasierter Wärmedecken und zur Mes-
sung der Blutgerinnung geschlossene Regelkreise aufgebaut werden. Neben einer weiteren
Arbeitserleichterung für die Pflegekräfte können solche Systeme zusätzliche Sicherheit
für den Patienten bieten und die Anwendung in nicht ständig überwachten Bereichen er-
möglichen.
Ein allgemeines und auch beobachtetes Problem für Regelkreise im medizinischen Bereich
ist die begrenzte Verfügbarkeit von Messwerten, insbesondere bei manuellen Blutentnah-
men. Als erster Schritt zur Lösung dieses Problems wurden Messparameter anderer Geräte
als potentielle Ersatzparameter mit verschiedenen Regressionsansätzen analysiert und ver-
glichen. Die dazu erforderlichen Trainingsdaten, Paare von Blutgas- und weiteren Vital-
daten, wurden mit Hilfe eines entwickelten Algorithmus zur automatisierten Erkennung
von Blutentnahmen erzeugt.
Abgesehen von diesen konkreten Anwendungen und Analysen konnten in der experi-
mentellen Evaluation auch viele generelle Aspekte der realen Implementierung eines
solchen Systems und die Interaktion mit Ärzten und Pflegekräften untersucht werden und
damit der Entwicklung weiterer klinischen Automatisierung dienen.
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1 Introduction
Would you entrust your life to a computer while staying critically ill in a hospital? One
might hesitate to answer such a direct question with yes, but everybody is more or less
unknowingly entrusting their lives to machines every day to a varying and even greater
extent. Would one hesitate in an equal fashion if asked to travel by plane? In this case, most
people would agree and not even contemplate too much about such a common situation.
But is this situation really that different? Sitting in an enclosed space, several thousand
feet above the ground with no way to exit. One might argue that the pilots in the cockpit
are flying the plane, but most of the time, except for the start and landing, the plane is
operated by computers controlling countless functions of electronic devices and navigating
with autopilots, only guided and instructed by the navigation and control input from the
pilots. Is this really so much different from a computer performing therapeutic actions in
a medical scenario, with physicians guiding the therapy? — But whereas automation and
computerization found appeal in most of our life situations, the medical sector is still an area
where people mostly trust the experience of another, professionally trained, human. But
can a physician always stay at your side, observe every little change in your condition and
immediately react to it? With no human being perfect and an aging society, the workload
and burden for caregivers is steadily increasing. Computer-aided decision making and
automated therapy guidance therefore will be an important aspect of critical care in the
future. Many questions covering various aspects concerning closed-loop systems for goal-
directed therapies, machine-learning, and decision making based on collected clinical data
are subject to basic research. Yet, fundamental technical aspects like the interconnection
and communication between different medical devices, data storage, and processing are
unsolved. Thus, in clinical practice, manual input and processing of data observed at another
medical device is still required on a daily basis. In the course of this thesis, these aspects
will be covered, providing experimental solutions for data collection and control systems
as well as first analyses based on collected data.
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1.1 Motivation
Research and advantages in clinical techniques and equipment allow for treatment of more
and more complex and life-threatening conditions [1]. Yet, most knowledge and decision
making still remains empirical [2] and understanding of physiological models and parameter
interactions is still limited. Whereas in other sectors, information technology and automa-
tion already play an essential role for reduction of workload and increased safety, within
medicine and critical care, those advantages are still mostly limited to patient management
and guidance systems [3] and still heavily rely on human action and expertise.
Despite an advancing technical progress, hospitalized care still involves countless manual
and repetitive tasks like manual calculations, and entering numbers and measurements to
various devices, instead of being able to focus on therapeutic tasks that benefit from human
knowledge, expertise and flexibility. When automation or closed-loop systems are available
in the medical sector, they often only are present in a less obvious scale. Such application
include automated management of gas concentrations in medical ventilators or calculations
within patient monitors.
Additionally, whereas an increasing number of medical devices in intensive care settings
is available, those systems often have made patient assessment and care even more com-
plex and resulted in an increased workload [1]. Nowadays, many point-of-care (POC) and
laboratory systems, e.g., for assessment of blood gasses of blood clotting time are readily
available. While aiding high-level critical care, manual workload and critical thinking is
often required for correctly handling those tools and resources by physicians and nursing
staff, instead of being part of clinical routine [1].
In general, assessment of critical situations and notification of caregivers is still based on
simple threshold alarms. Given such a broad variety of medical devices monitoring the
individual patient, this results in high false alarm rates and additionally increased workload
for caregivers. Comparison of measurements from different sources could lead to major
improvements as such a comparison of different vital parameters would allow to determine
if a sensor, like a clip-on sensor for oxygen saturation just has fallen off, while related
measurements are still present from other sources, or if in fact a critical condition requiring
imminent action and notification to caregivers is present.
In line with the concept of simple threshold alarms, many aspects of care are still based
on simple therapeutic protocols, check-lists, and guidelines. This protocolized care may be
useful in situations with limited staff but cannot provide the high quality of care achievable
by well-trained ICU physicians and nurses [3]. Whereas for usage by caregivers, such tools
are essential for fast reactions, reduction of workload, and to provide a basic level of care,
implementation of those protocols is just a first and initial step for automated systems. For
personalized medicine of the future, therapeutic decision making must be performed on
individual patient basis [3]. Thus, more advanced systems utilizing machine learning for
information gathering from a large data base of medical knowledge and adaption to the
individual patient are required.
Along with the trend of an aging population, a rising demand for critical care and a limited
number of skilled clinicians, problems like understaffing and providing adequate care for
all patients may become more severe in the future [3, 4]. By application of information
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technologies (IT) to this sector, there is a large potential for patient management to be
revolutionized [3] as the trend of computerized medicine has just started within the last
decade and developed into a growing research field. Medical device software already plays
an increasingly important role in healthcare [5] and research provides tools for better patient
care and access to patient resources [6]. As automated systems do not require to share their
workload between different patients, they may provide significant advantages in therapeutic
adjustments. This may include the detection and assessment of critical situations more
easily, thus allowing more proactive interventions [3].
As the Intensive Care Unit (ICU) setting is used for treatment and monitoring of possibly
life-threatening conditions and stabilization of critically ill patients, many technically
advanced medical devices and a high level of monitoring is already present, providing
a unique opportunity for revolutionizing critical care [7]. Moreover, given that the ICU
is one of the most resource-intensive and expensive hospital areas, further research
and technological advantages for reduction of workload and aiding the delivery of
evidence-based, cost-effective care that may lead to better patient outcome and reduction
of time of stay should actually be a well-established research field even from an economic
standpoint [8]. Yet, whereas the great potential of automation and closed-loop systems for
improving care can clearly be seen, there are still many obstacles and difficulties on the
way towards automated systems.
An important difference to many other industrial and research fields, mainly driven by the
laws of physics and mastered by skilled engineers, is the still present lack of knowledge
regarding the human body and life itself. One difficulty for application of any automation is
the system to be controlled: the human body as a very intricate and multifaceted system [7]
that cannot easily be described by biochemical, physical, or other models. Thus, especially
given such a complex system like the human body, a comprehensive base of knowledge
and interactions for various medical conditions and demographics as a digital foundation
for development of better models and algorithms is essential.
Unfortunately, whereas more and more medical devices are available to collect a multi-
tude of patient information, displayed on the numerous medical devices, especially in the
technologically advanced ICU [7], the majority of displayed information is forever lost as
it cannot be collected and be made available for further processing [9]. This is caused by
the historically independent development and implementation of such systems and medical
devices, additionally performed without a strong focus on further data processing and thus
still lacking standardization and interoperability among them [7, 10, 11].
This problem needs to be addressed as an uttermost important first step as high-resolution
data from a broad variety of vital parameters and devices is a requirement for any fur-
ther processing. Once such information is obtainable and gathered, machine learning and
data mining can be used to transform the collected information into useful data for better
diagnosis, event detection and decision making [12].
Besides those major technical obstacles still present, the problem of data abundance must
be considered from a legal perspective, too. Many aspects regarding patient safety and the
certification of medical devices and computer systems that might be able to collect such data
in the first place are a further limiting factor. And additionally, once data can be collected,
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legal limitations considering patient rights and privacy aspects of clinical patient data as
well as many unresolved questions regarding liabilities by using automated systems, even
beyond the scope of clinical decision making, must be addressed.
Another mainly non-technical but not less important aspect needs to be considered when
dealing with the idea of automated systems and closed-loop therapies: Acceptance of such
novel approaches might be highly impaired by generating a feeling or even fear of being
replaced in caregivers. Additionally, given an automated system, even including patient-
specific adaptive algorithms, applied to each patient in the same way, a contradiction be-
tween such a generalized approach and the philosophy of individualized care to best of
knowledge by physicians and caregivers may arise on first sight. To achieve acceptance for
this novel technology, such aspects should be considered and addressed, providing a helpful
tool aiding the caregivers, still allowing flexibilities and adaptions, but not forcing them to
decisions that might contradict their expertise and critical thinking [1].
Yet, despite all those limiting factors, obtaining a substantial data base and practical eval-
uation of different approaches are essential first steps for further advantages regarding the
reduction of workload and application of machine-learning and closed-loop systems for
better patient care in the clinical environment that need to be performed for developing
the future of medicine and critical care. Furthermore, such fundamental first steps might
allow to evaluate approaches that will help to establish concepts accepted by the medical
community and provide a foundation for legal considerations outlining possibilities and
risks that need to be weighted against each other.
Given the outlined significant legal obstacles regarding development of new medical devices
and collection of patient data, one way of collecting knowledge applicable to humans is by
using appropriate animal models in a first step. With such studies, fundamental knowledge
regarding automated systems and the interaction with the caregivers may be developed and
evaluated prior to further clinical trials. However, such studies should always be performed
in a way to gather and preserve all available information and knowledge, thus limiting
animal harm and the required number of animal subjects. Therefore, instead of directly
developing individual therapeutic systems and concepts with limited and often still man-
ually performed data collection for only few required parameters, fundamental questions
regarding the future of medicine with the interconnection of medical devices should as well
be solved for studies involving animals in such a first step. Once given information stored
in a central, digital database, this information may then be used for further analysis and the
development of advanced models that may improve patient care and reduce the need for
further animal studies as the already gathered knowledge might be usable and sufficient for
the evaluation of other or more in-depth research questions asked in the future.
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1.2 Outline of the thesis
The thesis is divided in several parts. Starting with Part I, a general introduction to the
relevant medical and computer science backgrounds is given. Thereafter, an overview of
relevant and related research with a summary of the state of the art is presented.
Next, an overview of the conducted clinical studies performed at the University Hospi-
tal Tübingen (UKT) is presented in Part II. As the presented studies were not especially
designed or solely carried out for the scope of this thesis but instead are part of ongoing
clinical research, those study details are presented as a background chapter to provide the
available clinical framework and setting. The conducted studies provided the working base
for the development of different automated solutions and applications described in sub-
sequent parts of this thesis. Yet, development of the framework and automated solutions
was of course interlinked with the progress of the clinical studies to improve and stabilize
study conditions and enhance therapeutic treatments to obtainable more reliable results for
clinical research.
For collection of data in the used experimental clinical setting, a framework for device
interaction and information gathering has been developed as an essential part of this thesis
and provided the foundation for closed-loop applications and machine learning. Part III
of this thesis describes the framework’s technical aspects with its requirements, functional
concepts, design, and implementation. Furthermore, the results of the successful application
of the framework during the conducted clinical studies are presented from a technical,
framework-based perspective, including the number and variety of collected parameters
and the framework performance as a general overview without a clinical focus or going into
detail of specific applications, which are described in subsequent chapters.
Following the general description of the framework, Part IV presents its clinical application
for specific tasks within the experimental study context, consisting of individual closed-
loop systems presented with their clinical motivation, used methods, implementation, and
the obtained results. Given the clinical context of the conducted studies, the presented
applications were chosen to stabilize the study conditions for the clinical research questions
by improving maintenance of hemo- and homeostasis and solving practical problems to
reduce workload and human error potentials.
Besides the closed-loop systems directly interacting with the animal subjects and influenc-
ing homeostasis, retrospective analysis of the collected data was performed and is presented
in Part V. As closed-loop systems based on measured blood gas parameters were relevant
for homeostasis management, prolonged measurement intervals provided a major limitation
for the adaption frequency. Therefore, retrospective analysis on the collected parameters
focused on the automated detection of blood withdrawal timepoints to reduce the influence
of measurement delays. Given a matched set of parameters within the time domain, this
allowed for the evaluation of surrogate parameters that might allow a faster adaption fre-
quency of the closed-loop systems by including more frequently available parameters from
patient monitoring instead of relying solely on the BGA results, thus potentially improving
homeostasis management.
Finally, this thesis concludes with an overall discussion about automated intensive care
systems and an outlook for future research with possible applications in Part VI.
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2 Background & Fundamentals
To provide a fundamental understanding for readers of different backgrounds, a brief in-
troduction to the relevant basics of the medical and computer science domains should be
given. First, the clinical background with its terminology, the overall clinical setting with
the used devices and a general understanding of human physiology and therapeutic mea-
surements is provided. Then, a brief overview of the fundamentals of animal studies and the
porcine surrogate model with a comparison of the most important vital parameters to the
human physiology is given. Subsequently, the computer science background with general
definitions and fundamentals, fuzzy logic and methods of statistics and machine learning is
outlined.
2.1 Medical Background
In this first section of the introduction, a brief overview of the medical background and
terminology used within this thesis, including introductions to the medical setting, devices,
drugs, and study model will be given. However, besides technical and physiological aspects,
another important aspect needs to be considered and should become clear alongside the in-
troduction of devices and procedures: The medical staff, caring for the critically ill patients,
often having several responsibilities and high workload.
2.1.1 Hospital Setting
Within the hospital, Operating Rooms (ORs) and Intensive Care Units (ICUs) are settings
for dealing with patients in critical conditions. Whereas the OR is used for surgical interven-
tions and procedures, the ICU is used for life-saving treatments and stabilization of acutely
ill patients using technologically advanced systems [7]. Evolved by the increased need for
intensive monitoring of such ill patients and improved patient outcomes, close monitoring
and treatment in specialized units for critical care medicine (CCM) has been established
since the first quarter of the 20th century, inter alia due to polio epidemics [7, 8, 13]. ICUs
in the US alone account for roughly $80 billion dollars, over 13% of total hospital costs or
about 4% of US health expenditures [7, 14]. Such a high level of patient care can only be
achieved by a broad variety of advanced medical devices and procedures, which are steadily
improved by ongoing research allowing the treatment of increasingly ill patients [8]. As
those devices are an important aspect of care, a brief introduction to those technologies,
devices and procedures is given in the following sections.
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2.1.2 Medical Devices and Systems
In the Operating Room (OR) and Intensive Care Unit (ICU) settings, a broad variety of
special devices, some illustrated in Figure 2.1, is required to provide an adequate support
for critically patients during their surgical interventions or the recovery phase. For the U.S.
market alone, over 200,000 medical devices were registered by the U.S. Food and Drug
Administration (FDA) in 2007 [10]. Whereas most medical devices provide interfaces for
data access and export, development was most often performed independently with a lack
of standardization. Thus, interoperability of those devices is limited [7, 10]. Hence, the
large volume of data that can be collected from those devices cannot be thought of as an
entity but a cluster of individual data management and recording system in a heterogeneous
landscape [7]. Integration of this data is a costly and non-trivial process, requiring well-
defined standards among many devices of competitive manufacturers [7]. Besides the data
collection and monitoring, experimental devices might be equipped with additional remote-
control capabilities, exceeding the current legal limits for such medical products and thus
only usable in experimental settings. To provide a general understanding of the devices
and procedures, mentioned and used in the further course of this thesis, this section aims
at giving a brief overview of the most important devices for patient monitoring, breathing-
support, drug infusions and laboratory analysis.
60
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Figure 2.1: Illustration of different medical devices used for patient monitoring, laboratory
analysis and therapeutic managements.
2.1.2.1 Patient monitoring
Patient monitoring is required to observe patient’s vital signs with the help of specialized
devices, collecting and presenting the measured information on a bedside screen. The most
generally known device is a patient monitor used to monitor vital signs like oxygen satu-
ration, heart rate, blood pressure, electrocardiogram (ECG), temperature, and potentially
many other more specialized parameters. The obtainable parameters are highly dependent
on the individual patient’s monitoring requirement and the availability of equipment within
the hospital ward. The most essential measurements like the blood oxygen saturation and
hearth rate were already establish in ICUs in the 1980s [7]. Nowadays, ECG is a stan-
dard measure but further analysis of the heart’s performance, complexes and characteristics
within the measured wave depend on the features of specific device [7]. To obtain informa-
tion about arterial blood pressure (ABP) and central venous pressure (CVP), specialized
catheters are used. Those catheters are inserted in central arterial and venous blood vessels,
respectively, and connected to pressurized fluid bags with in-line pressure sensors to obtain
measurements of a standing fluid pillar that can be displayed on the patient monitor.
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2.1.2.2 Ventilation devices
Mechanical ventilation devices are used for artificial ventilation of a patient’s lung if they
cannot breathe naturally [15]. This, for example, is the case in a fully sedated patient, where
muscle relaxants prohibit voluntarily movements including breathing efforts. To deliver the
required air or even pure oxygen and ventilate the lungs, ventilators are most commonly
connected to a tracheal tube, inserted through the patient’s mouth to provide access to the
airways.
In ICUs, ventilators were one of the first established support devices [13]. Whereas ventila-
tion was initially based solely on pneumatic or gas driven processes, developments during
almost 100 years have led to sophisticated designs. By utilizing embedded computers and
microprocessors to electronically control servo valves and transducers and for measurement
of various volumes and pressures among many other parameters, device performance and
settings are constantly monitored to maintain the desired state and report any errors or
malfunctions [7, 15].
Breathing itself consists mainly of two phases: an inspiratory phase and an expiratory phase,
whereas in the first phase, the lungs are inflated and in the second one deflated. The amount
of air moved during such a breath is called the tidal volume (TV) [15]. The number of
breaths observed within a minute is called the respiratory rate (RR). By multiplication of
this rate with the TV, the minute volume (MV) can be calculated [15]. During general anes-
thesia and other conditions, where no self-breathing of the patient is possible, mechanical
ventilation is performed in a mandatory mode, forcing the patient to breath in a specific
way. To prevent the lung’s alveoli from collapsing during the expiratory phase, a Positive
End-Expiratory Pressure (PEEP), can be used to retain a therapist-defined pressure level
within the lungs at the end of expiration cycle [15].
Included within the long and differentiated developments of ventilation support, two rather
distinct modes for mandatory breathing evolved: The first, pressure controlled ventilation, is
a mandatory mode giving rise to a defined inspiratory airway pressure. The second, volume
controlled ventilation, delivers a specific TV during inspiratory phase. Both modes try to
achieve the desired pressure or volume independently of patient’s airway resistance or other
restricting factors, respectively [15, 16].
2.1.2.3 Infusion Pumps
Infusion pumps are used for a controlled administering of drugs. As many different medica-
tions may be needed, multiple infusion pumps are often arranged in pillars. Administering of
the infusions to the patient is performed through an intravenous (IV) access with defined in-
fusion rate sets at the individual infusion pumps. This intravenous (IV) administering allows
a rapid distribution of substances and continuous drug therapy through the blood stream.
As the circulatory system is the body’s primary pathway for distribution and exchange, pro-
viding a complete circulation within 60 seconds in healthy adults, IV administering become
the mode of choice in clinical care. To perform the infusion, pumps generate an active flow
to push fluids through the IV access into the patient’s blood stream. This is performed with
high accurate over a wide range of infusion rates that can reach up to 1000 mL/h. Mainly,
two specific types of infusion pumps can be distinguished: Pumps using infusion lines to
connect to bags or bottles and pumps with inserted syringes. When using infusion lines
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for connection to fluid reservoirs, sensors for counting fluid drops passing through a drop
chamber are often used for automated recalibration and monitoring of the desired flow rate.
To move the fluid within the infusion line and provide positive pressure, linear peristaltic
pumps using an array of cam-driven actuators are used on a short segment of the infusion
line to provide a sinusoidal wave motion, thus forcing the fluid toward the patient’s IV
access. Syringe pumps employ a syringe as a fluid reservoir and administer its content by
linear advancement of the syringe plunger with a motor and precision gears [15].
2.1.2.4 Blood gas analyzer
The blood gas analyzer is a device used to perform a BGA by measuring the composition
of blood samples using a set of electrodes and other measurement units. It utilizes solutions
with defined compositions as well as different gases for measurement and flushing. Analysis
itself is performed by transportation of the aspirated blood sample through an arrangement
of tubes, passing sensor arrays of measurement electrodes.
2.1.2.5 PiCCO system and measurement
The stroke volume (SV) and cardiac output (CO) are important cardiological measurement
obtainable by using specific aortic flow probes. Based on this measurement, the difference of
SV between inspiratory and expiratory ventilation phase, the stroke volume variation (SVV),
as an important hemodynamic parameter can be calculated. To replace the need for such
a specific invasive sensor, systems using a pulse contour analysis and calculation of SVV
and CO were developed [17]. One such a well-established system in Europe is the PiCCO
technology for expanded hemodynamic monitoring [16]. Measurement is performed with
a central venous catheter (CVC) and an arterial catheter. Both catheters are equipped with
thermistors, measuring the blood temperature for analysis with transpulmonary thermodi-
lution. Therefore, a defined amount of cooled infusion fluid can be injected into the CVC,
resulting in a temperature change at the venous and arterial thermistor, whereas the mea-
sured delay in temperature changes is used for calculation of a continuous CO [16]. Besides
the measurement of the CO, additional parameters and continuous estimations, dependent
on the device’s specific algorithms, can be obtained.
2.1.2.6 Clinical systems and information storage
Besides clinical measurement devices, a variety of different systems is used for management
of patient data within the hospital setting. Management of administrative data from patients,
like demographic, location or billing information from several departments is normally
stored using hospital information systems (HIS) [15]. On contrary, clinical information
systems (CIS) are used for management of the clinical and nursing needs of the patient [15].
Beside those two, more technical and administrative systems, the clinical patient record
(CPR), also called electronic health record (EHR), is used for storing the patient’s vital
data and measurements [15]. Digital data within the CPR can then be used by clinical
decision support systems (CDSSs), which are computer-systems aiding physicians’ decision
making [15].
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2.1.2.7 Legal framework & clinical requirements
Given the technical progress in other industrial fields and the great potential for improve-
ment in healthcare, the development of novel medical devices with more advanced features
and improved therapies is an ongoing task and challenge. Yet, technical possibilities and ad-
vantages are only one side of the coin during development. Due to high safety requirements
and responsibilities of the individual devices, a large legal framework shapes the other side.
Of course, even used software and algorithms are often to be classified as a medical device
and therefore must satisfy the specific regulations regarding their application and functional
characteristics. This classification is graded by assessment of the risk for human harm, pro-
viding a variety of applicable restrictions regarding the risk level [6]. Explicitly stated by
current European legislation, electronic systems and software shall be designed to ensure re-
peatability, reliability and performance [18, p. 17.1.]. Therefore, the general functionality of
all parts, formulation and composition, namely including the software, shall be represented
by diagrams and drawings, to aid understanding of the underlying mechanism [18, Annex
2 1.1(j)]. Given this legal framework, many advanced machine learning approaches cannot
directly be applied to the medical sector, as the obtained results and knowledge is hidden
within a black box and often cannot be comprehended to fulfill such legal requirements.
2.1.3 Patient management
Within the given critical care environment and the presented essential devices, critical care
for the patient can be provided. This care can be categorized in different aspects, which
are briefly introduced to provide the essential context for aspects of automation regarding
hemo- and homeostasis management to stabilize the animal subjects that will be presented
in further parts of this thesis.
2.1.3.1 Anaesthesia management
Anaesthesia can be provided as local or general anesthesia (GA). Whereas local anaesthesia
is used for pain reduction (analgesia) on specific regions on the body, GA is further used
to induce patient’s unconscious (hypnosis) and loss of memory (amnesia) in a reversible,
controlled manner [8]. This is achieved through special anaesthetic drugs binding to specific
receptors throughout the brain, brainstem, and spinal cord and thus interfering with neural
signal processing [8]. Such anaesthetic agents can be administered through gas inhalation
or as total intravenous anesthesia (TIVA) with a combination of drugs like fentanyl, mi-
dazolam and ketamine. Beside patient’s unconscious, general anesthesia is used to induce
immobility by muscle paralysis to inhibit patient’s response during surgical procedures [8].
This inhibition of voluntary and involuntary body response is also an important factor for es-
tablishing mechanical ventilation with endotracheal intubation [8]. However, by inhibiting
pain and muscular responses, patient’s brainstem may still react to stimuli with increased
ABP, heart rate (HR) and RR [8]. Therefore, monitoring of the patient’s HR, RR, pressures
and oxygen saturation is mandatory during GA [8].
2.1.3.2 Respiratory management
Respiratory management is the task to maintain gas exchange and avert critical conditions.
Those may include, hypo- and hypercapnia, with critically decreased and increased CO2
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levels in the blood gases, respectively, or similar conditions regarding the oxygen saturation
(hypo- and hyperoxemia). This goal can inter alia be achieved by adaptions of the oxygen
saturation or the MV, depending on the ventilation mode defined by RR, PEEP and Peak
Inspiratory Pressure (PIP). An important aspect of management is to keep the lungs inflated
and avoid collapsing by maintaining positive pressures. Yet, increased pressures should be
avoided as they can damage the lungs and impede weaning from mechanical ventilation.
2.1.3.3 Hemodynamic management
Hemodynamic management is the process of maintaining stable conditions regarding the
blood circulation by hemodynamic monitoring. This involves observation and control of
blood pressure (BP), e.g., to avoid hypo- and hypertension, and monitoring of CO and the
overall intravascular fluid content to detect and avoid hyper- or hypovolemia.
2.1.3.4 Homeostasis management
For management of the balance of the biochemical body functions, homeostasis, a broad
variety of parameters needs to be observed and kept within the physiological ranges. The
blood pH value is one of the most important parameters to be kept within a nominal range
of 7.35 to 7.45 [8]. Only within this range, essential vital functions like metabolism and
oxygen transport for cellular perfusion can be maintained [8]. Acid-base balance and the
resulting pH value is challenged by a broad variety of metabolic processes altering the acid
and alkali composition within the body. However, a healthy body is able to compensate
this fluctuations by means like buffering hydrogen ions (H+) in the blood and elimination
thereof through CO2 exhalation by the lungs through adaption of RR and MV or excretion
within urine by the kidneys [8, 16]. For this buffering system to work, electrolytes like
calcium, chloride, magnesium, potassium and sodium are essential and need to be main-
tained within defined ranges. Restriction of the body’s abilities to achieve this goal, often
caused by respiratory or metabolic complications lead to conditions known as acidosis and
alkalosis, resulting in a decreased (acidemia) or increased (alkalemia) pH, respectively [8].
In critical care, were medical conditions often substantially prohibit the body’s own abili-
ties, recovery and maintaining a balanced state is in general aided by periodical BGA and
administering a variety of IV buffering solutions with additives of the required electrolytes.
Thus, considering automated solutions for homeostasis management, these different buffer-
ing solutions play an important role. A brief overview of the individual electrolytes and
metabolic conditions is given in the following sections.
2.1.3.4.1 Sodium and natremia Sodium (Na+) is one of the most important electrolytes.
Disruptions of physiological levels caused by loss of water through the kidneys or thirst as
well as administering of hypertonic solutions can lead to hyponateremia [8]. On contrary,
significantly increased levels are termed hypernateremia.
2.1.3.4.2 Potassium and kalemia Perturbations in the extracellular potassium (K+) lev-
els may need to be treated to prevent conditions that may have lethal consequences. A sig-
nificantly increased potassium level (hyperkalemia) may cause severe cardiac disorders [8].
On contrary, reduced levels of potassium (hypokalemia) may be the result of severe diuresis
and may cause cardiac arrhythmia, too [8].
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2.1.3.4.3 Calcium and calcemia Dissolved calcium (Ca2+) is another important elec-
trolyte that needs to be monitored to prevent cardiac complications. Increased levels of
calcium (hypercalcemia) can be observed by a shortened QT interval in ECG measure-
ments [8] and with BGA. Alkalosis may be caused by lack of calcium (hypocalcemia) and
needs to be treated with calcium supplementation among other therapeutic measures [8].
2.1.3.4.4 Metabolic acidosis and alkalosis Changes in the measured pH caused by var-
ious changes in metabolic processes are called metabolic acidosis and alkalosis, leading
to accumulation H+ or a loss of HCO3- in acidosis or vise versa for alkalosis. Primary
metabolic acidosis is characterized by an arterial pH < 7.35 and a concentration of HCO3-
< 22mEq/L. On contrary, alkalosis is diagnosed if pH > 7.45 and HCO3- > 26mEq/L [8].
Causes for alkalosis include hypokalemia, hypomagnesemia, chlorine deficit as well as ex-
tracellular volume depletion (hypovolemia), e.g., due to use of diuretics [8, 16]. Acidosis on
the other hand may be caused by increased chlorine levels, hypoglycemia or other general
causes that disturb the acid-base balance like hypovolemia. BGA is therefore an essential
tool for correct assessment of the present condition and underlying causes.
2.1.3.4.5 Respiratory acidosis and alkalosis Critical changes in the pH level due to
respiratory causes are called respiratory acidosis if the pH level of the blood is decreased
or increased respectively and changes in the partial CO2 pressure are observed. Respiratory
acidosis is defined a pH < 7.35 and a measured partial CO2 pressure level above 44 mmHg,
whereas the alkalosis condition is defined as pH > 7.45 and CO2 below 36 mmHg [8]. As an
increased CO2 level decreases the pH, the measured partial CO2 pressure is a representation
of the balance between the body’s CO2 production and exhalation [8]. Increased respiration
rates are a cause for respiratory alkalosis, whereas low RRs or airway obstructions can lead
to respiratory acidosis [8]. Management of RR and monitoring of the partial CO2 pressures
are therefore an important therapeutic aspect as a precaution and for treatment of these
conditions.
2.1.3.5 Glucose management
The blood sugar level can be measured with BGA or other specific tests. In critically ill
patients, injuries can introduce increase glucose levels (hyperglycemia) due to inflammatory
or hormonal processes. This may increase the risks of infection and influence patient out-
come. Target levels of 80 mg/dL–110 mg/dL are desired, but a drop in glucose levels below
this range can easily result in life-threatening hypoglycemia. Therefore, in clinical prac-
tice safer levels of 140 mg/dL–180 mg/dL are often accepted as levels below 140 mg/dL
require tight control and active management [8].
2.1.3.6 Anti-coagulation management
The balance of blood thickness and clotting characteristics is another important aspect of
intensive care. In hospitalized patients, which are often bedded for an extensive period of
time, the risk of thromboses or other clotting incidents is drastically increased. An effec-
tive method to reduce this risk is the management of clotting factors within the patient’s
blood. Unfortunately, whereas reducing the clotting risk is solving one serious medical
complication, it is facilitating another: By reduction of the blood’s ability to clot, the risk
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of life-threatening internal bleeding is increased. Therefore, clotting factors cannot arbitrar-
ily be reduced, but must be managed carefully as a tradeoff between the risks of internal
bleeding and thrombosis. This can be performed by regular measurements of the current
coagulation state and appropriate adaptions. Besides laboratory analysis taking a significant
amount of time, assessment can be performed with significantly faster POC tests. Regard-
ing to coagulation, measurement of activated clotting time (ACT) is the most commonly
used bedside test, whereas the activated partial thrombin time (APTT) is a well-established
laboratory analysis [1]. The ACT test, first described by Hattersley in 1966 [19], is a whole-
blood coagulation test based on clotting through the activation of the intrinsic pathway of
the coagulation cascade involving fibrinogen, platelets and red blood cells [1, 20]. Measure-
ment is performed by adding a blood sample to a sample tube containing an activator agent
to increases clotting speed and measuring the required time to achieve clotting [1]. Given
the measured ACT results, therapeutic action can be taken by administering of unfraction-
ated heparin to decrease clotting as the long standing standard drug for anticoagulation
management [1, 21].
2.1.3.7 Temperature management
Management of patient temperature should be seen as an important part of the overall inten-
sive care strategy. As a goal-directed approach, targeted temperature management (TTM)
defined by a therapeutic temperature profile may be used [22]. Yet, temperature is often
not regularly checked in perioperative settings [23] and, given the overall workload, only
performed as a subsidiary task besides the other goals. Assessment of patient temperature
can be performed by a variety of different methods, including measurements on the skin,
oral, rectal or with temperature sensors included in catheters that are inserted into blad-
der or blood vessels [24, 25]. In general, a normal body temperature (normothermia) of
36.5 ◦C–37.5 ◦C [26] should be kept. If the body temperature exceeds this nominal range an
increased body temperature (hyperthermia) due to fever or other responses, or hypothermia
due to heat loss can be observed. This loss is caused by radiation, conduction, convec-
tion and evaporation [25]. Especially under GA, this auto-regulation of the body can be
impaired. Drugs may have vasodilating effects, leading to a dilation of blood vessels and
redistribution of the body heat to the surface, causing additional heat loss. This can lead
to a decrease of body temperature by 0.5 ◦C–1.5 ◦C within the first 30 minutes of an op-
eration [27, 28] and may continue attenuated for up to three to five hours [28, 29]. This
perioperative heat loss is linked to prolonged length of stay as well as an increased patient
mortality rate [30]. It may cause nausea [31] and lead to cardiac events like arrhythmia and
heart attacks [32], coagulopathy, increased transfusion requirements [33, 34] and effective
duration of anesthetics [35], a higher risk of wound infections [36] and even promote pres-
sure ulcers [37]. Furthermore, changes in the serum K+ concentration [37] and reduction of
the subcutaneous oxygen partial pressure [27] have been observed and linked to hypother-
mia. However, besides the general goal of maintaining normothermia, in some medical
conditions like traumatic brain injuries a reduction of body head and slowed down body
functions can reduce intercranial pressure (ICP) in the patient’s head which has been shown
to be beneficial for patient outcome [38].
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2.1.4 Lab Practices and medical workflows
2.1.4.1 Arterial and venous accesses, measurements and blood withdrawal
To obtain a reliable way of administering medications and collecting blood samples, access
to large and central blood vessels needs to be established [16]. An arterial access is mainly
used for obtaining arterial blood samples for analysis, whereas venous accesses are used
for administering of the various required drugs. To provide enough throughput for the
often various and simultaneously required infusions, venous catheters with multiple lumen
(individual tubes within a single catheter) are used. Additionally, these separate channels
prohibit mixing of the different infusions prior to reaching the blood vessel, which might
cause undesired effects or complications like clotting or flocculation. Those multi-luminal
CVC have a length of about 15 cm–30 cm [16] and are advanced within the venous blood
vessel to be positioned close to the heart.
To provide access for blood withdrawals and control of blood and infusion flows through the
catheters, three-way taps are used. Those valves can be arranged in different configurations
to route the fluid flow between each possible combination or to block it. Due to clotting
effects of blood, which may accumulate within the catheter and three-way taps, throughput
may be reduced, rendering drug administering and measurements inaccurate or impossible.
To prohibit such problems and maintain the access, flushing of the catheter with a sterile
solution may be required infrequently when indicated.
2.1.4.1.1 Seldinger technique The so called Seldinger technique is a method for inser-
tion of catheters into blood vessels. First, a sharp, hollow needle is inserted into the blood
vessel, often guided by ultrasound. Second, a guidewire is inserted into the hollow needle,
which is removed once the wire is in place. Next, the catheter to be inserted is passed
over the guidewire into the blood vessel. Last, the guidewire is removed through the in-
serted catheter, which is then fixated in place to maintain the established access [16]. This
method allows a minimal invasive establishment of an arterial or venous access, minimizing
infection risk and complications.
2.1.4.1.2 Blood withdrawal process Blood withdrawals can be performed through the
established venous and arterial accesses. Therefore, a small amount of blood is withdrawn
with a syringe from the installed three-way tap to remove residual, non-representative
blood from the catheter. Then, a small heparinized syringe or a laboratory adapter and
a blood collection tube is connected and the blood sample is withdrawn. Heparinization
is used to inhibit blood coagulation of the blood sample, e.g., for BGA, whereas specific
blood collection tubes with additives are used for various laboratory blood analyses. After
successful sampling, the catheter needs to be flushed to avoid clotting of residual blood
within the catheter.
2.1.4.2 Blood analysis
Given the previously described accesses to a patient’s arterial and venous system and the
general method of withdrawal, collected blood samples can be used for different laboratory
analyses. BGA is a first, regularly performed analysis for many important parameters. Lab-
oratory analysis provides additional information about the initial patient state and progress
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by in-depth analysis of collected blood samples with methods not covered by the fast per-
formable BGA.
2.1.4.2.1 Blood gas analysis blood gas analysis (BGA) is an important measurement
to obtain information about oxygen partial pressure (pO2), carbon dioxide partial pressure
(pCO2), pH, dissolved electrolytes like Na+, K+, Ca2+ and blood sugar as well as hemoglobin
levels. Given this broad spectrum of obtained parameters, BGA is the most ordered test for
patients in intensive care. It is frequently performed to allow diagnosis and management of
respiratory and metabolic problems like acid-base disturbances and assessment of sufficient
gas exchange and oxygen delivery [8, 15].
2.1.5 Caregivers’ tasks and workload
For maintaining the high medical standards and providing the necessary care for critically
ill patients, caregivers like physicians and nurses have to provide optimal care by using
the presented subset of medical devices and protocols to prevent the mentioned critical
conditions. Additionally, due to the patient’s condition, this care must often be performed
as a time-critical task. Whereas ICUs in general have an increased number of caregivers
compared to other hospital wards, where understaffing is a more severe problem [7], time
management and high workload are often a relevant and burdensome factor for caregivers
to achieve the therapeutic goals. Given the many devices and protocols, stress and large
amounts of information in the ICU environment may lead to errors despite many efforts to
improve communication and information transfer with checklists, protocols and by other
means [8]. However, while guiding care and reducing errors, workload is further increased
and many manual tasks like collection of blood samples, adapting rates for infusion pumps
or managing therapeutic anticoagulation with often still handwritten protocols and process-
ing steps remain.
2.1.6 Drugs and Infusions
Most drugs on the ICU or within the OR are administered by IV infusion. They are used for
management of anesthesia or to provide supplementary fluids and electrolytes for therapeu-
tic purposes or account for blood loss. Ready to use infusions are most often provided in
glass bottles or flexible plastic bags that are placed bedside and administered using infusion
pumps. Other pharmaceuticals and fluids, are often drawn up with a syringe from small
glass bottles or ampules and administered in a defined dilution using the same means. If
they don’t have to be administered continuously or need to be provided as a bolus at once,
injection is often performed directly by hand.
2.1.6.1 Drug overview
Concerning the scope and focus of this thesis, only a short and general overview regarding
the names and potential effects of the used and mentioned drugs can be given.
Regarding more specific and reliable information about applications, potential contradic-
tions and other important aspects, please refer to medical and pharmaceutical literature.
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Artrenol (Norepinephrine) causes vasoconstrictions, narrowing of the blood vessels,
therefore increasing blood pressure [39, DB00368].
Atropine is a naturally occurring belladonna alkaloid used as an anti-parasympathetic
drug, increasing heart rate and counteracting parasympathomimetic drugs [39,
DB00572].
CaCl (Calcium chloride) is used as a diluted infusion solution for homeostasis man-
agement and treatment of critical conditions like hypokalemia [39, DB01164]
Fentanyl is a synthetic opioid processed in the hepatic metabolism that can be adminis-
tered via IV infusion. It is used for analgesia and sedation, causing increased
pain tolerance while decreasing the perception of suffering. It depresses the
respiratory and cough reflex, reduces heart rate (HR) and causes urinary reten-
tion [39, DB00813][8].
Furosemid (Lasix TM) is used as a diuretic, promoting the voiding of urine by inhibition
of water re-absorption within the kidneys [39, DB00695].
Glucose is used in solution as an IV infusion to manage the blood glucose level, as
an obligatory energy source [39, DB09341]. The different dilutions are often
incorporated in the infusion solution name, therefore G20 refers to a 20%
glucose solution.
Heparin (unfractionated) is used as a prophylaxis of venous thrombosis and pulmonary
embolisms by inhibiting clotting of the whole blood. Therefore, it is also used
for preserving blood samples for several laboratory analyses [39, DB01109].
Jonosteril
TM
is the trade name of an infusion solution marketed by Fresenius, providing
fluid and electrolytes in balanced and acidic conditions [40].
KCl (potassium chloride) is used in dilution for homeostasis and ion-concentration
management [39, DB00761].
Ketamine is a general anesthetic that can be administered via IV infusion and is processed
in the hepatic metabolism. It is not a skeletal muscle relaxant and may cause
hallucinations and increase HR and BP among other effects [39, DB01221][8].
Midazolam is a benzodiazepine used for depression of the central nervous system (CNS)
that is processed by the hepatic metabolism and can be administered via IV
infusion. It is used for sedation and amnesia, acting as relaxant and anti-seizure
drug [39][DB00683][8].
NaBic (Sodium bicarbonate) is used in solution as a buffering agent for treatment of
metabolic acidosis, which may be caused by circulatory insufficiency, shock
or severe dehydration [39, DB01390].
NaCl (Sodium chloride) is used in isotonic watery solution as a source for elec-
trolytes and water while maintaining the intra- and extracellular osmotic bal-
ance. Additionally, it is often used as the foundation for dissolving and diluting
other pharmaceutical additives [39, DB09153].
Propofol is a sedative-hypnotic agent and can be used for introduction of general anes-
thesia with a rapid onset of hypnosis about 40 seconds after injection [39,
DB00818].
Tris (Tris(hydroxymethyl)aminomethane, THAM) [39, DB03754] is used as a
buffering infusion for treatment of metabolic acidosis.
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2.1.7 Common units of measurement
Within the medical context of this thesis, several parameters using different units of mea-
surement will be discussed. To provide a basic understanding of the relevant and often
non-SI units for measurements, a brief overview is given in Table 2.1.
Table 2.1: Brief overview of common units for measurements within the medical context.
Unit Description
mmol/L, µmol/L Molar concentrations of substances
mmHg millimeter mercury pillar
common pressures unit for fluids (e.g., blood pressures)
mbar millibar
common pressures unit for gasses (e.g., ventilator)
U, IU International Unit (IU),
used for defined pharmaceutical doses
U/kg Unit per kilogram,
used for doses related to patient weight
U/kg/h like above, with
time relation for continuous administering
1/min, bpm beats or events per minute
e.g., heart or respiratory rates
kgBW kilogram body-weight
used for describing relations to body weight in kg
2.1.8 Animal Studies and Porcine Model
Animal studies may be used and required if the understanding of a specific problem is
not sufficient enough for study on humans and no other means like sufficient models for
simulation can be used. In a well-defined study setting, scientific research to gain a better
understanding of the problem, for example, regarding critical conditions that might be rare in
human patients but essential for understanding of biochemical properties can be performed.
Additionally, clinical methods and devices may need to be tested prior to or as a certification
for human application.
2.1.8.1 The three Rs
In 1959, a time where animal welfare regulations did not yet exist in most countries [41], the
pioneering publication by Russell and Burch [42] proposed three fundamental principles
for the handling and use of animals in scientific research — Replacement, Reduction and
Refinement. Whereas in short but not concluding Replacement aims to avoid animal studies
whenever alternative models or methods are available, Reduction should be performed to
limit the amount of animal studies to the necessary amount for providing significant results
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and minimize the suffering. And, last but not least, Refinement should be done to improve
methods and study protocols to further limit the amount and burden of animal subjects
during such studies.
These principles, nowadays well known among researchers and protectors of animal
rights [43], became an essential part of scientific ethics and legislation, including directives
and regulations by the EU [44] and the European Laboratory Animal Science Associations
(FELASA). Regarding detailed interpretation and implementations, controversial opinions
exist. It is up to ethics debate if reduction of total number of used animals or relative reduc-
tion by gaining more knowledge from a single animal is a desirable goal [43]. Stated as first
and most important principle by Russell and Burch, replacement should be the uppermost
goal regarding animal studies, however full replacement of animals is not yet possible for
all scientific aspects and stated as a long-term objective by EU directives [44].
2.1.8.2 Porcine surrogate model
Whereas traditional biomedical models, like Drosophila, zebra fish and rodents, are well
suited for basic genetic studies or analyzing individual effects, they often cannot represent
the complexity of a more general physiological model [45] or are not applicable to devices
and procedures designed for humans. In such cases other models are required.
Swine, especially young pigs with body weights of 30 to 40 kg, are one such alternative
and frequently used for medical training and research [46]. They provide many anatomical
and functional similarities to humans, including aspects like physiology, immune system
and disease progression, especially in metabolic and infections conditions, and are good
models for the cardiovascular, urinary and digestive system as well as wound healing [45–
49]. Furthermore, they are accepted as general surgical model in many areas of biomedical
and "‘-omics"’ research [45, 50, 51]. Porcine studies allow for investigations related to
potential treatments and preventions strategies for many human diseases and conditions in a
rigorously controlled setting [52] as nearly every medical procedure can be performed [49].
Thus, such models are approved for preclinical evaluations regarding biocompatibility and
function of implanted devices for various organs and used for training of techniques that
cannot be adequately simulated using computers or anatomical models [49]. Additionally,
factors like availability, cost and ease of handling play an important role regarding the
choices of animal models [47]. As such factors are beneficial in swine, this has led to a
significant increase in using porcine models as a replacement, e.g., for canine models, in
recent decades [51].
Regarding the scope of this thesis, considering the interconnection of medical device and
development of automated solutions for critical care in humans, the use of medical devices
that are available and approved is favorable. Thus, the used model animal should be com-
patible regarding body size, measured parameters, device settings and medical procedures,
covering aspects like placement of catheters and collection of blood samples. Under these
conditions, a porcine model is well suited and obtained results can easily be transferred
to humans. Thus, female German Landrace (DL) pigs were used in the performed studies,
as DL is the most common domestic breed in Germany [53] and differences as between
domestic farm breeds and miniature breeds often used as models are only related to growth
rate and handling factors, not regarding anatomical differences [49].
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2.1.9 Physiological References
To provide references for assessment of performance for different methods and automations
presented in later chapters, a brief overview of several physiological parameters as a com-
parison between humans and swine is provided in Table 2.2. It can easily be observed that
most human and porcine parameters have similar nominal ranges. Thus, porcine models
provide a good general model for human physiology. The presented porcine references for
the German Landrace (DL) breed are based mainly based on the theses of Kixmöller [53]
and Nebras [54]. For the former, the measured parameters are based on 50 samples of
10 to 12-week-old pigs, whereas the latter performed a more general comparison to other
published references, giving raise to similar results.
Table 2.2: Reference ranges for nominal physiological parameters for humans and surrogate
porcine model at rest.
Parameter human porcine model Unit Sources
low high low high hum.,por.
pH (art) 7.37 7.45 7.45 7.51 - [55],[56]
pH (ven) 7.35 7.43 7.40 7.43 - [55],[57]
pCO2(art) 32 43 37.7 42.3 mmHg [55],[56]
pCO2(ven) 37 50 41.8 49.1 mmHg [55],[57]
O2 (art) 71 104 68 74 mmHg [55],[56]
O2 (ven) 36 44 18.8 39.1 mmHg [55],[57]
K+ 3.5 5.0 4.35 6.87 mmol/L [16],[53]
Na+ 135 147 137 149 mmol/L [16],[53]
Ca2+ 2.2 2.6 2.55 3.27 mmol/L [16],[53]
Cl− 95 105 100.42 110.62 mmol/L [16],[53]
Fe2+ 6.6 29.5 12.49 34.29 µmol/L [55],[53]
Lactate ≤2 0.5 11.0 mmol/L [16],[58]
Glucose 3.9 6.1 3.7 7.3 mmol/L [16],[53]
=̂ 70 100 66.7 131.5 mg/dL [16],[53]
Haemoglobin 12.3 15.3 6.3 8.7 mmol/L [55],[53]
BE −2 3 1.3 5.1 mEq/L [55],[57]
Body temp. 36.5 37.5 38.7 39.8 ◦C [26],[59]
ABPm 106 114 92.7 111.3 mmHg [60],[56]
HR 48 98 70 120 1/min [61],[59]
RR 12 18 17.1 22.9 1/min [62],[56]
TV(lung) ≈500 ≈200 mL [15],[63]
Body Fluid ≈600 ≈600 ml/kgBW [64],[65]
When available, references for women and female DL swine were used.
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2.2.1 Software Architecture
In outlook on Chapter 7, where the developed software framework is described, a few
fundamental concepts and definitions of software architecture used within this description
should briefly be introduced.
Classes and abstract classes
A class is an object definition with object-oriented programming. It can provide encap-
sulated functionality, can contain an internal state and defined interfaces to the outside.
An abstract class is an abstract definition, providing templates or reusable methods. Other
classes realize the abstract objects by implementing the defined methods and using the
provided methods.
Interface
An interface is a definition for the interaction of different program parts. Different classes
can provide a common interface and thus be interchanged. Using interfaces provides clear
separations and defined interactions for different parts of programs.
Plugin
A plugin is an encapsulated part of a program that adds specific features to a base program.
For interaction with a plugin, defined interfaces can be used.
Factory
A factory is an object for creating instances of other objects. For example, a factory can be
used to create instances of objects loaded from dynamic libraries during program run-time.
Smart Pointer
A pointer is a reference to an object within the memory. The allocated space for this object
needs to be freed to be available again. A smart pointer keeps track to the references linking
to this object within the memory and performs automatic deletion of the object once its
reference count reaches zero and it thus is no longer needed and accessible.
2.2.2 Infrastructure and Networking
Besides the terms of software architecture, for understanding the implementation of the soft-
ware framework within a real hardware environment, several more specific terms regarding
network infrastructure and technology need to be explained briefly.
DHCP
The Dynamic Host Configuration Protocol (DHCP) is based on a client-server model
where a DHCP-server allocates IP addresses and configure client hosts by transmitting
host-specific configuration information within a TCP/IP network [66].
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DNS
The Domain Name System (DNS) is a system used for mapping host names to IP addresses
as well as defining name spaces and domains [67–69].
NTP
The Network Time Protocol (NTP) is used to synchronize computer clocks among different
clients using a single timeserver or a chain of local and remote timeservers synchronized to
each other [70].
VLAN
A Virtual Local Area Network (VLAN) is a virtual network within a single physical net-
work. Multiple VLANs can be used independently on a single physical layer, e.g., with a
single Ethernet cable. To allow for such an implementation, the used network infrastruc-
ture, including switches, must support the VLAN infrastructure. Managed switches can be
configured to assign individual network ports to a specific VLAN. Therefore, the client
does not observe any other virtual networks except the designated one. On contrary, the raw
connection, the trunk, can be forwarded to the client. The client’s network card can then
select the specific desired VLAN [71] itself.
Link Aggregation
Link Aggregation or Trunking is a method of combining multiple network connections
to a single logical connection, or a Link Aggregation Group (LAG), therefore increasing
bandwidth and reliability as well as sharing the load between the individual links of the
LAG. It is defined by the most recent IEEE standard 802.1AX-2014, superseding previous
standards for Link Aggregation [72].
Spanning Tree Protocol
The Spanning Tree Protocol (STP) is part of a smart switch infrastructure and used to
prevent loop-backs in Ethernet networks. It is defined in the most recent IEEE standard
802.1D-2014. The original STP and the more recent successor Rapid Spanning Tree Pro-
tocol (RSTP) are used to provide fault tolerance through automated reconfiguration of the
network by finding the fastest link to a client, therefore besides other means, preventing the
creation of network loops that would cause network problems [73].
2.2.3 Qt
Qt [74] is a cross-platform software development framework for embedded and desktop,
based on C++. It is available as a commercial or open-source variant. For the implementa-
tions described within this thesis the open-source variant was used by dynamically linking
the executable files to the Qt libraries [74].
2.2.3.1 Signal-Slot concept
The Qt’s Signal-Slot concept [75] is a fundamental feature of the communication between
different objects within the Qt framework and its meta-object system. The general idea is
to allow a communication between different objects as an alternative to callback functions
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often used by other frameworks. Pre- or user-defined signals can be emitted by an object.
Other objects can register to listen to the emitted Signals by a callback method, the Slot,
which is triggered if a signal is received [75]. Therefore, the Signal-Slot system is a ben-
eficial simplification to the general concept of subscriber patterns, where each object has
to perform the management and processing of information and clients itself. It provides
a good abstraction layer for interaction of different objects or plugins and is used in the
developed medical software framework described within this thesis.
2.2.4 R
The R language and programming environment is managed by the R Project for Statistical
Computing [76] and provides a powerful open-source software for statistical computing
with a broad variety of statistical, analytical and graphical tools for processing and visu-
alization of scientific data [77]. Besides the multitude of integrated features, the program
scope can be further expanded by using the various available libraries for specific problems
and calculations provided by a large active scientific community.
2.2.5 Data formats and Protocols
For storage of the accumulated data, a variety of data formats and protocols may be used.
Besides commonly used and well-known formats like comma-separated values (CSV),
binary or Extensible Markup Language (XML)-encoded files, more specific formats used
for data gathering and processing will briefly be described in the following.
2.2.5.1 HDF5
The HDF Group [78] aims at supporting mission-critical and scientific needs for accumula-
tion of data with open source software since 1989 with the goal of providing technologies
for managing large and complex datasets [78]. The hierarchical data format (HDF), cur-
rently in the most recent version 5, provides a flexible data model for representation of
complex data objects and meta-data in a file-based, portable, platform-independent for-
mat [79]. The HDF5 software library provides an application programming interface (API)
for implementation in a broad variety of programming languages. Its format allows a theo-
retically unlimited file size for the stored data objects and provides a general, hierarchical
data model with a variety of predefined data types and the ability of adding meta-data to
the entries. Additionally, the HDF5 format provides a variety of compression and chunking
strategies to improve the performance of data handling and storage [80]. The HDF5 file
format can be processed with Matlab [81] or in R with the help of the Bioconductor rhdf5
package [82, 83].
2.2.5.2 HL7
Health Level Seven (HL7)[84] is an international non-profit organization founded in 1987
dedicated to providing American National Standards Institute (ANSI) and International Or-
ganization for Standardization (ISO) approved standards for exchange of electronic health
information and most commonly known for their standards regarding data exchange be-
tween medical devices, HL7 Version 2.x [85] and HL7 Version 3 [86]. Whereas Ver-
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sion 3 is based on an XML structure, the most popular and established Version 2 uses a
plain-text format with the pipe or vertical bar character | as a delimiter.
2.2.5.2.1 HL7 message example A reduced example of a message from a BGA is illus-
trated in Figure 2.2. The message header MSH is followed by fields for the device ID, here a
Radiometer ABL835 BGA device. The result is described with the ORU (observation result
section), which first states a patient identification (PID), followed by a variable amount of
observation results (OBX). In this example, the measurement result of the partial CO2 level
in the blood sample is reported as 41.7 mmHg.
Figure 2.2: Example for a message in the HL7 message format in the standardized version 2.
MSH|^~\&|ABL835^A5W - 7|ABL835^A5W - 7|||20141008103105||
ORU^R31|1|P|2.5|||AL|NE||||||
PID|1||ap003||^|||||||||||||||||||||||||||||||||| [...]
OBX|2|ST|^^^pCO2^M||41.7|mmHg||N|||F|||||^||| [...]
2.2.6 PostgreSQL Database
PostgreSQL [87] is an open-source object-relational database, based on the structured query
language (SQL). A relational database is the combination of relational database schemata
and stored information. The used relational schemata specify the attributes and domains
of the individual relations. Information is stored by creating instances of those defined
relations with the desired values [88]. Once the information is stored, specific subsets of
information can be retrieved by querying the database with user-definable requests.
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2.3.1 Handling missing Data
One important aspect in data processing and analysis is the handling of missing data. Espe-
cially in raw data streams, outages of individual devices or measurement errors will result
in gaps within the stream. Such occurrences are often only seen as lost information and an
unfilled gap [89]. Yet, despite being missing information, the absence may be caused by
different reasons, allowing a classification of the type or reason.
2.3.1.1 Types of missing data
In regard to classification of missing data into different types, three distinct entities can
be observed: First, data can be Not Missing At Random (NMAR). This is the case if
the absence of data depends on other factors. Therefore, the absence is not at random
but depending on the current state, related parameters, settings or measurements with a
causal relation to the absence of the measurement [7]. Second, data can be Missing At
Random (MAR). This is the case if absence of data is unrelated to the observation [7].
Third, data can be Missing Completely At Random (MCAR). Reasons for this observation
may be technical failures, breakdowns that are itself completely unpredictable [7].
2.3.1.2 Data processing & imputation
For further processing of a dataset, missing data has to be dealt with. This can be performed
in a variety of ways. In general, two principles are used: masking and data imputation.
Whereas the first approach is used to discard the erroneous sections of the data scream, thus
excluding it from further analysis, the latter one, known as data imputation, tries to calculate
or predict the missing sections with the knowledge of the surrounding data in a variety of
ways. Such methods include mean imputation and (stochastic) regression imputation [90].
Depending on the reason why data is missing, such methods can introduce a bias to further
analysis and only if data is MCAR, data imputation results in unbiased estimates [7, 89].
Yet, another view of the problem is to see the missing observations as its own measurement
outcome. Using this approach, such data points are not discarded, but further processed as
its own type of information [89]. This is especially useful, if data is NMAR, thus having an
underlying cause or reason and knowledge of it may be beneficial for further analysis.
2.3.2 Fuzzy Logic and Fuzzy Controllers
Fuzzy Logic (FL) is a mathematical logic first described and refined for various applications
by L. A. Zadeh [91–95]. On contrary to the well-known binary logic with precise reasoning,
one of the strengths of FL is being more approximate using precise definitions only as
the edge cases [93]. Thus, it is well suited for relationships that cannot easily be modeled,
including vague human assessments [96], and successfully used for process control since
the 1980s [93]. One of the fundamental concepts of FL is establishing a relationship to
linguistic variables for description of states and implications [96].
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2.3.2.1 Fuzzy Sets
The foundation of fuzzy logic is the definition of fuzzy sets that can be seen as an extension
of the well-known ordinary (or crisp) set theory. Like those crisp sets S, a fuzzy set F is a
collection of objects within a domain X = {x}. On contrary to crisp sets, the membership
is not a simple binary decision in fuzzy sets, but defined by a membership function µ,
assigning a grade of membership to the individual elements x in the fuzzy set f . This
graduate membership dissociates fuzzy logic from other multi-variate logic systems with
more precisely and limited grades of memberships [91].
2.3.2.1.1 Fuzzy membership function A membership function µF(x)→ [0,1] is used
to assign a grade of membership of an element x ∈ X in a fuzzy set F within unity. This
general function can be seen as an expansion of the membership in crisp sets, where only
the binary mapping fS(x)→ {0,1} is allowed. The membership function µF(x) itself is
completely non-statistical but has similarities to a probability or density function and often
is derived from empirical observations to assign grades of membership based on statistical
analysis [91].
2.3.2.1.2 Fuzzy set operations Given the fundamental definitions of the sets and mem-
bership functions for assigning grades of memberships, operations on some single or mul-
tiple fuzzy sets need to be defined. Similar to operations on crisp sets, mathematical rules
for dealing with fuzzy sets can be defined as an expansion of those crisp operators.
The most fundamental set operation is the complement F ′ : µF ′ = 1−µF . For the edge cases
0 and 1, this more general definition for fuzzy sets yields the same results as for crisp sets.
The next fundamental operation is the union∪ of two fuzzy sets A,B: C=A∪B. In crisp sets,
an element x is included within C if it is included in A or B. Expansion to partial member-
ships for fuzzy sets, is performed by retaining the higher degree of membership. Therefore,
the fuzzy union ∪ can be defined as a membership function µc(x) =max(µa(x),µb(x)) or in
short µc = µa∨µb. Equality for crisp edge cases can easily be observed again. Last but not
least, the intersection ∪ of two fuzzy sets A,B: C = A∪B is defined in a similar way, main-
taining the lowest degree of membership: µc(x) = min(µa(x),µb(x)) or µc = µa ∧ µb [91,
92].
Using these fundamental definitions of set operations, other properties and other mathe-
matical laws, like distributive and De Morgan, can be defined similar to crisp sets. This
provides a well-defined mathematical foundation of fuzzy set theory. Besides the presented
and original definitions of fuzzy set operations by Zadeh, other operations for union and
intersection can be and have been defined for specific purposes over the decades but those
shall not be further elaborated upon.
2.3.2.1.3 Fuzzy functions Fuzzy functions f = {µ1, . . . ,µn} are a combination of differ-
ent membership functions µ allowing the modeling of different grades of membership for
different conditions of a single crisp variable. Often, membership functions within a fuzzy
function are related to and derived from linguistic terms and expert knowledge, for example
describing an observation in terms of severity with membership functions like slightly low,
normal, high or critical.
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2.3.2.2 Fuzzy controllers
Fuzzy controllers are controllers based on fuzzy set theory using fuzzy sets f and a rule
base with IF . . . THEN rules to perform control. Application of fuzzy logic in a control
algorithm was first described by Mamdani [97] for a steam engine controller by extension
of fuzzy logic as proposed by Zadeh with the rule base and an implication rule similar to
classical binary logic. This Mamdani implication is defined as µA→B = min(µA(x),µB(x))
or A→ B = A∧B, limiting the implication to the minimal degree of membership for the
premisses.
In general, such a fuzzy controller needs to perform three separate steps: The first step is
the fuzzification of the crisp input values, mapping them into the fuzzy space. The second
step is the inference, evaluating the defined rules and implications to obtain membership
grades for the output functions. Finally, in a last step, the fuzzy degrees of membership of
the output variables need to be defuzzified to obtain crisp output parameters. In the sequel,
these three steps will be elaborated in more detail.
Guiding this general description, and example is provided and illustrated in Figure 2.3:
Let’s assume a vital parameter can be low, normal or high, based on medical knowledge.
Therapy should be led by this observation and some medication should be administered if
the vital parameter is low or normal, otherwise none.
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Figure 2.3: Illustration of the processing within a FL controller for a simple example using a
single input for an observed vital parameter. Administering of a medication is decided
by the output variable. A simple rule base with two simple rules is used and
processing is performed in five steps: fuzzification (1), processing (2–4) and
defuzzification (5).
2.3.2.2.1 Fuzzification The first processing step within a fuzzy controller is transforming
the crisp, numerical input values xi to membership grades of respective fuzzy functions fi.
These fuzzy functions fi are defined for any input variable xi and often incorporate expert
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knowledge. The member functions µ f i within a fuzzy function fi are often equally spaced
triangular functions as simplifications of Gaussian curves. At the boundaries of the input
range, trapezoid functions as approximations of sigmoid curves are often used. By evalu-
ation of each input value xi within its respective fuzzy function fi, the fuzzy membership
grades can be obtained f (xi) = (µ f i,1, . . . ,µ f i, j . . . ,µ f i,n). For the assumed working example
with the measured vital parameter, three membership grades µlow,µnormal,µhigh would be
calculated for a present input value.
2.3.2.2.2 Rule application and implication Given the membership grades f (xi) of each
input variable xi within its corresponding fuzzy function fi and its membership functions,
evaluation of the input can be performed. The rule base consists of a set of simple IF–THEN
rules, where conditions and implications refer to the individual membership functions. Eval-
uation of all rules is performed in parallel in two steps: In a first step, premisses of each
rule are evaluated. They consist of a single membership function of an input variable or a
combination of individual variables of multiple inputs. Interference of those variables can
be performed by logical operators like AND or any other well-defined operator within fuzzy
logic. The result of the evaluation of the premisses for a single rule is a grade of member-
ship m = µ(x). In the second step, rule implication using the defined implication operator
is performed. For Mamdani controllers, this implies limiting the grade of membership to
the minimum of premises membership and the output membership function. In the working
example the rule base would consist of the two rules for implication:
1 : IF x = low OR x = normal THEN y = some
2 : IF x = high THEN y = none
The measured vital value x would be evaluated regarding those two rules to:
mlow∧normal = min(µlow(x),µnormal(x)) and mhigh = µhigh. Implications would be per-
formed for both rules, resulting in two membership functions µy1 =max(mlow∨normal),µsome
and µy2 = min(mhigh,µnone).
2.3.2.2.3 Defuzzification The last step within a fuzzy controller is defuzzification to
obtain a crisp output. The parallel rule application and implication results in respective
membership functions, which need to be combined to obtain a single output. This step, ac-
cumulation, can be performed with well-defined fuzzy operators like multiplication or sum,
resulting in a single membership function. Now, only conversion of a membership function
to a crisp value remains to be done. This step, called aggregation, is performed with fuzzy
operators like max, min or centroid. The defuzzified result then is the output of the fuzzy
controller. If more input variables and multiple outputs are used, this process is performed in
parallel for each output variable. In the used example, accumulation would combine the two
membership functions µy1 and µy1, e.g., using a maximum operator µout = max(µy1,µy2).
Aggregation then could be performed by finding the centroid of this membership function
providing the output value y = centroid(µout).
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2.3.3 Linear regression
Regression aims to find a function f (x) = β · x+b to predict an output f (x) = Y by calcu-
lating a response from an input vector X , using regression coefficients β and an intercept b.
A well established and one of the most important regression methods in statistics for almost
40 years is linear regression [98]. Normally, a least squares approach is used to determine
regression coefficients β, minimizing the residual sum of squares using the Euclidean or L2
norm || · ||2. While being a simple approach, adequate and interpretable results can often be
acquired and even outperform more complex models with sparse or limited training data
[98]. The general form of linear regression for finding optimal coefficients βˆ for prediction
of a response vector y ∈ Rn using an input vector X ∈ Rp can be described as follows:
βˆ= argmin
β∈Rp
= ‖y−Xβ‖22
2.3.3.1 Ridge regression
Ridge regression aims to counter problems like large variances as a tradeoff for providing
a low bias present in common linear regression by regularization. Regularization tries to
minimize the coefficients by imposing a penalty on the size of the β coefficients, a concept
similar to weight decay in neural networks [98]. Thus, ridge regression is also known
as Tikhonov regularization. Similar to simple linear regression, ridge regression uses the
Euclidean L2 norm for minimization and utilizes a complexity parameter λ to control the
strength of regularization. For λ= 0, the penalty term is eliminated, resulting in common
linear regression. If an intercept term is included in the regression model, this term is
normally excluded from the regularization penalty. Due to the imposed penalty term ‖β‖22,
an optimization bias for different numerical ranges of the regression coefficients can occur
and should be avoided for larger coefficients by standardizing the inputs [98]. Due to the
used L2 norm || · ||2, no variable selection can be performed as ridge regression can only
shrink coefficients towards zero but not eliminate them entirely. Like for common linear
regression optimal coefficients βˆ of the ridge regression using the L2 penalty term λ‖β‖22
are determined by:
βˆridge = argmin
β∈Rp
= ‖y−Xβ‖22 + λ‖β‖22
2.3.3.2 Lasso regression
Lasso (Least Absolute Selection and Shrinkage Operator) regression is another deviation
from common linear regression first described by Tibshirani [99]. Whereas ridge regression
is able to perform regularization by introducing a penalty term using the L2 norm || · ||2, it
is not able to solve the problem of variable selection. Lasso solves this problem by a small
modification of the ridge regression through regularization using the L1 norm || · ||1, also
known as Manhattan distance. Using this tweak, regression coefficients can be set exactly to
zero. This can significantly aid interpretation in problems with a large number of predictors
[98]. Similar to ridge regression, Lasso regression solves the optimization problem using
the L1 norm in the penalty term λ‖β‖1:
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βˆlasso = argmin
β∈Rp
= ‖y−Xβ‖22 + λ‖β‖1
2.3.3.3 Elastic-net regression
Another variation of the linear regression methods described beforehand is elastic-net regres-
sion, first described by Zou and Hastie [100]. As both ridge and Lasso regression provide
benefits and drawbacks under different conditions, elastic-net regression aims at finding an
optimal solution combining both approaches with an additional weigh factor α ∈ [0,1]. For
the extrema of α, elastic-net regression is equal to ridge regression (α= 0) and lasso regres-
sion (α= 1) [98]. Combinations of the two regression types can be described by adaption
of the weighting factor α. With λ1 = α ·λ and λ2 = (1−α)·λ2 , the optimization problem can
then be described as follows:
βˆelastic net = argmin
β∈Rp
= ‖y−Xβ‖22 + λ2 ‖β‖22 + λ1 ‖β‖1
2.3.3.4 Robust regression
Models based on least-square optimization are sensitive to outliers, which may be caused
by artifacts and disturbances uncorrelated to the observation. To counter those effects, more
robust regression methods have been developed. One approach is using bi-squared weights,
as it includes the commonly used least-square fitting while simultaneously providing a
more robust regression by minimization of outlier effects. To achieve this, a weight wi
is included in the calculation of the sum of square weights for each observation. The
optimal solution can be found by an iterative re-weighted least squares approach, in which a
weighted least square regression is iteratively performed with updated residuals and weights
until a convergence is reached. Using bi-square weighting, observations close to the fitting
line will get small error weights, whereas points further away are associated with reduced
weights [101, 102].
2.3.4 Support Vector Regression
Support Vector Regression (SVR) is a nonparametric approach that can be used to find an
estimator function. A common way to obtain a solution is by using linear epsilon-insensitive
SVM (ε-SVM). In this method, optimization is performed to obtain a solution where for
all trained points none deviates more than ε from the known target and deviations within
the ε range are not penalized [103]. Therefore, similar to SV classification, only a subset of
training points is considered for defining the solution [104]. Additionally, a regularization
is performed by solving the minimization problem of finding a function that is as flat
as possible [104]. Thus, SVR aims to achieve a minimal generalization error bound (a
combination of the training error and a regularization term) instead of minimizing the total
training error itself [104]. Given an input vector X ∈ Rn, a response vector y ∈ Rn and an
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intercept b, the ε-SVR minimization problem can be described as follows:
f (x) = βx+b
minimize :
1
2
‖β‖22
subject to : ∀i : |yi− (β · xi+b)| ≤ ε
For non-linear regression, the problem can be solved by mapping the input space to a
higher dimensional feature space or using an optimized solution utilizing kernel functions
in the feature space without the need of mapping to the higher dimension itself (kernel
trick). Unfortunately, when solving a SVR problem, a solution where the ε margins can be
fulfilled for all points may not exist. To obtain a solution for those cases, softer margins
allowing penalized error margins larger than ε can be introduced by using so slack variables
ξ [103].
Given the description of the minimization problem, the final step is algorithmic solving.
This can be performed in various ways, sequential minimal optimization (SMO) [105] being
the most popular inter alia due to its good general convergence properties [103]. It splits
the problem space in chunks of size to and tries to optimize the target function with respect
to those sets [103].
2.3.5 Statistics and Performance metrics
Given a trained model with calculated predictions or an implemented closed-loop automa-
tion, assessment of the performance is a final crucial step. For this task, a broad variety of
methods and performance metrics can be used. The ones relevant to the results of this thesis
will briefly be introduced in the following.
Mean absolute deviation
The mean absolute deviation (MAD) is a relative measure for deviation from the mean. For
an observation X = (x1, . . . ,xn) with mean x¯: MAD = 1n
n
∑
i=1
|xi− x¯|
Interquartile range
The interquartile range (IQR) is a statistical dispersion measure. It is a metric for the
difference between lower and upper quartiles Q: IQR = Q3−Q1.
Standard error of the mean
The standard error of the mean (SEM) is a measure for the dispersion of individual obser-
vations around a population mean. It is calculated from the standard deviation s divided by
the squared root of the population size n: SEM = s√n .
(Root) mean square error and relative deviation
The mean square error (MSE) is a quality measure for an estimator yˆi by calculating
the mean average of the squared deviations from a desired target vector y: MSE =
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1
n ∑
n
i=1 (yˆi− yi)2. The root mean squared error (RMSE) RMSE =
√
MSE applies an ad-
ditional extraction of the squared root of the MSE.
The two previously described measures are measures for the absolute deviations and er-
rors. For a relative description of the error, the normalized root mean square deviation
(NRMSD) can be used by dividing the RMSE by the range of the observations of y:
NRMSD = RMSEymax−ymin .
Coefficient of determination
The coefficient of determination r2 is the squared correlation coefficient r between two
variables and provides a measure for the strength of linear relationship between those.
Sensitivity, specificity, F1 score
Given a classification with a known ground truth, the performance of the model can be
evaluated regarding the correct classifications if several or all class memberships are known.
In general, four different classification results can be distinguished: true positives (TP),
false positives (TN), false negatives (FN) and true negatives (TN). Based on a subset or all
of those 4 groups several metrics can be calculated, those include:
The sensitivity or true positive rate (TPR) as a measure of fraction of correct hits among all
events of the ground truth, precision or positive predictive value (PPV) yielding the fraction
of correct hits among all detected hits and accuracy (ACC) as a measure of the fraction
of true predictions among all predictions. As a deviated measure, the F1 score combines
sensitivity and precision using the harmonic mean.
T PR =
T P
T P+FN
PPV =
T P
T P+FP
ACC =
T P+T N
T P+FP+FN+T N
F1 =
2 ·T P
2 ·T P+FP+FN
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3.1 Existing data sources
Analysis and predictions are always only as good as the potential within the underlying
data sets. Therefore, a large data base and the availability of training data sets, especially
for machine learning approaches, is beneficial. Unfortunately, publicly available collections
of medical data are very limited due to difficulties in data collection and patient’s privacy
rights. One of the few available data sources is the Multiparameter Intelligent Monitoring
in Intensive Care (MIMIC) database in its second (MIMICII) or third (MIMICIII) version,
providing a broad variety of patient information and vital data [106–108]. However, avail-
able data is often oriented towards diagnosis and patient identification. The provided vital
data is most often limited to few parameters with measurements once an hour or limited
to uncorrelated high-resolution sequences of individual parameters. Additionally, as the
protection of patient rights and anonymity is of highest priority, (meta-) analysis methods
that might be able to correlate different datasets and match patient data, yielding additional
and more complete information of data sets for individual patients, are limited or prohibited.
3.2 Data collection
Given this lack of data, the need for collecting and accessing the various medical data
sources has emerged over the last decade to facilitate event prediction and decision making
for improved and personalized care [7]. One problem for data collection within the medical
field is the lack of standardization and interoperability among medical devices [7, 10, 11].
Observing the technical evolution of such clinical systems, they mostly have been inde-
pendently designed to document clinical activity for liability and billing reasons [7]. This
yielded a heterogeneous landscape of record systems and databases, providing a variety
of data sources including laboratory results, real-time monitoring devices, image scans,
free text nodes, waveforms, billing codes, procedure codes and other formats [7]. Unfortu-
nately, whereas efforts for data integration were successfully performed in other industrial
fields [9], the heterogeneous landscape in the medical field continues to exist. Fundamental
data integration for documentation and billing is only achieved with higher-order system
handling and converting the various obtained data formats as well as manual input. As the
heterogeneous data sources might change at any time, those systems need to be adapted
dynamically and are often still limited [7]. Generating a more homogenous data landscape
would require well-defined standards for data transfer between different devices of vari-
ous cooperative manufacturers [7, 11]. Additionally, devices like the ones used for POC
tests, often only provide retrospective bulk data export and have no capabilities of directly
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accessing the results like those of ACT measurements.
Given those complications, collection of data mostly has been performed by researchers
only for their specific needs. Yet, several more general concepts for data collection have been
proposed. Norris et al. [109] suggested a network-based system for collection of alarms from
individual devices and notification of caregivers. Pölsen et al. [110] presented a concept
for a web-service based plug-and-play system for medical devices with a decentralized
structure. Another system, based on individual laptops connected by WLAN to a central
database, was developed by Feng et al. [111]. Further applications with the goal of data
collection include telemedicine [112] and management of clinical workflows [113].
Regarding the heterogeneous landscape and incompatibility of medical devices, approaches
to unify this landscape gain increasing attention within the recent years as an enhanced
focus in the computer science world is put on the medical field and new IEEE standards like
IEEE 11073 [114] for communication between medical devices are under development.
Looking beyond the box of medical research, a prominent example for an automation frame-
work in the context of robotics is the robot operating system (ROS) [115], providing a client
server-based system with message-based communication. Whereas, general application to
other fields like the medical environment may be possible, many fundamental aspects of the
system, including sensor-physics, path-planning and visualizations, are specifically tailored
for its intended application and would provide additional overhead. Additionally, ROS is
developed for Linux clients, whereas many medical devices run within a Windows envi-
ronment where drivers and libraries for interaction with the medical devices often only are
provided for Windows operating systems by the manufacturers.
3.3 Data processing, filtering and decision-making
Once clinical data is made available one way or the other, further challenges arise.
Collecting information from different databases, which itself is a challenging task, provides
no guaranty to obtain usable data sets as information from the different sources often
cannot be linked with the other information [7]. This is frequently caused by the lack of
common identifiers or time offsets due to the heterogeneous data sources that hardly can
be corrected retrospectively. Yet, if a comprehensive set of data can be obtained, another
subsequent challenge is data corruption. Clinical settings and the operation room are a
hostile environment for signal acquisition and processing [116]. Whereas in other domains
data is often collected by researchers for analysis and machine learning, clinical data
is intended to facilitate patient care and not data analysis. Raw data collected from the
multitude of sensors and data sources most often contains artifacts from sensor drop-offs,
treatment interventions and incomplete measurements. Paired with the often fuzzy nature
of medical data this provides additional challenges for secondary data use and analysis [7].
To deal with artifacts, a broad variety of approaches for filtering and sensor fusion have
been developed [117]. This is an important step, as pre-processing can even be more
important than the use of nonlinear machine learning classifiers capable of capturing
higher order interactions during further analysis [118]. Often median filters [119, 120]
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are used as an initial filtering approach and for reduction of false alarms. Furthermore,
Kalman filters can be used for sensor fusion and filtering for short term errors and
drifts [121–123] or be included in methods for event detection [124]. Other approaches
utilize fuzzy-classification [125], regression-based templates [126], robust regression [127],
auto-regressive models [128, 129], phase-space embedding [130] or transformations into
the frequency domain [131]. For data sources with a high temporal resolution, like pressure
curves, wavelet analysis [132, 133] and localized fittings [134] approaches can be applied.
This can be used for artifact detection and filtering, e.g., removal of blood-sampling events
from the monitoring data stream [135].
Another and often subsequent task is the closed-loop control of individual parameters based
on pre-processed measurements. Within the intensive care environment, a broad variety
of specific approaches were developed during the recent decades. This research includes
the development and evaluation of closed-loop systems for decision support in anesthesia,
glucose management, ventilation and fluid management [136].
Various successfully evaluated approaches for medical decision making are based on fuzzy
logic. Examples for such applications are fluid-administering [137], assessment for urgency
of care, e.g., based on mean ABP and oxygen saturation levels [138]. Even more complex
models use fuzzy decision trees and cognitive maps for dosage of radiation treatment [139]
or an adaptive neuro-fuzzy inference system (ANFIS) to train a set of fuzzy rules for
detection of hypovolemia [140].
Additionally, a few more specific aspects of care, covered by more comprehensive research
regarding management and closed-loop control, are now presented in more detail.
3.3.1 Temperature management
Targeted temperature management (TTM) can be performed by different means, including
different types of surface cooling systems or intravascular systems using special catheters
placed in the venous bloodstream [141]. Such invasive systems mostly include temperature
sensors and perform closed-loop control to maintain the desired temperature [141]. Further-
more, systems used during dialysis can perform warming of the blood to a desired level.
Non-invasive systems can achieve heating or cooling by utilization of tempered water or
air. In water-based systems, water is circulated through fine tubes in special blankets by a
control unit including a water pump and a heating/cooling unit. Those specialized systems
are mainly used for patient cooling and rewarming for prevention or reduction of the effects
of brain injuries by reduction of ICP. In general, they can be equipped with temperature
sensors for closed-loop TTM and allow for a fine adjustment of the desired temperature.
Another type of systems are forced-air warming devices with special air-filled blankets
providing a continuous stream of air with a defined temperature to the patient’s skin [28] to
allow for a defined warming or cooling and prevention of conductive and convective heat
loss [142]. Those systems are smaller and more portable than the water-bases ones and
only require inexpensive disposable blankets, allowing cost-effective and more widespread
application in different hospital settings. However, those systems only provide limited
temperature settings and no closed-loop control.
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Regarding the stabilizing of study conditions in animal studies, temperature management
was successfully applied by various researchers [143–145].
Besides special temperature management devices, an example for interconnection of medi-
cal devices for temperature control is the research by Britto et al. [146]. Using data obtained
from patient monitoring, infusions were automatically stopped if body temperature of in-
fants fell below a defined threshold [146].
3.3.2 Glucose management
Control of glucose levels and administering of insulin is one of the most developed fields
regarding closed-loop control in the medical sector. Yet, there is still no superior method
or designated algorithm for treatment of hyperglycemia or reduction of glycemic varia-
tion [147]. Several researchers have evaluated different filtering methods to improve glu-
cose monitoring [121, 148] as the first essential step for glucose management. For this
management, beside simple approach based on the manual glucose control using look-up
tables, several methods using proportional–integral–derivative (PID) controllers or model-
predictive control have been proposed [147, 149]. One simple example is the open-loop
ePtotocol-insulin algorithm by Thompson et al. [150] that can be run on a dedicated laptop
computer. Caregivers can input the currently measured glucose level and a new infusion
rate is automatically calculated by the algorithm based on the recent input and historic
values. The obtained new rate can then manually be set at the infusion pump. The algorithm
uses a classification approach for the observed measurements and calculates a response
based on the rate of change. Using this approach, severe hypoglycemic events were only
observed in 1.42 percent of the 12.886 performed glucose measurements and adaptions
based on the algorithmic suggestions [150]. Other proposed solutions use PID or model-
predictive controllers. Such algorithms require little patient-specific information and are
very adaptive [147]. Plank, Pachler et al. [151–153] were able to develop a model predictive
control (MPC) algorithm for tight glycaemic control (TGC). Evaluation of the proposed
solution was performed in clinical trials with 50 patients for about 72 hours each using
an average sampling interval of 117 minutes. Control was performed by a laptop-based
solution connected to the infusion pumps with manual data input. The algorithmic pre-
dictions and adaptions were based on the measured glucose levels, administered insulin
infusions and carbohydrate content of parenteral and enteral nutrition [153]. Regarding the
performance of the proposed algorithm, only a single hypoglycemia event with a measured
glucose level below 40 mg/dL occurred in the automatically controlled group, whereas with
manual control, no such event was present [152]. Further clinical evaluation with direct al-
gorithmic integration into infusion pumps system was performed by Kulnik et al. [154].
Their evaluation included 10 patients with a median therapy duration of 66 hours. Nominal
glucose levels between 80–110 mg/dL could be achieved in 47 percent of the observation
time. Based on those studies, the commercial B. Braun Space GlucoseControl [155] is
marketed. Other commercially available open-loop systems based on PID control include
EndoTool (Monarch Medical), GlucoCare, Glucommander (Glytec, LLC) [156], GlucoSta-
bilizer (Medical Decision Network, LLC) [147].
However, common to all automated approaches is the requirement for frequent glucose
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measurements, often exceeding 18 measurements per day [147]. Additionally, those so-
lutions often cause additional workload due to interaction with the devices and manual
parameter input [147]. Thus, insulin and glucose management is still an ongoing research
field, requiring substantial expert input, training, and supervision [149]. Hence, solving
the problem of automated data collection and processing could reduce manual interaction
and workload [147]. Whereas the already presented solutions are used in a clinical setting
and mainly dependent on manually obtained samples for glucose measurement, another
field is the long-term application for diabetes management. In such applications, minimal-
invasive, implanted sensors under development or already marketed [148] can be used for
continuous glucose monitoring (CGM) within the research context of closed-loop artificial
pancreases [157].
3.3.3 Anesthesia and blood pressure management
Another well-established field with a strong research focus is computer-aided management
of anesthesia. As management of depth of anesthesia has been a well-defined goal for a long
time [116], a broad variety of automated approaches have been developed and evaluated
during the recent decades [12, 116, 158–170].
One of the biggest challenges in anesthesia management are difficulties in data access and
control of the devices. Paired with the vital role of anesthesia management, additional limi-
tations regarding the scope of functions and possible adaptions have to be considered [116].
With technological advantages, ventilation devices gained more and more internal closed-
loop capabilities for maintaining a defined state and experimental approaches using rule-
based systems and neural networks have been evaluated. Nowadays, management of anes-
thesia depth is mostly based on the bispectral index (BIS) as a measure for brain activity
and consciousness with closed-loop control to minimization BI variability [171].
Allen et al. [116] developed a neuro-fuzzy closed-loop system for control of depth of anes-
thesia that provides a powerful tool for incorporating practical experience of physicians.
Their goal was to achieve a desired anesthetic depth as fast as possible and maintain this
level regarding changing conditions during surgical stimulation with auditory-evoked po-
tentials (AEP) from EEG signals. To achieve the control, a simple three-layer perceptron
network with subsequent fuzzy controller, processing the outputs of the neural network,
was used [116]. Hemmerling et al. [165] developed an automated closed-loop solution
for the administering of intravenous anesthesia to maintain a target BIS and with their
McSleepy system based on a single PC with touchscreen show an improved performance in
comparison to manually administered anesthesia. Their data collection was carried out by a
measurement every 5 seconds and writing the obtained data into a spreadsheet. Furthermore,
management of ABP has successfully been evaluated by Luginbuhl et al. [159], controlling
the depth of anesthesia.
39
3 State of the art and related work
3.3.4 Respiratory management
Automated and adaptive systems for mechanical ventilation provide a potential solution
for problems like long ventilation times in an aging population paired with the problem of
understaffing and increased healthcare cost [172, 173]. In the context of faster weaning from
mechanical ventilation, protection of the lung, while still providing sufficient ventilation,
is one of the most important aspects. To achieve this goal, systems utilizing a dynamic
combination of different ventilation modes with automatic and frequent adaptions of the
settings are used [163].
Nemoto et al. [174] developed a decision support system using a weaning algorithm based
on fuzzy logic, which included measurements from heart rate, arterial oxygen saturation,
TV and RR. All input parameters were fuzzified and the current state and optimal action to
be applied was determined by an extensive rule-base obtained from empirical knowledge.
Therani et al. [175–177] developed and improved an open-loop decision support system for
management of arterial blood gases to aid care and reduce weaning time. Data acquisition
for control is limited to manual input of the required parameters by the physician. Using a
rule-based system and the breathing model by Otis et al. [178], optimal ventilation levels
were then calculated based on the input and suggested to the caregiver for application.
Commercially available systems using dynamic ventilation patterns and closed-loops are
VentAssist (Philips), SmartCare (Dräger), INTELLiVENT (Hamilton Medical): VentAs-
sist [179] uses a fuzzy logic inference system for evaluation of respiratory parameters,
including a trained neural network to estimate the patient’s breathing effort [180]. Smart-
Care is able to apply a weaning protocol in pressure support mode by adapting pressure
to allow for spontaneous breathing efforts. Therefore, average RR, lung volume and end-
tidal CO2 level are evaluated every 2 to 5 minutes and the next action is suggested to the
caregiver [181]. INTELLiVENT is able to perform continuous adjustment of mechanical
ventilation to require the least work of breathing based on knowledge obtained from various
clinical trials [181]. Using this dynamic adaption, better performance than classical, static
modes has been observed in various studies [173, 181, 182].
3.3.5 Predictions of blood gas parameters
Several studies covering the prediction of arterial blood gases from venous samples were
conducted [183, 184]. Using regression methods, high overall correlations (r > 0.9) could
be achieved in various studies for pH, pCO2, HCO3. No significant correlation between
arterial and venous pO2 and O2 saturation measurements was observed. Yet, besides such
comparisons between arterial and venous blood samples, obtained from central veins or
earlobes, no direct comparison of the various arterial blood gases to possible surrogate
parameters, obtained as high frequency data from different patient monitoring devices, can
be found in scientific literature.
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3.4 Preliminary work at the Schenk Lab
Given a long-standing experience regarding porcine models in the Schenk Lab at the Insti-
tute of Experimental Surgery at the Department of General, Visceral and Transplant Surgery
at the University Hospital Tübingen (UKT) [185–190], ideas and concepts for standardiza-
tion and automation of clinical protocols and the need for data collection had already been
considered. First tests of closed-loop controls and fuzzy logic applications for automa-
tion of different parameters were performed on distributed systems with individual laptop
computers. Thus, problems like data compartmentalization and time synchronization still
remained in those initial attempts for data collection from medical devices, central data
presentation and closed-loop control using PID controllers and fuzzy logic. An example for
the exploratory approach using a graphical pipeline within DASYlab, a graphical labora-
tory data acquisition and control system, is shown in Figure 3.1. This research provided the
technical foundation as well as a thematic guidance for the scope and solutions presented
within this thesis.
Figure 3.1: Illustration examples to provide an impression of the performed initial exploratory
tests of closed-loop control using block-based graphical data flows in DASYlab with
various connected modules for fuzzy-logic and PID controls.
3.5 Summary of the State of the Art
Availability of clinical datasets is limited and often restricted to small sets of collected
parameters and low data collection rates. Additionally, such datasets are often oriented
towards clinical diagnosis and as a measure to protect patients’ rights, further analysis and
correlation of different datasets to obtain additional or correlated information is limited or
prohibited.
Whereas standardization is well established in many other areas of research and industry, a
heterogeneous landscape continues to exist due to predominantly independent developments
in the medical field [7, 10, 11]. Due to this lack of interoperability among medical devices,
collection of clinical data for further processing and research is a difficult task. To close
the data gap, different concepts for interconnection of medical devices have been proposed,
including network-based alarm systems [109], web-service based data-collection [110] or
individual laptops connected to a central database by WLAN [111]. Additionally, new IEEE
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standards like IEEE 11073 [114] to improve device interconnection are under development.
Overall, those systems are designed for data collection and not intended for the additional
task of controlling and configuring medical devices as it is required for closed-loop appli-
cations.
Once data is collected, further processing needs to be performed as the raw data stream
contains numerous measurement artifacts and other disruptions. Therefore, various filtering
and sensor fusion approaches have been developed and optimized for specific parameters.
Regarding the measurement frequency, blood samples generally pose a major problem as
this procedure is a manual and invasive task. Yet, for the specific problem of analyzing
BGA results, only correlations between various arterial and venous blood samples but
no comparison to real time data of various other parameters from patient monitoring are
described in published literature.
Beside data collection and (retrospective) analysis, the collected information can be used
for decision support and therapy guidance. For modeling of physiological parameters and
relations, fuzzy logic is an often used and successfully applied approach. Open- and closed-
loop approaches for intensive care have been developed for different specific parameters like
temperature management, glucose or insulin management, control of depth of anesthesia
or respiratory management. Yet, all those solutions are specifically tailored and limited to
individual parameters and not integrated into a general software framework or designed
for the interaction with other systems. Instead, and of course by accounting for the legal
limitations for clinical application on patients, those systems are standalone solutions, still
requiring manual data input and adaption of the target devices by the caregivers.
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4 Overview
The assessment of goal-directed closed-loop management in intensive care medicine by
developing a data integration and processing framework and retrospective analysis was
performed at the Institute of Experimental Surgery at the University Hospital Tübingen
(UKT) alongside and within the context of ongoing clinical research using a porcine model.
This setting provided the available and legal framework for testing the developed software
and, as swine have a similar physiology and size as humans, allowed the usage of medical
devices intended for human application.
The two clinical studies associated with this thesis were not specially designed or conducted
for the task of automation but guided by different clinical research questions like the evalu-
ation of medical products or the assessment of patients’ volume states. Thus, these studies
are presented as background information which will be referenced to in subsequent chap-
ters dealing with the development and evaluation of the proposed software and closed-loop
applications within those framing conditions.
Within this given study context, the goal was to establish a system for collecting all available
data and use automation to stabilize and standardize study conditions by management
of hemo- and homeostasis within and between the individual animal subjects to obtain
more reliable research data and thus reduce variance. Therefore, reducing the need for
an increased number of animal subjects. As those clinical questions and research topics
guided the technical implementations and provided a focus for the desired solutions, the
progress of those studies and software development of course often advanced hand in
hand. Furthermore, many practical aspects relevant to those conducted studies, like repeated
manual tasks according to protocols, were evaluated and subject to automation to limit the
influence of human variance and error potential and reduce caregivers’ workload.
In the following, a short overview of the two relevant studies will be given. This provides the
general context guiding the progress of this thesis and frames the used medical environment
for development and technical implementation of data collection as well as the evaluation
of closed-loop solutions. The studies are presented within the clinical context, covering
the necessary information regarding their approvals, conduction as well as the performed
surgical and medical procedures. Additionally, a brief outlook to the relevant technical
aspects regarding data collection and automation in relation to the individual studies is
given.
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4.1 Applications and Approvals
Both studies were approved by the local animal experimental committee in accordance to
the National Guidelines for Animal Care and Handling and reported to the animal protec-
tion commission at Regierungspräsidium Tübingen (Germany) by the animal protection
commissioner of Tübingen University according to applicable guidelines and regulations
(German animal protection law (TierSchG) §7a). Care and treatment were performed under
guidance of a veterinarian in accordance to the national and European animal protection
laws to prevent animal harm. Study animals were kept in standardized conditions with fast-
ing at the operation day, water was available ad libitum. All animals were sacrificed in deep
general anesthesia after the permitted duration in terminally trials classified as non-recovery
according to the European guidelines (2010/63/EU [44]).
4.1.1 Study Setting
An overview of the final study setting is provided in Figure 4.1. General monitoring was
performed with a Philips MP50 monitor, Osypka ICON and Pulsion PulsioFlex. For ven-
tilation a Dräger Evita XL was used. Infusions were administered with infusion pumps of
the B.Braun Space series. Body and urine weight were measured with in-house developed
scales. Temperature management was performed with a heat mat and post-operative with a
3M BairHugger forced-air warming device. Laboratory analysis was performed with a Ra-
diometer APL800 Flex BGA analyzer and ACT was measured with a Medtronic ACT Plus
device.
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Figure 4.1: Schematic illustration of the fully equipped study setting (left) and photo (right). A
central control interface and laboratory equipment are not included in this figure.
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4.2 Common Protocols & Procedures
4.2.1 Pre-operative protocol
Sedation of the pigs was performed by intramuscular injection of atropine 0.05 mg/kgBW
and azaperone 4.0 mg/kgBW. Narcosis was introduced about 20 minutes later by intramus-
cular injection of midazolam 0.2 mg/kgBW and ketamine 14 mg/kgBW. After another 10
minutes, tracheal intubation and an injection of up to 100 mg propofol was performed by a
veterinarian. Ventilation was performed in a volume-controlled mode with an enhanced O2
level of 40 percent to maintain sufficient oxygen saturation. General anesthesia was then
maintained by TIVA of ketamine, midazolam and fentanyl through an IV access at the ear.
Patient monitoring for ECG, oxygen saturation, and temperature was established.
4.2.2 Surgical Procedures
For venous access, a 5-lumen catheter was inserted in the vena jugularis by ultrasound
guidance (Seldinger technique) or if necessary in open surgery by a physician. Thereafter, an
arterial catheter with PiCCO temperature measurement was inserted into the aorta through
punctuation of the arteria sapherena by the same means. This provided arterial and venous
access for infusions and collection of blood samples and established blood pressure and
hemodynamic monitoring. Finally, a suprapubic urinary catheter was placed by minimal
laparotomy.
4.2.3 Post-operative & observation protocol
In the post-operative phase, the animal was given time for physiological stabilization and
used for connection and calibration of all required medical devices and measurement setups.
Therapeutic anticoagulation was performed as a thrombosis prevention with unfractionated
heparin. Prophylactic antibiotics (ceftriaxone 2 g/d) were administered daily. Observation
and research were performed as described in the protocols of the individual studies. Super-
vision by physicians and animal study investigators for observation of vital functions and
anesthesia was present at all times.
4.2.4 Post-observation protocol
After the permitted study and observation times, the animals were sacrificed with an in-
travenous injection of embutramide (T61) and general pathological findings were noted.
An autopsy of selected tissue samples was performed postmortem if any indications or
complications occurred during the trial.
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5 Study details
5.1 Autopilot Study (AP)
This first study, Autopilot (AP), consisting of research on ten porcine animal subjects
(ap001–ap010), was conducted in the years 2013 to 2015 and approved with application
C2/13 with the title "Entwicklungsbegleitende Evaluation von Medizinprodukten in Ter-
minalversuchen" (development-related evaluation of medical devices in terminal animal
trials). For each animal subject an observation period of 72 hours was admitted. The scope
of this study included the medical evaluation of various devices and the integration into
a unified framework was established alongside those tests. Beside this evaluation of com-
mercially available devices, measurement setups, e.g., for diuresis were custom build and
tested. Fundamental development and testing of the software framework, described in the
next part of this thesis, was performed and used to collect clinical data from an increasing
number of sensors and sources. This allowed for and guided the integration of more and
more automated procedures within the experimental clinical setting. Research for the first
animal subjects (ap001-ap004) was performed to establish data collection of individual
devices and development of device interfaces to guide the overall framework development.
From animal subject ap005 onward, the framework was fully functional in a first version
and all data could be collected within a unified database.
5.1.1 Clinical Questions
During this study several clinical questions were researched. This included, the evalua-
tion and comparison of different state-of-the-art medical devices and finding practical and
clinically relevant aspects subject to automation. Vital data for changing conditions was
obtained as the pigs were bedded in different positions (left, right, back) every few hours.
5.1.2 Technical aspects
From a technical viewpoint, this study was used for the development of the medical frame-
work and integration of individual devices. Therefore, the communication protocols for ven-
tilator (Dräger Evita XL), patient monitor (Philips MP 50), and infusion pumps (B.Braun
Space) were analyzed and the devices were integrated as individual components of the
framework. Ventilation device and infusion pumps were configured with remote control
capabilities and could be used for automation of different aspects like CO2 management by
adaption of RR and management of various infusion rates. From animal subject ap002 on-
ward, glucose and calcium control was automated using a developed fuzzy logic controller.
A diuresis scale for measuring of accumulated fluid within a urine bag was developed and
integrated.
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5.2 Volume-Need-Analysis Study (VNA)
The second study, Volume Need Analysis (VNA), was dedicated to the clinical research
question of assessing the volume state of patients and conducted on ten individual animal
subjects (vna001-vna010) in the years 2016 and 2017 under application C1/16 "Evaluation
eines automatisierbaren Indikators für den Volumenstatus" (evaluation of a volume state
indicator that can be automated) with an admitted duration of 96 hours for each individual
animal subject. Guided by the observations of changes in the volume state of the individ-
ual pigs regarding their bedding position in the data collected by the developed software
framework in the AP study, the question of assessing a reliable volume state of the animals
became of clinical interest as preliminary research showed insufficient knowledge regarding
assessment of the volume state in clinical practice for hospitalized patients. As development
of the framework was finished during the AP study, data collection for analysis could be
performed for all animal subjects of this study. Thus, given a comprehensive set of reliable
collected data, yet unknown relations between the volume state and other physiological
parameters might be detected and guide further clinical research regarding this important
topic. To obtain almost complete knowledge about the volume state of the studies animals,
information about all infusion rates and diuresis as well as the body weight of the pigs was
continuously monitored. To establish reproducible conditions, the developed automation
using fuzzy controls was utilized for management of homeostasis. During the study and
this management, the topic of better temperature control became of interest and usage of
forced-air warming blankets was implemented and suspect to research regarding collection
of data, control and closed-loop management from animal subject vna005 onward.
5.2.1 Clinical Questions
The clinical questions regarding this study were the collection of research data aiding the
assessment of patient’s volume states according to the S3 guidelines with methods and
protocols proposed and recommended by the Arbeitsgemeinschaft der Wissenschaftlichen
Medizinischen Fachgemeinschaften (AWMF). Therefore, all vital signs and data regarding
the volume state were collected with the developed software framework and are subject to
further analysis, exceeding the scope of this thesis. For providing a broad variety of research
data, the animals were given defined amounts of fluid by IV infusions to reach an increased
fluid state. Thereafter, fluid supplementation was stopped and the body fluid was reduced by
usage of diuretics. Assessment of the fluid state was performed at defined volume states by
performing a variety of tests, including a Trendelenburg maneuver, a respiratory hold test,
laboratory analysis, and ultrasound measurements of the diameter of the vena cava. Due to
the mass distribution in pigs, instead of raising legs during the Trendelenburg maneuver, the
entire pig was tilted 20-25 degrees head-down. The respiratory hold was performed after
the inspiration cycle, allowing for the pressure and volume of the lung to displace liquid in
the thoracic cavity, presumably having a similar effect on the volume state as the leg raise
test.
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5.2.2 Technical aspects
With the framework fully functional at the beginning of this study, the integration of addi-
tional devices and the development of further closed-loop systems was the main research
focus. A measuring setup using an array of load cells for continuous body weight monitor-
ing was developed and integrated into the framework. Automated homeostasis management
using the developed fuzzy logic controllers was utilized for all animal subjects. Hemostasis
management was automated by integration of an ACT measurement device and implemen-
tation of closed-loop for a heparin infusion pump. Additionally, besides numerical data
collected every second, the interfaces to patient monitor and ventilation device were ex-
panded for collecting high-frequency waveforms of ECG and respiratory parameters. Using
temperature management from animal subject vna005 onward, the forced-air warming de-
vice was extended with remote control capabilities and automated closed-loop control was
established for animal subject vna007 to vna010.
5.3 Study overview
A general overview of the porcine subjects of the two conducted studies with details regard-
ing gender, weight, study ID, and study application are given in Table 5.1 as a reference for
subsequent parts of this thesis. In total 20 DL pigs were used for the studies. All animal
subjects were female with an average body weight of 44.1±1.5 SEM. The total observation
time of 1373 hours is composed of 500 hours for the AP study and 873 hours for the VNA
study with mean observation times of 50 and 87.3 hours, respectively.
Table 5.1: Overview of the individual porcine subjects with study application.
animal subject duration [h] gender weight [kg] application
ap001 24 ~ 43.5 C2/13
ap002 24 ~ 44.8 C2/13
ap003 74 ~ 30.5 C2/13
ap004 65 ~ 37.8 C2/13
ap005 72 ~ 44.8 C2/13
ap006 36 ~ 30.6 C2/13
ap007 72 ~ 55.4 C2/13
ap008 52 ~ 51.5 C2/13
ap009 68 ~ 49.4 C2/13
ap010 13 ~ 47.6 C2/13
vna001 96 ~ 40.8 C1/16
vna002 57 ~ 46.5 C1/16
vna003 96 ~ 42.0 C1/16
vna004 96 ~ 48.5 C1/16
vna005 96 ~ 38.6 C1/16
vna006 96 ~ 51.1 C1/16
vna007 96 ~ 43.6 C1/16
vna008 96 ~ 55.0 C1/16
vna009 96 ~ 41.3 C1/16
vna010 48 ~ 39.0 C1/16
Σ 1373 ∅ 44.1
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6 Motivation
To perform data analysis and machine learning, the essential first step is acquiring a suffi-
cient amount of data for the analysis. Unfortunately, in the field of healthcare and medical
informatics data is hardly available. Public databases like MIMIC [106–108] only provide
subsets of vital data and are not sufficient for a full-scale analysis and development of
closed-loop systems. Therefore, gathering of the needed data was the uttermost important
task to be performed prior to any subsequent analysis. Currently, most medical devices pro-
vide only manufacturer-specific protocols or are designed for billing and quality assurance
purposes only, while lacking the required data resolution for exporting research data. This
provides difficulties for matching of individual measurements from different devices within
the time domain.
The collection of data to aid better understanding of interactions and the development of
better models is also an important step for further research in animal studies. It has signif-
icant potential for reducing required animal studies by simulation with sufficient models.
Furthermore, given a working system, the concept for clinical applications is not limited to
theory anymore, but can be shown in a practical setting used and evaluated by physicians.
This is a very relevant aspect as such systems will be used by physicians and nurses in the
hospital and thus, an early feedback from those users may provide important information
and guide further development.
Unfortunately, no medical framework for the task of data collection and testing various soft-
and hardware concepts regarding automation and closed-loop controls in an experimental
clinical environment exists. Only independent solutions for individual aspects are available
for some specific tasks and devices. Using an existing framework from other research do-
mains like ROS may be possible. However, due to a mixed Linux and Microsoft Windows
environment with dependencies on manufacturer-specific drivers and libraries, usage and
adaption of a mainly Linux-based solution could lead to high amount of work for integrat-
ing those required devices if possible at all. Therefore, trying to adapt such an existing
framework to the needs of the medical environment was ruled out due the uncertainty of
compatibility and the goal of avoiding limitation to a single operating system or platform
in the heterogeneous landscape of medical devices and systems.
Still left with the fundamental problem of connecting medical devices in a scalable, inter-
changeable, and not manufacturer-specific way, the presented framework was developed
as an essential part for automation and data collection covered in subsequent parts of the-
sis and partly published with its fundamental concept [191]. The following part with its
chapters presents the developed concepts in depth, including the physical implementation
at the Institute of Experimental Surgery at the UKT. Finally, the evaluation during the con-
ducted porcine studies outlined in the previous part is presented from a technical viewpoint,
including the amount of collected data and the achieved data throughput.
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6.1 Framework Requirements
Given the freedom of developing a novel framework for interconnection of medical devices
within an experimental medical setting, requirements and needs for such a system had to
be chosen in the best possible way to facilitate the desired goals for data collection and
automation. Those fundamental requirements are:
First, the framework must be capable of processing and logging arbitrary information
from all devices connected to it and transmit the information between any two devices.
As automation in the goal, providing only a data collection framework is not sufficient
but information must be distributed between the devices without limiting the available
communication paths.
Second, the framework and its applications must be able to handle arbitrary information
provided by various interfaces and information formats of the available medical devices,
still lacking standardization. Thus, interfaces to each device must be developed individually
and integrated into the common framework.
Third, all information, once gathered from the individual devices using the respective and
specific interfaces, should be processed and transmitted in a standardized format within the
framework to allow easy expansion, interaction, and storage.
Fourth, information from all devices should be available for all connected devices within
the framework on time, therefore allowing algorithms and other programs to process the
data and perform analysis as well as adaptions of the medical devices to truly achieve an
online closed-loop system.
Fifth, no distributed solution with many devices, individual logging, or transmitting all
information independently should be used as this would require retrospective collection
and matching of the individual data sets and maintain data dispersion. Thus, all data should
directly be stored in a single central database with a common format for further processing.
Sixth, all messages and devices should maintain a homogenous time base to allow a
matching of the obtained results, allowing for the analysis of causalities and closed-loop
controls. Thus, a loosely connected system involving various individual laptops would
be prone to errors due to differences in the systems’ clocks. A retrospective collection
and matching of the obtained data may therefore hardly possible. To solve this problem, a
common framework with time synchronization is therefore required.
Seventh, the system should be modular and scalable for multiple patients and beds, while
sharing centralized systems like the one used for BGA. This especially provides difficulties
in the hardware and network domain, where separation of the individual patient’s systems to
avoid interferences and crosstalk between numerous medical devices may become relevant.
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The developed software framework for collection of medical data and control of medical
devices in an intensive care setting is designed for bidirectional transmission of any type of
data including measurement results and control commands. Using a client-server concept,
a controlled interaction between the individual devices can be established while maintain-
ing an overview of the current setting. Using a server as a message relay, all transmitted
information can easily be logged and collected for retrospective analysis. The presented
framework is designed as a modular research system where the ability for expansion and im-
provements was the uttermost important aspect. Other aspects like security, redundancy, or
error handling during the transmission process were only subordinate goals. However, those
goals were still considered during development of the framework, yet functional implemen-
tation would require additional expansions and further testing. To achieve this modularity
and expandability, a plugin-based concept, allowing for extension or replacement of single
components and providing re-usability of already implemented features, was chosen. This
re-usability is an important aspect as it allows for faster development. Furthermore, it al-
lows for better testing of the individual reusable components due to a larger number of test
cases for the detection of flaws and bugs. Once such problems are detected, they can easily
be fixed for all usages within the framework at once. This is especially useful for critical
applications like network communication or encoding and decoding of messages, utilizing
a single implemented and reused plugin.
In this chapter, an overview of the plugin architecture and its features is given by introduc-
ing the individual components. Then, interactions between those plugins and interaction
between different applications within the framework are presented, including the processing
of messages using filter rules. Furthermore, aspects like the used database structure and
configuration of the individual applications are briefly highlighted.
7.1 Plug-in Architecture
The framework is developed using a plugin architecture for rapid development and inte-
gration of additional features, modularity, and reduction of redundancy. Therefore, a core
application with a variety of different plugin types was developed. An overview of the
entire architecture with the different types of plugins and general interactions is shown in
Figure 7.1. The details of each plugin and the application core are described in the following
sections.
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Figure 7.1: Overview of the plugin architecture. For initialization, the settings are read from an
XML-based file and used for configuration of the application core with a plugin loader
and logger. The class objects for application and communication plugins are then
crated from factory objects loaded from individual dynamic libraries. Message-based
communication is performed using objects loaded from message plugins. For
transmission, these plugins are set-up by the application plugin and processed by a
Communicator object with an encoding (ENC) and communication (COM) plugin. To
receive messages, this process is reversed. Communication with medical devices can
be performed using this message-based system of through direct communication
implemented within the individual plugin. Additionally, utility (UTIL) plugins can be
loaded and used for encapsulation of specific, reusable features.
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7.1.1 Core application
The central building block of the software framework and plugin architecture
is the core application. This executable contains the base functionality and
performs a variety of general tasks. First, it is used to load a XML-based config-
uration file that contains further information about the plugins and settings to be
utilized. Second, it provides a central logging of status and debug messages for all plugins
within the framework. Logged data is reported in a console window and written in a log-file
based on an error reporting level that can be set at the start of the core application with a
run-time parameter. There are several levels reaching from trace, e.g., containing dumps
for array elements, over debug information and program states to warnings and errors. The
core application scans the available plugins and provides them for usage by loading the
dynamic libraries and interacting with the plugin factories to create plugin instances when
requested. Additionally, all physical network or bus connections to be used by the plugins,
e.g., via Ethernet or serial port, are initialized by the core application. For identification
of the running core application, the program provides a unique identifier (UUID) of the
running application, which among other applications is used for tracking the client at a
reconnect to the server.
7.1.2 Plugins
Plugins are used to provide additional and specific functionality for performing various de-
fined tasks within the framework. Plugins are loaded and maintained by the core application
and defined in the XML-based configuration file. Each plugin is stored as a platform-specific
library developed in C++, utilizing the plugin interfaces provided by the Qt framework. For
easy development and integration, each plugin consists of a fixed base structure and well-
defined interfaces to the application. To allow attachment to the core application, each
plugin implements a factory pattern for initializing individual instances of the plugin. Each
plugin has a unique plugin name that is compiled into the application and used in all lo-
cations where the plugin needs to be referenced by its name. Depending on the function,
which can be inherited from a few different basic types (application, communication, mes-
sage, utility, encoding/decoding), specific templates and abstract classes with interfaces are
implemented to allow seamless integration within the framework. Each plugin provides its
plugin name and plugin type and has common methods for initializing, starting, and stop-
ping that can be called by the core application. Interaction with the core and other plugins
is implemented using Qt’s signal and slot concept. For communication within the frame-
work, information is passed through those signal- and slot interfaces using messages, or
more specific, message objects that are loaded from specific message plugins. This provides
an abstraction layer between the information to be transported and the message handling
process itself. As used messages objects are stored as smart pointers, this allows automated
destruction if the reference count reaches zero, indicating the message object is not needed
anymore. In what follows, a short overview of the different plugin types and their usage
will be provided.
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7.1.2.1 Application plugins (APP)
APP
Application plugins of the developed framework integrate individual program
functionality and rely on obtained and sent messages for communication and in-
teraction. Each application plugin can provide a graphical user interface (GUI)
if needed. If the plugin is integrated into a graphical environment, the core ap-
plication can request and show the GUI in an appropriate manner. This is especially useful,
if multiple plugins are loaded (e.g., in a multi-plugin application as described in section 7.5),
where many plugins are integrated into a common graphical environment. The individual
parameters and settings required by the plugin are read from the XML-based configuration
file and used for the configuration of the plugin, e.g., by defining constants, parameters, IP
addresses, scaling factors, or other required settings. Most APP-plugin are inherited from
an abstract base class, providing basic functions like handling of configuration parameters
and message processing. In each APP-plugin, filter rules for the messages to be received
and processed by the plugin are provided. If some functions are required by different appli-
cations, they can be outsourced to utility plugins and accessed by the application plugin to
limit code duplication.
Abstract application client The abstract application client is a fundamental base for all
client plugins and used for methods and functions that are required in all client application
plugins to reduce functional redundancy and code duplications. It implements many general
and fundamental methods for communication with the core and interactions within the
framework. Those functions include management of the connection to a central server
within the framework, sending alive beats, and pre-processing messages with filter rules.
On application start-up, the required parameters within a XML-based configuration file
are parsed by this base class and accessible by the APP-plugin. Additionally, required
parameters can be defined and are ensured to be present in the configuration file on program
start.
7.1.2.2 Communication plugins (COM)
COM
Communication plugins are used to provide an abstraction layer between the
message-based objects within the framework and the physical communication
over the chosen transport medium. They provide basic functionality for estab-
lishing communication channels, e.g., by opening serial ports or TCP connec-
tions, maintaining the connection, and handling errors. Data processing is performed on
raw strings or byte arrays without further knowledge of the message context. Messages are
padded with delimiters and sent over the chosen physical interface. For example, by using a
COM-plugin implementing the Ethernet protocol, messages are sent as TCP packages using
defined start and stop characters. Alternatively, by using another plugin, message objects
or direct byte commands can be encapsulated and transmitted by serial communication.
If a COM-plugin receives data from the physical data stream, the obtained information is
buffered and automatically parsed. If the defined delimiters are detected, individual mes-
sages are extracted and a signal indicating the availability of a new message is emitted
for further processing by APP-plugins. For sending messages, APP-plugins emit message
objects which are processed, serialized, and then transmitted by the COM-plugin. Those
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intermediate steps during transmission and reception of messages are performed by other
plugins and modules like the encoding/decoding plugin, described next.
7.1.2.3 Encoding/Decoding plugins (ENC)
ENC
0010110
Encoding/Decoding plugins are used for structuring the information stored in
message objects any may provide secure encryption for data transport. An
example for such a usage would be manufacturer specific commands to be ex-
changed between different devices of this very manufacturer, without providing
information to the framework, central database, or other devices. The information would be
processed and distributed encrypted only and if connected to a central database stored en-
crypted as well. For debugging purposes or other analytical tasks, the stored and encrypted
information could be decrypted by the manufacturer at any time. For communication, mes-
sage objects need to be processed and embedded into a well-defined serial data structure.
Between different framework applications, communication is performed over Ethernet us-
ing an ENC-Plugin with XML-encoding to store and transmit the required information
within a defined XML-schema. Other encoding standards required for communication with
specific device, like HL7, are provided by additional ENC-plugins.
For sending a message, the message object is serialized by the specific methods provided
in the appropriate message plugin and embedded in the general structure generated by the
ENC-plugin. This general structure includes header information, containing details of the
sender and designated receivers, a unique message identifier, and the message type.
Received messages are processed by parsing the raw data to obtain this universal header
information. As the message type is included, the receiver can determine the required
message plugin. Further processing of the message content is then performed by this plugin,
resulting in the desired message object that can exchanged within the application. If the
message type is unknown to the receiver, the message is automatically discarded.
Besides the message-specific processing, commands for interaction between clients and
server, like ACK messages or settings, are directly implemented in the ENC-plugin.
7.1.2.4 Message plugins (MSG)
MSG
Message plugins are the most essential plugin type and used for information
exchange within the framework by message objects. They can be used to define
arbitrary message objects and must provide methods for serializing the stored
information to be encoded and transported over the framework. For interaction
with other parts of the framework, especially the APP-plugins, they have appropriate setter
and getter methods for handling the stored information. As specific serialization and de-
serialization is implemented within the plugin, only the sender and receiver of a message
need to have access to the appropriate MSG-plugin for handling the message. Other devices,
may just process the header information and discard the message if no appropriate plugin
is available. This allows for easy expansion of the framework and limits the overhead of
plugins at each device. As already implied in the description of the plugin architecture and
the other plugin types, message information is first obtained by the COM-plugin, processed
by the ENC-plugin, and finally decoded and converted to a message object by the MSG-
plugin. Using Qt’s signal-slot concept, the message object is then provided by emitting
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an event to the receiver’s APP-plugin. The APP-plugin can fetch this message object for
further processing. The individual instances of the message objects are referenced as smart
pointers within the framework and automatically deleted if the message information is no
longer needed. Whereas for receiving a message, the ENC-plugin obtains a message object
instance from the factory of the MSG-plugin, a new object instance is obtained by the APP-
plugin for sending. Information then is added by accessing the specific setter methods of the
MSG-object. Once all information is included, the message object is pushed into the send
pipeline where ENC- and COM-plugins perform further processing as already described.
Message abstraction layer In general, all information can be stored as a key-value pair.
As all messages need to be serialized for transmission and de-serialized at the receiver, such
a general approach allows for an easy and homogenous processing, especially when using a
XML-based structure. However, by using such a general strategy, only generic getters and
setters can be provided. With such a high level of abstraction, the only guidance for usage of
messages would be a sufficient documentation of the message type and the valid key-value
pairs. Error handling for each get and set operation with possible additional or missing keys
would be required. Therefore, a better approach is to maintain name-specific getters and
setters for the different types of message plugins as described earlier to avoid such possible
mix-ups and provide separation of message types. Thus, the described high abstraction level
with a key-value structure, denoted as the general message data format (MDF), is only used
as a foundation for the individual message plugins and inherited by them as the underlying
message structure. The individual message plugins provide a defined interface with named
getters and setters for the individual key-value pairs, therefore allowing the developer to
easily gain self-explanatory knowledge about the information that can be obtained from or
stored within a message. This promotes easy validation and reduces coding errors. Hence,
providing a tradeoff between generalization with reduced overhead and required work on
one hand and maintaining self-explanatory code on the other. Additionally, embedding of
the key-value functionality in specific getters and setters of the individual plugins allows the
encapsulation of the specific methods for storing, retrieving, and validation of the specific
key-value pairs within the plugin itself, providing further reduction of dependencies and
better encapsulation of the code.
7.1.2.5 Utility Plug-ins (UTIL)
UTIL
Utility plugins are an additional and optional type of plugins for general pur-
pose encapsulation of code to reduce redundancy. Whereas other plugins have
defined interfaces and are mandatory for framework application and communi-
cation, UTIL-plugins and can be used in a more general way.
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7.2 Identification of messages and applications
As already outlined within the description of the plugins, each core, application, and mes-
sage provides unique identifiers for processing and filtering of information within the frame-
work. This information is transmitted among each message and used for routing by the
server. Additionally, this information can be stored with the message content in a database,
allowing for complete traceability of each interaction. As identifiers are essential for mes-
sage filtering, described in subsequent sections, a brief overview of the different identifiers
is now provided:
Application identifier
Identification of each running application within the framework is performed by an appli-
cation identifier for the core application and the running plugin. Each one is unique and
can be used to identify specific program instances or linkage of individual applications at
run-time. Additionally, this unique identification is used for handling client connections to
the server, including the detection of newly connected or reconnected applications, and for
message processing.
Patient identifier
A patient (or animal subject) identifier is used for identification of the current patient. Each
device that can be associated with a single patient is assigned their unique patient ID. The ID
is used for filtering patient-specific messages within applications. For the database, where
the information of multiple patients is stored, it provides the necessary information to assign
the received data to the correct patient-specific database table.
Location identifier
Besides identifiers for applications and patients, additional identification can be performed
by the location of the used devices. It is useful for devices or applications in a fixed setting
like the bedside ventilator, patient monitor, scales, and infusion pumps. As such devices
often remain stationary and linked to each other in hospital settings, a new patient ID can
easily be set or updated for a group of devices. Given a common location, this can even be
performed if different patient IDs were previously set, otherwise requiring more complex
updates to reach each device within the group by means of other identifiers.
Device identifier
Another identifier is provided by setting a unique name for an application or device.
Besides the name of the running plugin and the automatically generated application ID,
this name can be set within the XML-based configuration file. This allows unambiguously
device identification independently from assigned patient, location, or running program
instance. It is especially useful if devices should always be kept paired, only listening to
each other’s messages, independently of similar messages exchanged between other devices.
Of course, all those presented identifiers may be used in combination, e.g., as a safety
feature to assure that a specific patient is assigned to the correct bed. This is especially
important for automated controls following a therapeutic scheme, where mix-ups could
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have fatal consequences. An illustration of the combinations and interactions with individual
identifiers is shown in Figure 7.2.
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Figure 7.2: Illustration of the usage for different identifiers. Control loops can be set to interact
with specific other devices independent of the assigned patient (left). Location
identifiers can be used for grouping devices and applying commands, like setting a
new patient ID for a specific bed (middle). Patient identifiers can be used to filter
messages associated to a specific patient (right). As some devices are used for
multiple patients, the individual patient ID is added on a message-by-message basis.
7.3 Message-based communication
Communication within the framework is based on transmission of individual messages be-
tween the individual applications. The individual components and plugins required for this
communication were already described and a brief overview of the implemented message-
based communication was given. To provide deeper insight, the detailed communication
flow and message processing with filtering will be described in the following sections. First,
an additional helper structure and abstraction layer for managing the interaction between
the described plugins and the core needs to be introduced. Then, the message flow with
filtering rules is described.
7.3.1 Connections
For processing of messages to be sent or received, the interaction between a pair of COM-
and ENC-plugins is essential within the developed framework. As the combination of
these two plugins is always required, a further abstraction for this relationship is used.
A Connection describes a specific communication channel for sending and receiving the
information by defining the names of the used ENC- and COM-plugin and, depending on the
connection type, the specific settings like IP addresses and ports. Each Connection is defined
within the application’s XML-based configuration file and has a unique name for referring
to this channel during runtime. At the start of the application, all defined connections are
loaded by the core. Based on those definitions, the communication channels are established
by creating a Communicator object within the application core for each defined Connection.
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7.3.2 Communicators
ENC
0010110
COM
COMMUNICATOR
Communicator objects are the implementation of this additional
abstraction layer for message processing within the framework.
They are the actual interfaces for communication through a spe-
cific channel like Ethernet using XML-encoded messages. Each
Communicator is created by the application core based on its Con-
nection settings, defined within the XML-based configuration file. As the Connections and
Communicators have a unique name, applications can easily select the desired communica-
tion channel at run-time for each message to be transmitted. Each Communicator provides
an interface for sending messages and is connected to the APP-plugins via Qt’s signal-slot
system. Thus, automatic notification and processing of received messages by the application
can be performed. Additionally, the Communicator provides interfaces and signals for the
detection of new clients or disconnects. This is especially useful for the server application
but also used by application plugins to stop creating new messages if the connection to the
server is closed. Transmission is only continued once the connection is re-established.
Furthermore, the Communicator provides a message buffer for automatic resending and
handles the acknowledgment process for successful message transmission. Once a message
is sent, the sender stores the message and the message UUID until verification is received.
Verification is performed by the receiving Communicator by returning an ACK message
with the UUID of the message. Upon reception, the sender discards the corresponding
message backup. If no ACK is received within a defined time frame, the Communicator
tries to resend the message for a defined number of times before finally discarding it and
reporting an error. A detailed illustration of the message flow within the Communicator,
utilizing the ENC- and COM-plugins is shown in Figure 7.3.
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Figure 7.3: Illustration of the message flow of message objects through a Communicator utilizing
ENC- and COM- plugins for sending and receiving a message.
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7.3.3 Message-flow and filtering
As the entire communication within the software framework is based on massage objects,
messages need to be identified and filtered for distribution and processing. This filtering
may be performed by broad variety of different criteria, for example, regarding messages
belonging to a specific study or a specific message type. To allow for such a filtering, each
message header contains information regarding to the message type and an optional subtype.
The message type is defined by the message plugin, providing the appropriate methods for
handling the message and the contained information. The additional subtype can be defined
if different data should be distinguished but inherits the same data structure and information.
An example for such a scenario is the measurement of blood gases. The BGA results for
arterial and venous blood samples are processed and distributed as the same message type
but with different subtypes. Because these two results have very different characteristics,
e.g., in the oxygenation levels, they must not be confused in further processing. Therefore,
filtering based on the subtype is an important feature. To allow general filtering based on
the different characteristics and identifiers for messages and applications, the various filters
need to be defined and processed. Those filter concepts and the processing will be described
in the following.
7.3.4 Filters
Filters are used for the management of information flow within the framework. Filter rules
can be created for different categories like patient ID, message types, subtypes, UUIDs,
and identifiers. For transmission of information to specific application instance only, device
identifiers with a unique device name may be used. Specific applications can be selected by
application identifiers and location filters, e.g., to only receiving messages from a specific
defined location like a hospital bed. Beside the combination of different filters for the
various identifiers, each filter rule can be inverted. This allows the exclusion of one or more
conditions and the definition of universal filters. To describe the filter concept in more detail,
a formal description should be given:
Each filter F = r ∈ R is a set of filter rules, where R is the space of all possible filter rules.
A filter rule r = (A, inv, t) ∈ R is a tuple, where A = {S1, . . .Sn},n = |A| is a set of strings
S = (c1, . . . ,cn),n = |S|, where c is a character. inv ∈ {0,1} is a flag
indicating if the set is an inclusive or exclusive description and t ∈
{type,subtype,UUID,deviceID,appID, location} is the filter type.
Using the combination of multiple filters with freely definable rules, all possible and specific
combinations for message filters can be defined.
7.3.4.1 Filter comparison
Within each application plugin, an individual set of filters can be defined. It is used for com-
parison with the characteristics of each received message to determine if further processing
is needed or if the message can be ignored. As each message provides the identifiers of the
source application and the details of the message in the universal header, comparison to the
filter rules can be performed for any message object processed by the Communicator.
The filtering step is performed by comparison of the message characteristics to the filter
66
7.4 Client-Server structure & interaction
rules in a top-down fashion. If a first filter match occurs, the message is accepted and will
be further processed by the application. Only if the message has passed through all filter
comparisons without a match, the message is discarded. For comparison to a filter, the
header information of a message is stored within a filter structure and compared.
A filter rule, e.g., a message characteristic, r ∈ R is matched to another filter rule s ∈ R,
if their types match rt = st and depending on the inversion rule sinv of the filter, a match
m ∈ 0,1 is an indicator function with
1m(r,s) =
{
∃ ri ∈ rA,s j ∈ sA : ri↔ s j for sinv = 0
@ ri ∈ rA,s j ∈ sA : ri↔ s j for sinv = 1
The matches are calculated for each identifier of the filter rule and once a match is found,
the message is accepted by the client. Otherwise, the comparison is continued with the other
filter rules and additional filters.
7.4 Client-Server structure & interaction
The client server structure in the developed message framework provides the foundation
for controlled message transport. Whereas devices could interact directly with each other
in small networks, e.g., by defining one application as a server and the other one as a
client, in a setting with multiple devices and many interactions or even multiple patients
processed in parallel, the large number of transmitted messages would flood the network
and cause unnecessary load and delays for handling and filtering required by each device.
Thus, it is reasonable and beneficial for messages to be transmitted only to devices for
which the message is relevant. This may be performed by a peer-to-peer network with
device identification. Alternatively, as mentioned in the introduction regarding the scientific
purpose and the evaluation of such a system, it is very important and useful to have an
overview of all interactions and messages that are transmitted. Therefore, a central server
with logging capabilities for all information in a central database is an important feature.
This client-server concept is implemented within the described software framework with the
client as well as the server being APP-plugins. The only difference, aside from APP-plugins
itself, is the configuration of the COM-plugin: Configured for running in server mode and
client mode, respectively. An illustration of the typical interaction between a client and the
server is shown in Figure 7.4 and briefly described in the following.
7.4.1 Server
The server is an APP-plugin that provides the necessary structures for handling multiple
clients. Additionally, it provides status messages for the state of the system, e.g., which
clients are connected. The server application manages client connections and stores the
login information of the clients. This information includes the client’s filter settings to be
used. As the server is aware of those filter rules, each message is processed at the server
and distributed only to clients, where running APP-plugins are interested in the message
content. Those filter rules can be updated by the client at any time by sending a filter update
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message. This, for example, will often be performed if the server sends a study update
request to change the patient ID of the current application. If the client is configured to filter
messages according to the patient ID, new filter rules are required and must be announced
to the server.
7.4.2 Client
Clients are all applications connected to the server via a Communicator using a COM-plugin
configured in client mode. Clients connect to the server at program start and exchange their
information, e.g., the identifiers, XML-configuration, and the filter rules with the server. The
server is then able to identify the clients to forward those messages the client is interested
in. To verify the running condition of each client and the network state, every few seconds
the communicators of each client send special alive messages as their functional vital sign
to the server.
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Figure 7.4: Client-server interaction with the different message types and the performed filtering
processes.
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7.5 Multi-plugin applications
For using a single computer with a multitude of different apps, the software could be started
several times. However, starting multiple Cores and Communicators, connecting to the
same server will cause an unnecessary overhead. Dealing with a network connection over
Ethernet, multiple communication channels will not cause a problem, as the connections can
be established to the server over different sockets and ports. However, using other transport
media like bus systems, e.g., CAN, a client computer can only establish a single connection
to the server. Otherwise, multiple parallel connection cables would have to be run between
client and server. For such applications, which should be covered by the general concept of
the framework as well, the communication from the individual apps to the server must be
channeled through a single Communicator, connected to the physical connection medium.
Additionally, especially when looking at a control interface for all automated solutions us-
ing a touchscreen, one might want to switch between the different applications. Therefore,
it is necessary to integrate the applications within a single executable that allows switching
between the different GUIs.
This concept can be realized by using a multi-application Core. An illustration of this
concept is shown in Figure 7.5. Using the developed and implemented abstraction layers,
multiple APP-plugins can access a single connection object of the Core for physical inter-
action and message handling. Messages to be sent are pushed to the Communicator and
then processed. As each APP-plugin provides its application identifier, messages can still
be identified, processed, and filtered. For receiving messages, the server sends a message to
the Communicator of the client computer if any of the running APP plugins associated with
this Communicator has matching filter rules. The received message is then distributed to all
APP plugins connected to the Communicator. Finally, filtering within each APP-plugin is
performed in the same way as in the simple case with a single plugin.
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Figure 7.5: Illustration of the multi-application core, allowing multiple APP-plugins to utilize a
single Communicator for message processing.
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7.6 XML-based configuration
The configuration of the application and the used plugins, as described previously, can be
performed entirely with a XML-based configuration file that is parsed and processed at the
program start-up. This configuration includes many of the features already described, like
the core functionality, the Connector definitions, and the used APP-plugins. This definition
is separated into three parts: First, general settings regarding the application core are defined.
This definition includes global constants like the path for plugins to be loaded and may be
expanded by additional definitions.
The second part describes the configuration of the communication interfaces and Commu-
nicators using the definition of Connections. This includes the names of the required ENC-
and COM-plugins with their settings. Such configurations include the selection of client or
server mode, host names or IP addresses, and ports.
Finally, one or multiple definitions of individual plugins are included in the XML-based
configuration file. After selection of the APP plugin by its name, the application identifiers
and additional parameter are set.
Using such a configuration, the individual devices can be configured and integrated within
the framework and adaptions can easily be performed. An example for such a configuration
file is given in Figure 7.6.
Figure 7.6: Example for an XML-based configuration file for an application to connect to the
developed 3M Bair Hugger interface as used within the implemented framework.
<?xml version="1.0" encoding="UTF -8" ?>
<control>
<config>
<pluginPath>plugins</pluginPath>
</config>
<connection id="con1">
<com plugin="ComTcp">
<mode>client</mode>
<ip>comserver</ip>
<port>5000</port>
</com>
<encode plugin="EncXml">
</encode>
</connection>
<app plugin="AppBairHuggerConnector">
<identifier>ICU1 -BairHuggerConnector</identifier>
<location>ICU -1</location>
<com>con1</com>
<comport>COM17</comport>
<baudrate>9600</baudrate>
</app>
</control>
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7.7 Database
As mentioned in the motivation, a feature of the developed medical framework is the connec-
tion to a single, centralized database for storage of the messages with control commands and
measurement results. The database is an important aspect for collecting the study data and
retrospective analysis, but not required for the framework applications to run and perform
automated therapy as the plugins should mainly rely on the framework’s message structure
and not on the information stored within the database. However, such stored information
may be used to initialize a plugin during a restart or to obtain additional information not
present in the current message stream.
Connection from applications to the database within the framework is realized by another
APP-plugin. The filter rules for this plugin are set to receive any message. Therefore, the
server will relay every transmitted information to the application running the database
plugin. This APP has a connection to the database server and will process all messages
for storage in an appropriate database table. For the performed implementation, the freely
available and relational PostgreSQL database was used.
As the primary function of the database within the framework is data collection and logging
of all events, its structure is optimized for fast writing performance, allowing to store all
messages in a timely fashion. Data export then can be performed retrospectively, where no
demand for a real-time application is required.
To allow easy differentiation between the individual patient identifiers, patient data is stored
in individual schemata within the PostgreSQL database. The database structure is defined
by a general header table, containing the information of the message itself and providing a
unique header ID for additional information to be linked to. The database tables are created
for data in the format of integers, real values, strings (less than 256 chars), and text. This
is done to achieve an improved performance within the table structure as all entries within
a table are of the same type. For waveform data from high-resolution sources with up to
several hundred Hertz per second, an additional table is used. It stores the measurements,
received as comma-separated data blocks, just like those to minimize database overhead.
The data content of all other messages is either stored in a raw data table as plain-text, or in
individual tables for different data types, depending on the availability of a plugin to decode
the message and the message type. Given the general message data format with key-value
pairs, implemented for most messages, the appropriate tables are automatically selected for
each key-value pair and information is stored and linked to the unique header ID of the
message.
To maintain the order of information and avoid mismatching of individual messages in the
time domain, the timestamp provided by the sender of the message is used. An additional
timestamp is stored at the moment of writing the information to the database. This pro-
vides further safety against time offsets and may allow for retrospective restoration of the
communication flow if time-stamps of one connected client are skewed, e.g. due to offsets
introduced by daylight-saving time.
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As an initial approach for data collection, message-specific database tables were used in the
AP study for animal subjects ap004 to ap009. With a growing number of different messages
and the performance drawbacks of tables with different types, this approach was replaced
with the more general structure defined by tables for individual value types, as described
prior, and used from animal subject ap010 onward. An overview and comparison of those
two implemented and used database structures is shown in Figure 7.7.
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Figure 7.7: Message processing with the current structure (top) and the initial approach at the
beginning of the AP study (bottom). In both approaches, an individual database
schema is used for each animal subject and header information is stored in a separate
table. In the current structure, tables for each data type are used and the information
content of each message is stored in those type-specific tables, linked to the header ID
(middle). In the initial approach, a separate table for each message type was
implemented, containing the individual fields of the message with various data types.
Within both approaches, a raw table is used to store unparsed message information if
no appropriate MSG-plugin is available or the information cannot be parsed.
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Using the theoretical and general concept described in the previous chapter, the framework
was implemented as the Tübinger ICU Control and Monitoring System (TICoMS) for the
specific needs in the experimental study settings at the Institute for Experimental Surgery
at the University Hospital Tübingen. This chapter describes the specific implementation,
some exemplary framework features, and the data export pipeline used for the retrospective
analysis, which will be covered in a later parts of this thesis. Finally, the results of the
performed studies are presented from a technical viewpoint in terms of collected data and
data throughput as an evaluation of the framework performance.
8.1 Physical structure & implementation
Given the theoretical concept and software design, a first step was the establishment of a
physical network between the individual medical devices. To provide an overview and as a
reference for the achieved results, a short overview of the physical implementation is given
in what follows.
8.1.1 Hardware setup & physical network structure
Implementation of a software framework for bidirectional communication of medical de-
vices can only be performed upon an existing or to be established physical connection layer
between the individual devices. Using the framework concept with modular plugins for
message encoding and communication with a physical transport layer, few restrictions were
given. The framework could be established using serial links, like industrial buses as RS232,
RS485, CAN, Field/Modbus or other available technologies. However, for easy integration
of computers, servers and available medical devices, a communication over Ethernet was
chosen for the implementation of the framework.
The implemented physical setup mainly consists of two parts or locations: First, a bedside
part for connection of all required medical devices and interaction with the system. Sec-
ond, a backbone consisting of servers and storage for data processing and running central
applications like communication server and database. As those parts are physically sepa-
rated on different floors, network connections were established with two smart switches as
central nodes. For load balancing and redundancy, link aggregation was used for intercon-
nection. Several network services are provided on a running network server, including NTP,
DHCP and DNS. The implemented setup is designed as a scalable solution for multiple
beds. As many medical devices can be connected to a network and may interference with
each other in the same broadcast domain, strict separation of signals on the physical layer
for the network devices is required to avoid unwanted traffic and possible interaction of
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the devices. This was achieved by implementing different Class B IP sub-nets. For central
ICU infrastructure, the 172.16.100.0/24 sub-net is used, 172.16.110.0/24 for the first ICU
setting, and 172.16.120.0/24 for a second one. The server room infrastructure and hardware
management is encapsulated in yet another sub-net, 172.16.10.0/24. Of course, this is just
a fundamental separation and classification and could be further scaled with additional sub-
nets for different compartments and more sophisticated needs. Yet, the different sub-nets
allow a clear separation of the traffic and routing between the individual components and
units of the network. To avoid the usage of different physical network cables, VLANs for
assignment of specific sub-nets to individual network outlets were used. This VLAN config-
uration for the individual network ports as well as routing between the individual sub-nets
was performed with the used smart switches. A schematic overview of the used physical
network setting and device interconnection is given in Figure 8.1.
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Figure 8.1: Illustration of the complete implemented physical structure of the entire TICoMS
network. General classification consists of common infrastructure in the server room,
common devices on the care unit, and individual bedside devices. Those individual
compartments are divided into separated sub-nets to avoid cross-talk.
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8.1.1.1 Central patient overview and control monitor
An ICU setting consists of a multitude of medical devices, each providing their own in-
terfaces and screens. Moving towards an integrated form of intensive care, the increasing
number of individual monitors and interfaces must be considered as is already far too
high [3]. Given many interconnected medical devices with their information integrated into
a common framework and the additional remote-control capabilities, a central interface is
a next logical step. To provide this interface, a patient interface consisting of a monitor
and a touchscreen was built and integrated in the framework. The implementation and
schematic overview can be seen in Figure 8.2. The top monitor shows current and historic
patient information, obtained from the vital parameters and settings stored in the central
database. It provides a detailed overview of the patient with a user-definable observation
window ranging from 15 minutes to up to 24 hours. The touchscreen at the bottom provides
a general interface to a multitude of framework-based control applications.
Overview Monitor
(Database-based
Trend Charts)
Interactive Control Screen
(Touchscreen with
MultiApp-Core & Plugins)
One Patient - One Interface
Concept
All curent and historic
data is available
Everything can 
be controlled
Figure 8.2: Patient interface with observation monitor on top of a touchscreen control interface. A
Photo of the actual hardware (left) and an illustration (right), highlighting the central
interface concept, is shown.
8.1.2 Applications and Plugins
Several plugins and applications were developed for practical implementation and evalua-
tion of the framework at the Institute of Experimental Surgery at the University Hospital
Tübingen. Mainly, two core executables are used: First, a single application core, used for
standalone applications; Second, the multi-application core with a GUI interface, used in
the central patient interface for selection of and interaction with various plugins.
For each of the used medical devices, a plugin for connecting the individual device to
the message-based network was developed. The Dräger Evita XL ventilator and B.Braun
SpaceStation infusion pump pillar, with SpaceCom network communication module, were
integrated to allow for remote control and data collection. A Philips MP50 patient monitor
was included to collect numerical values on a second by second basis as well as reading
high-frequency curves up to several hundred Hertz. Weight measurements are collected
from in-house developed diuresis and the body scales. A 3M BairHugger forced-air blanket
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temperature-management unit was included via a developed interface board. Furthermore,
laboratory measurements from a Radiometer BGA device and a POC ACT test device were
added. For the latter one, a Raspberry Pi was used as the framework interface. Besides
those device-connecting plugins, several additional and interactive plugins, mainly on the
patient control monitor, were implemented. Those include manual control interfaces for
the infusion pumps, ventilation device, temperature management unit, allow for paperless
comments and manual inputs for parameters like weight, and implement interactive thera-
peutic protocols. Furthermore, plugins visualizing the overall system state and providing
warnings, if devices should malfunction or not respond to the medical framework server
anymore, were implemented.
8.1.3 Examples
To provide a brief example for the implementation of the proposed plugin architecture and
message communication, the network communication and pump control is outlined and
examples for the interactive touchscreen on the central patient monitor are shown.
8.1.3.1 Com-Plugins (TCP & RS232)
A central component of the message framework is the communication with other applica-
tions. As previously described, Ethernet connections are used for communication in the
used experimental setting. A single COM-plugin is used for communication between all
applications of the framework. The COM-plugin provides configurable options, e.g., for
client and server mode, and delimiters for start and end of the message. Therefore, it is not
only used for the communication between the framework applications, but utilized with an
individually adapted configuration for the communication with the B.Braun Space Station,
body scale, the Raspberry Pi for connecting the ACT device, BGA device, and other inter-
faces relying on an Ethernet connection.
For communication with other devices over serial port using the RS232 protocol, a second
COM-plugin was developed. Equally to the TCP plugin, it provides an abstraction layer
for communication between different devices by serialized message objects. For example,
communicating with the ventilator, patient monitor, and diuresis scale.
8.1.3.2 Control of infusion pumps
The control, configuration, and reading of the infusion pumps of the B.Braun Space Station
is performed by two important plugins. First, a device connector APP-plugin, performing
communication with the pumps and providing base functionality like timers for bolus
durations and processing of relative and absolute rate changes; Second, an interface for
configuration and monitoring by the caregivers. An in-detail illustration of this setup is
given in Figure 8.3 and described below.
Device connector The device connector is the control application that connects to the
B.Braun SpaceStation via Ethernet interface. Therefore, a second Communicator is used by
the application, handling the entire communication to the pumps. For communication with
the framework, three types of messages are used: Two messages are used for information
about the infusion pumps and sent by the application. First, a data message is used to inform
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about the current infusion rates that are important for many applications. Second, a status
message with information about the present pumps, their settings, and other information
about the state of the infusion pump. A third message can be received by the application,
allowing for pump control. This control message allows setting different parameters, in-
cluding the pump rates, limits, minimal speed, bolus durations, and volumes. Given the
desired input, the application plugin handles the timers for automated administering of
bolus infusions and is a hard limiter for the user-defined infusion rate limits. Therefore, no
application can override these limits by simply setting an infusion rate, but must explicitly
adjust the limits. This is especially important for remote control applications with drugs like
Arterenol, where even small infusion volumes and changes may have severe consequences.
Device interface The second application is the device interface on the patient overview
and control monitor. This application allows the observation of the pump states and the
control of the individual pumps, e.g., for setting the infusion limits and rates. It is only a
GUI, showing the current state and sending pump control message based on the user input
to the connector application. Yet, this application is a very important safety feature and
plays an essential role as it provides the ability to override automated commands. Each
pump control message has a flag to indicate if the message was generated automatically
or triggered manually. Therefore, manual commands can be distinguished and override
automated settings, e.g., if automated rate changes need to be reverted or an active timer-
based bolus need to be stopped.
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Figure 8.3: Overview of pump interaction with pump connector and GUI application. Status
messages for the pumps are sent to the monitor and other applications. Pump control
messages can be received from any sender within the network.
8.1.3.3 Interactive GUIs on the touchscreen interface
The developed central patient overview and control monitor is used for presentation of the
current and historic patient data on the upper monitor and for interactive applications on
the lower touchscreen interface. Using the developed multi-APP core, various framework
applications can and controlled, including interactions with infusion pumps, ventilator and
other medical devices. Selection of individual plugins can be performed with a tab-bar at
the top of the interface. The GUI for the selected feature is then provided and handled
by the appropriate plugin. As this interface is perfectly integrated within the framework
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and can be easily expanded, it provides an essential component for automation of medical
protocols and development of custom interfaces which could not easily be developed in
other dedicated hardware. Examples for such plugins with touch-screen optimized GUIs
are shown in Figure 8.4 for the control of infusion pumps and the interactive step-by-step
study protocol for assessment of the volume state in the VNA study.
Figure 8.4: Examples for the GUIs of the touchscreen user interface. Pump-control screen for
monitoring and manual control of the infusion pumps with colorized pump states
including settings for rates and limits (top). Integrated step-by-step workflow for
assessment of the volume state in the VNA study (bottom).
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Data export is an essential step for retrospective analysis and further processing of informa-
tion with methods of machine learning. Given the stored information within the PostgreSQL
database, export is performed with an R script pipeline. This entire data processing pipeline
with all intermediate steps for export and documentation is shown in Figure 8.5. The gen-
erated results include overview plots for an animal subject as PDF files for documentation
purposes with an overview of the vital parameters and the administered drug infusions.
Further export processing of the individual parameters is dependent on the data frequency
and separated in numerical data with frequencies up to 1 Hz and high-frequency wave data.
Export using R scripts was performed for a variety of reasons, including the requirement
that the documentation of the performed studies should be available all the times, which can
easily be achieved with the simple PDF export by R and the fact that R is freely available
software. Thus, in comparison to MATLAB no internet connection and license renewals
are required, which would provide an obstacle for such an essential step of an isolated
productive system.
HDF5
.mat
CSV
individual les
for parameters
protocols of 
vital signs
& drugs
conversion
Matlab processing
Matlab
analysis
JMP
analysis
Conversion
R processing
DB
      R
analysis
JMP Processing
binary
waveforms
BinaryPDF
Figure 8.5: Data export pipeline for documentation and further processing of the obtained data in
different file formats.
8.2.1 Numerical data
Numerical data is exported by an R script pipeline to individual CSV files for each parameter.
This CSV files can be used for further processing with statistical tools like JMP or combined
to other CSV files, containing a subset of parameters of interest. Additionally, the R scripts
generate a HDF5 file as a compact storage solution for all numerical results. A schematic
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Figure 8.6: General HDF5 tree structure for storage of the results (left), example for structure
within the used context (top right) and example for access to individual parameter by
path names (bottom right).
overview of the export structure within the HDF5 format is given in Figure 8.6. As the HDF5
format provides a directory structure, each device is represented by its own folder. Each
parameter of the device is then represented by an array of timestamps and values within
this folder. Due to this directory structure, each parameter can be addressed by a unique
path. This is especially useful, as the measured parameters may vary between individual
trials. The generated HDF5 file can then for example be imported in MATLAB and used to
create an intermediate .mat file for performance reasons. Then, further analysis, including
the comparison of different animal subjects with machine learning may be performed.
8.2.2 Curve data
Besides numerical results, high-resolution curve and waveform data with up to 500 Hz is
stored and exported for ventilation device and patient monitor. As this high-resolution data
would yield enormous overhead by comma-separation of each measurement result, data
export is performed with binary files. Within this format, timestamps and measurements
are encoded by a fixed number of bytes without further delimiters. A short example for
obtained wave data from the ECG-II curve of vna007 is shown in Figure 8.7.
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Figure 8.7: Short snippet of collected high-resolution ECG curve data from animal subject
vna007.
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The framework as described and implemented was used for measurement of all data during
two performed and presented medical studies at the Institute of Experimental Surgery at the
University Hospital Tübingen. However, besides any medical relevance, individual aspects
of automation, and data analysis, which are described in later chapters within their appro-
priate context, the results of this full-scale implementation and long-term evaluation of the
system with a significant amount of collected parameters and the achieved data throughput
shall be presented from a technical perspective in the following.
8.3.1 Framework implementations
The implemented framework was expanded to 2 core applications, 42 APPs for connecting
devices, user interfaces and automation controllers, an XML encoding plugin, 2 Communi-
cation plugins for Ethernet and serial communication, over 30 MSG plugins, and an UTIL
plugin for HL7.
To give an estimate of the size of the developed and tested framework with various medical
devices and interactions, a total number of 496 .cpp and 560 .h files with a count of 113 869
and 21 583 lines of code, respectively, and additional 24000 lines of comments for defining
the interfaces and methods were implemented.
8.3.2 Integrated devices and protocols
In total, over 13 different data sources, including bedside and laboratory devices, were
integrated into the developed framework for data collection and remote control. An overview
of the different parameters, collection rate, and the animal subjects for which information
was collected, is shown in Tables 8.1 and 8.2. For integration of the Philips patient monitor,
the Philips IntelliVue protocol for medical devices is implemented. Communication to the
Dräger Evita XL ventilator is performed using the Dräger MEDIBUS RS232 protocol. For
integration of the Radiometer blood gas analyzer, the HL7 protocol was processed. More
specific details regarding automation and further processing of the collected information
will be provided in the subsequent parts of this thesis, covering closed-loop applications
and data analysis.
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Table 8.1: Overview of the collected parameters from the different devices and applications with
temporal resolution and individual animal subjects for which those parameters have
been collected.
Philips MP50
patient monitor
Measurements: CFI, external HR, dPmax, CCO, CCI, C.I. ABPdia,
ABPmean, ABPsys, CVPmean, Perf, Pleth, Tblood, ITBVI, ITBV, SI,
SVV, SV, EDVI, EDV, EVLWI, EVLW, Pulse
1 second ap004-ap010, vna001-vna010
Patient data: ID, name, BW, gender, age
event based ap004-ap010, vna001-vna010
Curves: 3 EEG channels, ABP, CVP
50-500Hz vna001-vna010
B.Braun Space
infusion pumps
infusion rates, infusion names, positions within the pillar, pump con-
figurations and settings
≈ 2 seconds ap004-ap010, vna001-vna010
Dräger Evita XL
ventilator
Measurements: CO2 production, Compliance, Deadspace, Endtidal
CO2, Expiratory Volume, Inspiratory O2, Lung time constant, Manda-
tory Trigger, Mean airway pressure, Minimal airway pressure, Minute
volume, PEEP airway pressure, Peak airway pressure, plateau airway
pressure, rapid shallow breath index, relative deadspace, resistance,
respiratory rate, spontaneous resp rate, spontaneous min volume
1 second ap004-ap010, vna001-vna010
Settings: ASB ramp, Apnea time, backup resp. rate, backup tidal vol-
ume, Flowtrigger, IEExp, IEInsp, InspO2, Insp. pressure, Max. insp.
pressure, Max. insp.pres. for CPAPASB, PEEP, RR, Tachypnea resp.
rate, threshold of end of flowcycle, Ti, tube compensation, tube diam-
eter
1 second ap004-ap010, vna001-vna010
Alarms: Alarm flags of the Evita ventilator device
1 second vna001-vna010
Curves: airway pressure, flow, insp. volume, start insp. cycle
50 Hz vna001-vna010
Osypka ICON raw data, age, ci-bsa, ci-wt, co, flc, gender, height, gr, icon, id, lvet,
pep, si-bsa, si-wt, sqi, str, sv, sw, tfc, timestamp, vic, weight
1 second ap010, vna001-vna010
Pulsion
PulsioFlex
APdia, APsys, CPI, CPO, CVPmax, CVPmin, DO, DO2I, HP-PR,
Height, MA, O2ER, PPV, time, SV, SVI, SVR, SVRI, SVV, ScvO2,
Type cCO, VO2, VO2O, CCl, cCO, dPmx, meanCVP, alarm settings
1 second vna001-vna010
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Table 8.2: Overview of the collected parameters from the different devices and applications with
temporal resolution and individual animal subjects for which those parameters have
been collected. (cont.)
Radiometer BGA
APL800 Flex
Type (Art., ven.), COHb, Ca2+, Cl-, Glu, HbF, K+, Lac, MetHb, Na+,
O2Hb, RHb, SBC, SBE, T, p50act, pCO2, pCO2T, pH, pHT, pO2,
pO2T, sO2, tBil, tHb, tO2
event based ap001-ap010, vna001-vna010
Medtronic
ACT Plus
two individual time measurements, mean clotting time
event based vna001-vna010
3M Bairhugger temperature setting, speed setting, control commands
1 second vna005-vna010
Diuresis scale total volume collected
1 second ap004-ap010, vna001-vna010
Body scale netto weight, brutto weight, status bits (e.g., stable measurement),
digital input pins (tilt detection)
1 second vna001-vna010
Fluid balance different derivative measures from the body and urine scale correlated
to infusion rates
1 second vna001-vna010
Volume Need
Analysis
blood pressures at specific points within the maneuver, settings, and
derivative values, sonographic results
event based vna001-vna010
Comments free text comments by caregivers
event based ap004-an010, vna001-vna010
8.3.3 Collected data & runtimes
During the two performed studies, all data was processed and recorded by the database con-
nected to the developed medical framework. In order to show the reliability and capabilities
of the developed framework, the evaluated runtimes and the total number of stored database
entries for all connected devices are presented. In total, data collection and evaluation of
the framework were performed for 1.332 hours and resulted in a total number of over 47
million transmitted and stored messages with almost 8 billion database entries. A more de-
tailed breakdown for each animal subject is given in Tables 8.3 and 8.4. Whereas the former
table provides an overview of the runtimes and the total number of messages transmitted
by the framework, the latter table presents the number of collected data entries in relation
to the data format within the database for both used table layouts. As noted in the database
description (7.7), the first format consists of tables for each message type, containing all
values of the specific message. The enhanced format separates all information according
to the message content in integer, real, string, text, and curve data for better writing perfor-
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mance. Technical messages, like client-server interactions and other non-vital data were
not processed further by the database and stored as raw strings. Variance and reduction
in the number of the messages from the infusion pumps (B. Braun Space Station) can be
observed for the old database format. This reduction of the pump polling frequency after
animal subject ap004 was required to maintain stable running condition for the entire study
duration as supposed problems with the network buffer within the infusion pump pillar led
to communication breakdown when using a higher polling frequency.
Table 8.3: Overview of the framework related statistics for the two performed studies.
Animal subject Collected param. runtime [h] Messages
A
P
St
ud
y
ap001 –(1) –(1) – (1)
ap002 –(1) –(1) – (1)
ap003 –(1) –(1) – (1)
ap004 171 65 631,192
ap005 248 72 862,207
ap006 250 36 433,697
ap007 245 72 1,017,164
ap008 253 52 1,648,579
ap009 246 68 999,880
ap010 229 13 177,342
V
N
A
St
ud
y
vna001 331 96 4,261,622
vna002 321 57 2,137,001
vna003 329 96 4,366,997
vna004 347 96 4,458,760
vna005 350 96 4,668,021
vna006 349 96 4,844,387
vna007 349 96 4,712,003
vna008 348 96 4,821,337
vna009 350 96 4,800,420
vna010 397 48 2,381,399
total 1332 47,222,008
(1) For animal subjects ap001–ap003 data was not yet collected in a central database. These animal subjects
of the ongoing clinical studies were used for collection of first real device data and implementation of the
device connections.
8.3.4 Network monitoring and statistics
To maintain an overview of the entire system, a Paessler PRTG [192] network monitoring
system was used. It provided the essential tools for monitoring the running conditions of
all connected devices prior and during the performed studies and for detection potential
problems and failures. As the system collects network statistics of all included devices,
these log files can be used for a brief evaluation of network performance and individual
device and server load while running framework applications during the conducted studies.
An overview of performance statistics is given in Table 8.5 to show the average data rates
handled by the individual components of the framework. Obviously, the highest load can
be observed at the server, handling all messages with an average data rate of 60.48 MB/s.
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Table 8.4: Overview of the number of individual database entries collected during the two
performed studies with old (top) and improved (bottom) database format as shown in
Figure 7.7. In the old format, entries were separated by message type, in the new
format by the data type.
subj. spacepump spaceinfo vital vital_value cmt raw
ap001 –(1) –(1) –(1) –(1) –(1) –(1)
ap002 –(1) –(1) –(1) –(1) –(1) –(1)
ap003 –(1) –(1) –(1) –(1) –(1) –(1)
ap004 3,643,872 331,273 229,342 4,806,954 0 577
ap005 1,278,201 106,524 751,717 16,478,432 47 3919
ap006 643,862 55,917 375,604 7,761,266 28 2146
ap007 1,284,829 107,196 800,470 16,317,540 25 109,473
ap008 2,054,269 171,329 1,302,250 28,092,128 37 174,963
ap009 1,207,051 100,595 796,567 16,873,684 24 102,690
total 10,112,084 872,834 4,255,950 90,330,004 161 393,768
subj. int real string curve text raw
ap010 2,813,818 3,523,466 5,138,301 21,328 0 17,625
vna001 23,203,728 36,282,600 38,262,653 696,121,883 0 113,394
vna002 13,942,500 19,589,726 23,290,228 416,777,581 0 69,613
vna003 23,751,801 35,065,238 39,172,263 759,641,273 0 118,736
vna004 24,353,045 36,517,198 39,630,009 772,456,394 0 121,271
vna005 27,537,384 35,517,571 39,226,083 750,241,651 0 119,129
vna006 27,003,387 37,550,681 38,586,663 763,503,660 0 118,687
vna007 26,656,903 35,265,170 39,209,214 758,786,855 1 118,006
vna008 27,895,840 36,982,688 39,599,740 772,611,988 0 119,870
vna009 27,107,424 37,385,694 39,834,473 764,798,344 0 117,196
vna010 13,780,297 17,468,900 20,450,167 396,455,021 0 62,873
total 238,046,127 331,148,932 362,399,794 6,851,415,978 1 1,096,400
(1) For animal subjects ap001–ap003 data was not yet collected in a central database.
Table 8.5: Median data rates for the individual network devices during the VNA trials. Trunk is
the backbone network connection between the ICU and server room switch, Server is
the load of the network connection to the server, running the application server,
database, and network services. The embedded PC is used for collection of
measurements from patient monitors, scales, and 3M Bair Hugger.
Network connection i˜n [Mbit/s] o˜ut [Mbit/s]
ICU embedded PC (data collection) 13.41 91.41
ICU SpaceStation (infusions) 2.13 9.68
ICU Monitor (User Interface) 126.61 25.10
Trunk (Switch interconnect) 161.31 461.05
Server (Server with VMs) 483.86 177.02
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9 Discussion
When dealing with medical devices, one of the most important problems is the lack of
standardization and interoperability [7, 10, 11]. Thus, any further processing or analysis
based on data gathered from such a loose collection of individual medical devices is hardly
possible until this problem is solved. Given the rare opportunity for practical evaluation
of possible solutions for this problem in an experimental porcine ICU setting with less
restrictive legal boundaries than in clinical practice involving humans, a novel, modular
framework was developed. This system allows for interconnection of medical devices using
message-based communication in a client-server environment.
The presented framework was especially designed for experimental academic research
with the main focus placed on scalability for fast and reliable expansion of the system
regarding changing and evolving research questions. Besides this aspect of fast expansion,
the re-usability of implemented parts was important during development as it allowed
for faster testing and debugging of established components. Thus, components required
in any or almost all applications, like communication plugins, were reused and potential
flaws and errors were successfully discovered and resolved faster during the expansion and
development phase.
An important aspect of the framework is the modular, plugin-based concept of information
exchange using individual message objects that are dynamically loaded from specific
plugins. Using this approach, only the general message structure but not the specific
implementation must be known to all clients beforehand. Only devices interested in
the message content require the respective plugin for further processing. This allows
standardized message-based communication between the individual medical devices
without the need for alternating the existing applications and implementation. If a device
receives a message, the header is processed and if no message plugin for decoding is
available, the message simply is discarded. Therefore, additional messages can easily be
included, maintaining a backwards comparability to the already implemented system. This
is an important feature, as in the case a message arrives at a wrong target by accident,
this must not result in any invalid states or problems. As another step to ensure that only
messages intended for the receiver are further processed, message filtering after successful
parsing is performed. This utilizes a set of rules and identifiers, allowing arbitrary com-
binations and exclusions as each filter can individually be designed for the appropriate need.
In comparison to various independent solutions for measurement and control of single
parameters as presented in Chapter 3, the usage of a software framework with a central
database provides advantages in terms of data synchronization and collection. An ensemble
of individual data sets, collected on different devices, for example various laptops, can
hardly be processed any further and matching of the timestamps may be very difficult.
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Additionally, many devices with large storage space are required for collecting all data,
rendering such a solution not scalable. Solving this problem, frameworks as for example
proposed by Feng et al. [111] are capable of collecting data for retrospective analysis.
However, such solutions still lack the ability for connected clients to communicate with
each other or for a server to send and relay control commands to the clients. Yet, this is a
requirement for anything more than retrospective data analysis and only achievable with
full-scale communication solutions like the developed framework.
By using a client-server based system, the server has the control authority over the connected
devices and information exchange. Additionally, it can provide an overview of all connected
devices. As all information is forwarded by this central node, collection of all data and
control commands can easily be performed and stored within a connected database. This
allows for the retrospective analysis of all performed actions. Besides advantages during
development and debugging, such a feature may be important for automation within the
clinical setting. If any malfunction or patient harm occurs, a complete track of actions can
be obtained and investigated. Due to the general message format, each message can be
logged at least as plain-text within the database. If messages are specifically encrypted,
e.g., for proprietary communication between devices of a single manufacturer, such logged
messages may retrospectively be decrypted to gain a detailed insight of the performed
measures.
Of course, such a client-server approach also has its drawbacks. Its central interaction point
provides a single point of failure as the large number of messages has to be handled by the
server to avoid clogging the network and cause severe delays. Regarding this weak spot and
for better scalability, peer-to-peer approaches as for example suggested by Pölsen et al. [110]
can be beneficial. Yet, such approaches face other difficulties, like maintaining an overview
of the network and provide access control. Furthermore, problems regarding a single server
might be countered by implementing redundancy with multiple instances, sharing the net-
work load and providing a fail-safe switchover. Thus, each solution is a tradeoff between
the various goals to be achieved. Yet, regarding the research scope for academic purposes
and early prototypes, the client-server concept allowed a better overview and control of all
devices and messages and thus was the concept of choice.
Software concepts with many possible and theoretical aspects are a first essential step, but
practical complications are easily overlooked. Thus, the experimental evaluation of such as
system was an essential step. For example, problems like connection loss must be addressed
in any medical framework. This includes questions like intermediate storage and automatic
retransmission of messages and notification of caregivers. Additionally, strategies for re-
turning to an operating condition from such a state need to be considered. One example
is a short outage of the connection to the server. Once this connection is re-established,
all clients would try to reconnect to the server at once. Obviously, such a load peak may
cause further problems. Thus, randomized reconnect times for reduction of such events
were implemented.
Furthermore, questions regarding the physical implementation and hardware have shown
to be at least as important as design and implementation aspects and must not be forgotten
in any further or related research. Given the heterogeneous landscape of numerous medical
devices, a large number of connections needs to be established for interconnection. Even
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in the used small research environment, a significant number of devices and servers is al-
ready present, requiring reliable and structured network and server infrastructure to handle
the data. As often many similar devices like infusion pumps or patient monitors are used,
cross-talk and interferences between those devices needs to be considered as messages of
the correct format might be obtained by the wrong receiver. Whereas hopefully further
checks ensure that no wrong commands are processed, filtering and processing may lead
to a significant overhead and problems, especially if a huge number of devices would be
interconnected within a single hospital-wide network. Therefore, separation of the IP net-
work into different sub-nets and broadcast domains should be performed. For the developed
system this was implemented by using separate VLANs, working independently on the
same physical network connection. VLAN management and routing between the individual
nets was performed with smart switches, which allowed for easy set-up and adaption of
the sub-nets and VLAN, assigned to individual network ports. Network infrastructure also
provides other important features like link aggregation and STP for finding the shortest
path and avoiding network loops. Caused by manual mistakes like erroneously connected
network ports, such events may take out the entire control systems with potential patient
harm.
For easy configuration of the application’s connections to the server and medical devices
by unique device names within the XML-based configuration file, identification was
performed using the DNS for forward and backward resolution of the IP addresses. Fixed
IP-address were used and automatically assigned to the clients using a DHCP server
whenever possible. Another important aspect is the management and synchronization
of the real-time clocks of the individual devices. As all data should be collected and
matched in the time domain for further analysis and processing, a common time base
among all connected devices is required. This aspect was considered by using the NTP for
time synchronization, providing consistent timestamps among all devices and messages.
Besides that, maintaining an overview of the network and all connected devices was an
important aspect to assess the operating condition of the system as a whole. Whereas each
device could be checked individually, network monitoring was used to maintain a tight
control and overview of any connected device regarding their network connection and
other aspects like remaining storage space. This allowed a fast and complete assessment
with notifications of potential failures at any time during the performed studies. Especially,
considering large scale implementations of such medical frameworks, network monitoring
will play an increasingly important role as it would not be feasible to observe each device
individually.
Using the implemented framework, over 1300 hours of observations for over 300
parameters and settings could reliably be processed and stored in a central database. As
this included all collectable parameters and settings provided by the medical devices, the
maximum amount of information was preserved and is available for detailed retrospective
analysis. Thus, minimizing the potential need for additional animal studies if specific
details or correlations between parameters of interest or device configurations were not
initially considered but become relevant during further analysis. Yet, despite the large
number of connected devices, still not all information can be stored. Unfortunately, many
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devices only provide data output on a second by second basis, whereas internal calculations
are performed with a much higher resolution. Therefore, high-resolution data exceeding
1 Hz could only be stored in the central database for a subset of parameters from ventilator
and patient monitor.
Whereas communication between different devices of the framework is based on transmitted
messages, the database is only used for retrieval of historic data and retrospective analysis.
Thus, the most important aspect was storing the collected information in a rapid fashion
with optimized write operations. To facilitate this aspect, the data obtained from messages
is separated into individual database tables of specific data types. For extraction of the
information and further processing, matching of all obtained information in the time domain
is one of the most important aspects. Using the central database, this can easily be performed
as the timestamps obtained from the devices, synchronized by NTP, and the current time at
the moment of writing into the database are stored for each entry. This second timestamp is
especially useful if any communication delays have occurred or for example daylight-saving
time settings of the connected devices cause offsets.
As information from multiple patients or animal subjects needs to be stored simultaneously,
an individual database schema is created for each subject. This allows easy querying of the
stored information for export and allows subjects to be easily removed from the database
as well. Especially with a large number of patients or animal subjects in continuous usage,
this separation helps to manage and clean up the stored information.
Data export from this central database is currently performed by a broad variety of ways
depending on specific research questions and the tools for further processing. Furthermore,
given changing experimental settings with different device configurations, infusions,
and obtainable parameters, changing datasets between each animal subject are the norm.
Therefore, export of a result matrix with fixed parameters was not feasible as further
processing would need to keep track of the location and availability of each observation
variable. Another aspect regarding the data export was the large amount of data with often
repeating measurements, especially for device settings. A solution for those problems and
challenges was provided by using the HDF5 format, supporting file compression for the
repetitive numerical observations, resulting in a single export file of around 80 MB for
all parameters of a single subject with 96 hours of observation. Additionally, utilizing
a folder-like tree-structure, the HDF5 format allows to access the information by path
names like bga/arterial/glu. This removes the need for numerical parameter IDs with
the potential for offset errors in variable parameter sets. Despite all these advantages,
many features of the HDF5 format are only available to a limited extend in the used R
and MATLAB packages. Utilizing both tools, only the intersection of the respectively
supported features could be used. Given the full potential, HDF5 may for example allow
improved compression and support tables containing different data types, thus providing
a more compact data structure. For high-frequency data of ventilator and patient monitor,
binary encoding was used to save space, resulting in around 2 GB for each parameter of
an animal subject. As this is a significantly larger amount of data, additional storage and
processing capabilities, and adapted handling for further processing and analysis may be
required. However, since high-frequency data has only been collected for the most recent
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animal subjects of the VNA study, no further processing with the collected information
is yet performed. Such next steps may include analysis of the pressure curves and ECG
using wavelets or other analysis methods in the time and frequency domain [132–134].
Additionally, given the amount of collected data and the different methods for data export,
the proposed data collection and export is a first and fundamental step for further analysis
and already the foundation for several medical doctorate theses.
Beside the potential for retrospective analysis, the collected data was used to observe and
facilitate therapy by the caregivers. Given over 300 collected parameters, aggregation and
presentation was another essential step to maintain an overview of the animal subject and al-
low for easy interaction with automated systems. Especially with an increasing degree of au-
tomation and more medical devices in intensive care settings, central interfaces, combining
the many various information sources, are required. For usage with the proposed framework,
a monitor and a touchscreen interface were included as the central patient overview and
control system. This allowed the implementation of various GUIs for framework-based ap-
plications, presenting current and historic patient conditions, allowing the control of medical
devices and automation settings, and interactive and semi-automated processing of stepwise
study protocols. Yet, the most important aspect was the ability for manual intervention to
the automated control systems in case of potential critical situations and erroneous actions.
Lastly, apart from those various use cases of such a touchscreen and the easy interaction,
the glass surface provided an optimal solution regarding hygiene and cleaning concerns in
the experimental setting.
9.1 Outlook
The framework was successfully implemented and evaluated during the performed studies.
Yet, several features may be added in the future. Developments regarding standards for
medical devices, like IEEE 11073 [114], are to be observed as those might guide further
implementations or redesigns of the framework and may help to facilitate better connection
to novel medical devices and their integration in the existing environment.
Given the academic focus, any clinical application would require several critical and impor-
tant steps like freezing the current state, considerations of several additional safety measures,
and formal verification. Even though safety-critical aspects such as data encryption, check-
sums, and verifications were considered during development, they still would need be added
to the communication and encoding plugins in a further locked down design iteration, po-
tentially requiring a re-design of some safety-critical aspects. Yet, given the research focus,
a spin-off of individual features for clinical application seams more feasible than converting
and locking the existing framework for such an application.
Based on the current implementation, better methods for configuration of the applications
and settings may be implemented as configurations are currently defined at program start
but not adaptable during runtime. For long-term application, dynamic adaption of running
applications or even remote configuration through the communication network would be
beneficial. Another aspect, especially beneficial during development, would be an auto-
update feature for the individual applications. Once a new version of a plugin is compiled,
it currently must be copied manually to each target. During compilation of each plugin, a
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version number and timestamp are already added. On program start, each program core
could compare the copy of the plugins stored in the local plugin folder with versions in a
remote shared folder or query a version database. Once a new version is detected, it could be
downloaded. This would be especially beneficial for plugins shared by many applications
like the COM-plugin and reduce the potential error risk by continuing to use an obsolete
version.
As the framework was developed to be platform independent, applications could be made
available for a broad variety of operating systems and devices. Currently, implementations
are only available for 32- and 64-bit Linux and Windows platforms. Initial tests were
performed for ARM architectures of android devices. Such implementations would allow
for a mobile control and monitoring interface, e.g., based on an Android tablet.
Further improvements could be made regarding a more advanced replay system, allowing
stored information to be converted to messages and resent for distribution through the frame-
work. Whereas individual messages already can be resent and simulator plugins for many
devices have been developed to inject artificial messages and measurements for debugging
purposes, such a general playback system would be useful for evaluation of new features.
As discussed earlier, the server is single point of failure and currently the system is depen-
dent on a network connection between the central server and each device. However, beds
and device groups may be moved. This may result in short, intermediate communication
loss. Especially automated systems, like closed-loop controls should continue patient man-
agement during these times. Therefore, a compartmentalization and encapsulation of the
features for a more autonomous bedside system should be performed. A local bedside server
should manage all devices for a single patient and may be moved with them. Additionally,
temporary storage of the collected information should be performed. Once again connected
to a clinical network, this bedside unit should re-synchronize with the central database
and server. An illustration of such a cascaded concept of bedside server and closed-loops
within a central infrastructure is shown in Figure 9.1 This concept may even be further
extended by the introduction of intermediate servers for individual hospital wards or units,
thus limiting the frequent information exchange to smaller units and only communicating
with the central infrastructure at a reduced rate for long term storage, management, and
billing aspects. Alternatively, such problems might be partly countered by using wireless
transmissions. However, given the large amount of data to be transmitted and still many
scenarios with limited connection, e.g., elevators, those aspects cannot be omitted.
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Figure 9.1: Concept of a self-sustainable bedside system with a local server for uninterrupted
closed-loops and local storage to allow for transport to another hospital unit where
reconnection and synchronization with the central system may be performed.
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10 Motivation
Within the given medical research context of the conducted studies with porcine animal
subjects, the developed software framework with its data collection and device control
capabilities, as describe in the previous part of this thesis, was used as the foundation for
the development and evaluation of several closed-loop applications.
During the ongoing studies, the main goal was collecting clinical research data to obtain
a reliable dataset for further analysis within the medical context. To achieve this goal,
well defined study conditions had to be established and maintained. Additionally, given
the medical protocols to be carried out during those studies, repetitive manual steps were
subject to automation to reduce workload and human error potential.
The most important factors for achieving those goals during the performed clinical studies
were the successful management of hemo- and homeostasis in the individual animal subjects.
To maintain hemo- and homeostasis, automated closed-loop management was applied to
the three most relevant aspects within the given study context: The management of the body
temperature, management of anticoagulation and management of blood gases, electrolytes,
and glucose as the sole source of nourishment during the observation period. These three
aspects of automated management will be covered in the following chapters, each including
an individual clinical motivation, methods, results, and a discussion within the context of
the performed clinical studies:
Anticoagulation management, presented in Chapter 11, was important for maintaining
hemostasis and reduction of workload during the performed studies as frequent ACT mea-
surements and adaptions to the heparin infusion pump had to be performed to avoid throm-
bosis or internal bleeding during the prolonged bedding times of the animal subjects.
Regarding the body temperature, presented in Chapter 12, the main goal was to stabilize
the temperature and avoid hypo- as well as hyperthermia as such changes can drastically
interfere with various biochemical processes and lead to physiological changes influencing
homeostasis.
Finally, the most important aspect was the management of the electrolytes, blood gases,
and glucose using fuzzy-logic based closed-loop systems, presented in Chapter 13. By
controlling the RR, the gas exchange and end-tidal CO2 (etCO2) can been managed, thus
stabilizing the blood gas concentrations and improving homeostasis. Furthermore, closed-
loop systems for managements of individual electrolytes and glucose were implemented
by utilizing fuzzy logic controllers to adapt to the specific needs of each individual animal
subject during the course of the study.
95

11 Anticoagulation Management
11.1 Motivation
As the porcine animal subjects in the conducted studies are observed for up to 96 hours,
therapeutic anticoagulation management to prohibit thrombosis due to the long bedding
times had to be performed. This task has been carried out manually for the AP study using
a Medtronic ACT Plus device for measurements of ACT and manual adaption of a heparin
infusion pump. Due to the many required manual steps, such a task has a high workload
and risk for human errors. Within this context, automated management of blood coagu-
lation therefore was a prime example and use case for every day procedures in intensive
care. Using the developed framework, various parameters and conditions can be observed
and appropriate tasks can be automated. However, faced with the task of automating ACT
processing, obtaining the measured clotting times provided a challenge. Unfortunately,
currently no point-of-care device, allowing a direct event-based export of individual mea-
surement results, is available and existing solutions are limited to retrospective export using
serial ports or even still floppy disks. To bridge this gap, an automated solution was de-
veloped and published [193]. The following part recites the development process and the
evaluation in depth.
11.1.1 Workflow
The manual task of anticoagulation management is prone to errors, especially in times of
high workload, as several steps need to be performed. The general workflow is illustrated
in Figure 11.1. After performing the measurement in a first step, the resulting clotting
times and their average have to be observed and noted. Next, the new heparin rate has
to be calculated manually according to a therapeutic look-up table like the one shown
in Table 11.1. This calculation involves consideration of patient’s body weight and the
heparin dilution, which may need to be looked up. Finally, the now calculated rate has to
be manually entered and set at the corresponding infusion pump [193].
blood 
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blood 
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Figure 11.1: Workflow for manual ACT measurement, consisting of several steps including
manual calculations and adaption of the infusion pump.
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Table 11.1: Therapeutic heparinization chart based on [194] with a reduced bolus. Measured
mean ACT is used for deciding the correct action and calculating the new continuous
and bolus rates dependent on patient weight and heparin dilution [193].
Measured ACT [s] Action Rate adaption
Initial Bolus 70 U/kg 18 U/kg/h
< 70 Bolus 70 U/kg ↑ 4 U/kg/h
70 – 90 Bolus 35 U/kg ↑ 2 U/kg/h
91 – 110 none no change
111 – 130 none ↓ 2 U/kg/h
> 130 Pause 1 h ↓ 4 U/kg/h
11.2 Method
Besides the tasks of blood sample collection and performing the actual measurement of
the clotting time, which still must be performed manually, processing of the measurement
results, calculating the rate change, and applying it to the bedside infusion pump are tasks
that can be automated. Due to the lack of appropriate interfaces for data export, the biggest
challenge was obtaining the measurement information. Therefore, possible new export op-
tions like measuring electrical signals or visual recognition had to be considered. The most
promising and simple approach was accessing the 7-segment displays of the Medtronic
ACT Plus measurement device as they provide an easily visible and accessible representa-
tion of the required information. In comparison, the results displayed on the LCD are very
small, have a narrow viewing angle, and are more complex to export electrically or using
image processing. As first tests and analysis of the device showed easy electrical access to
the 7-segment displays, this option was chosen and implemented.
11.2.1 Hardware Development
The device was dissembled and the printed circuit board (PCB) with the traces to the display
was analyzed. All relevant electrical signals to the display are transmitted through a 40-pin
ribbon cable, which was replaced with another cable with three pole plugs to branch of the
required information. Observation of all signals was performed with an oscilloscope and
the corresponding data lines and frequencies were identified. The next step involved the
decoding of the multiplexed signal of the two 7-Segment displays. A Raspberry Pi [195]
Version 1 Model B+ with a 32-bit ARMv6 processor was chosen as an appropriate device,
as is provides a sufficient amount of input pins and an Ethernet connector for integration
in the medial framework. As the electrical signals are branched off after the current lim-
iting resistors for the LED segments, difference in logical voltage levels compared to the
Raspberry Pi general purpose input/output (GPIO) pins are present. Thus, an adapter board
for connection to the Raspberry Pi has been developed by using open-collector differen-
tial comparators for the individual signal lines and pull-up resistors for logic level shift.
Schematic conversion and developed board are shown in Figure 11.2, the entire hardware
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setup for ACT measurements including the adapter board and Raspberry Pi is presented in
Figure 11.3.
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Figure 11.2: Schematic conversion flow for an individual digit (left) and the hardware board
(right) as an interface between Medtronic ACT Plus and a Raspberry Pi.
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Figure 11.3: Photo of the ACT measurement setup with Medtronic ACT Plus device, converter
board and Raspberry Pi for connection to the TICoMS framework (left, [193]) and
schematic illustration (right).
11.2.2 Software development
Signal processing and analysis of the converted signals is performed on the Raspberry Pi
using C++ and the Wiring Pi library [196] for accessing the GPIO pins connected to the
segments via the developed converter board. Using the information of the lit individual
displays, demultiplexing of the digits is performed, resulting in a 3-digit number for each of
the both displays. For enhancement of number recognition and error reduction, consecutive
readings are collected and the most often occurring number is selected by majority vote.
This process is illustrated in Figure 11.4. For automated detection of start and end of a
measurement, a state machine detecting zero times and invariability of the recognized
numbers for a defined short timeframe is used. After detection of the measurement end,
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the mean value is calculated and, together with the two raw readings, send to TICoMS.
The message is then processed by an application, implementing the therapeutic table from
Figure 11.1, calculating the infusion rates with patient weight provided by the user through
a GUI, and sending the new rates to the infusion pump. This workflow is illustrated in
Figure 11.4.
1 2read individual digits
pattern
matching
0110000
1101101
1111001
 1111110     0
 0110000     1
 1101101     2
 1111001     3
 0110011     4
 1011011     5
 1011111     6
 1110000     7
 1111111     8
 1111011     9
1
2
3
3 majority vote
123123 123
123
723
128
123 : 2x
723 : 1x
128 : 1x
? 23 : 1x
?23
4 measurement & result detection
000?
counting up &
still changing?
yes
yes
no
no
send result
or error
Figure 11.4: Automated ACT measurement workflow with pattern recognition. Individual digits
are processed to obtain a numeric representation by matching the bit patterns.
Detection errors are reduced by aggregating several readings and selection by
majority vote. Then a state machine is used for detection of start and end of ACT
measurements.
11.2.3 Evaluation
Evaluation of individual components was performed during individual trials of the AP
study and complete functionality available for use during the entire VNA study. The patient
weight and heparin dilution were set with the GUI of the heparin control application. Manual
verification of the measurement results and actions was performed with another GUI for
evaluation and safety reasons. All other steps, like processing of the results and calculation
of rate and bolus, were performed automatically. If a bolus was necessary, the caregiver was
prompted a notification to verify sufficient amounts of fluid are present within the heparin
syringe. Thereafter, the bolus was administered automatically by the system.
11.3 Results
Automated processing and calculation of the correct adaptions and heparin infusion rates
was successfully performed for 125 measurements during the VNA study and adaption
was performed according to the used therapeutic table at all times in the used experimen-
tal ICU setting. On average, each animal subject was kept at a mean ACT measurement
time of 95.5 s. As an example, the therapeutic management for vna006 is shown in Fig-
ure 11.5. With this successful automation the desired workload and error reduction could
been achieved.
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Figure 11.5: Example for the automated adaption of the heparin (Hep.) infusion rate (bottom)
according to the measured mean ACTs (top) for vna006. The arrow indicates initial
bolus administering.
11.4 Discussion
The proposed hard- and software provides a successful implementation for an automation
of anticoagulation management using a Medtronic ACT Plus device not supplied with
the required data export features. The branching out of the electrical signals from the
7-segment display of the Medtronic ACT Plus device provided a successful solution for
automated gathering of the measured results as it is less prone to errors in comparison to
image processing using machine learning where factors like physical obstructions during
the measurement, sunlight, reflections, movement, and other things would have to be
considered. Of course, automation could have been implemented without the performed
extraction of the measurement results, however this would retain the crucial step of manual
input of the results with the corresponding human error potential. The remaining steps of
blood collection and sample processing at the ACT measurement device cannot be further
automated with the given technology as handling of the blood samples still requires manual
labor.
For evaluation purposes of the algorithm and automation pipeline, manual verification of
the measurement results has been performed. It became clear that this step is not only useful
for evaluation purposes but in general for such a critical parameter as anticoagulation, where
handling errors may lead to severe consequences like thrombosis or internal bleeding. Thus,
especially the administering of a bolus has been and should be verified. Whereas this still
requires manual interaction, the work intensive task of collecting the measurement results,
calculating the change of the infusion rate according to patient weight and drug dilution,
and setting the actual continuous and bolus rates has been automated.
Given the achieved automation the risk for human error and the required workload can be
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reduced significantly. This is especially beneficial in settings where understaffing is present
or with junior staff who are still developing clinical assessment skills as such solutions
support the decision-making process and provided additional safety [1].
Within the given study setting, the automation of anti-coagulation management achieved
such a reduction of human error potential and workload and improved the management
of hemostasis. Furthermore, it allowed the automated collection and storage of the ACT
measurements, which previously could only be collected manually on a sheet of paper and
were not integrated into the central database.
11.4.1 Outlook
For future improvements of automated anticoagulation management, other parameters
and factors might be considered and included in the calculations. Adaption of the heparin
rate shows that coagulation is highly dependent on the dilution and amount of body fluid.
During the VNA studies with purposeful increase and decrease of the volume state, the
clotting time is changing and the heparin infusion rate must be adjusted accordingly.
For further, advanced versions of this automation, factors like infusion rates and vital
parameters, exceeding the look-up table as hospital standard, may be considered. As ACT
measurements are often influenced by various additional factors, such as hypothermia,
haemodilution, thrombocytopaenia, and platelet inhibitors or antagonists [197], even
further improvements may include measurements of the body fluid content as a derived
variable of infusion rates, weight measurements, and body temperature. This could further
be extended to a learning algorithm able to adapt to the patient’s needs by observing the
effect of rate adaptions and increasing or decreasing the changes by closed-loop feedback.
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12.1 Motivation
Besides the given example for automated processing of laboratory results and the ACT
management, other parameters and procedures performed during intensive care can be
automated as well. Another such example is management of patient temperature. As moti-
vated in the background, temperature management is still not performed at all times within
the operation room [23] and is often only a subsidiary task. Whereas invasive methods
for blood warming can provide automated temperature management, more commonly and
wide-spread applicable forced-air units with special blankets require manual observation
and adaption of the device according to patient temperature. As most of the time, a TTM
with a defined target temperature is desired [22], observations and adaptions have to be
performed regularly. Forced-air warming devices only provide a limited number of settings,
thus most often no optimal steady state can be achieved with those adaptions. Instead,
continuous observation and corrections are needed to keep patient temperature within the
desired range. Distractions or other more important therapeutic goals might restrict those
observations or prolong adaption intervals when performed manually.
As task itself is simple – adapting airflow and temperature settings to keep a desired patient
temperature – it’s a good candidate for automation and workload reduction by reducing
the need for manual observation and interaction. This may allow anesthetists or other care
givers to focus on more important tasks and can reduce human errors causing hyper- or
hypothermia due to delayed corrections. Within the context of conducted experimental
studies, automated management of temperature was one important aspect to achieve more
stable study conditions and more comparable results by reducing potential effects of hyper-
or hypothermia to the desired homeostasis management and maintenance.
For application of temperature management, a very commonly used product is the
3M Bair Hugger for forced-air warming unit with different temperature and speed settings.
Using the developed framework, temperature measurements of the patient were already
available and closed-loop automation and control messages could easily be implemented.
However, because the 3M Bair Hugger provides no interface except for manual buttons, an
electrical interface for remote control had to be established. The performed development
process and the evaluation were successfully published [198] and are presented below.
12.2 Hardware and microcontroller
The used 3M Bair Hugger 755 warming unit [199] provides settings for 3 defined tem-
perature levels (32.0±1.5 ◦C, 38.0±1.5 ◦C, and 43.0±1.5 ◦C) and ambient temperature.
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Besides temperature, the airflow speed can be adapted with two speed settings: Fast (4700
rpm) or Slow (4100 rpm), resulting in a maximal airflow of 23 L/s [199]. As the used
3M Bair Hugger 755 provides no external interface for those settings, development of a
hardware interface had to be performed as a first step.
Dismantling and analysis of the device and its integrated circuit boards revealed the
electrical traces and logic levels of the 3M Bair Hugger’s electrical connections, providing
the essential knowledge for development of an interface for reading the current settings and
providing remote inputs.
For processing the current state, the information of the lit LEDs of the 3M Bair Hugger
device was sensed. This was performed by tapping the 10 LED outputs and using TLC 374
comparator ICs for conversion of the LEDs analog voltage after the limiting resistor to
digital levels that can be processed. The information obtained from the LED signals in-
cludes fault state, temperature in range, and settings for current speed: standby, slow, or
fast. The current temperature is shown with LEDs for ambient, 32 ◦C, 38 ◦C, and 43 ◦C set-
tings [199]. For interaction with the 3M Bair Hugger’s switches and simulation of manual
key strokes, HFC 4066 ICs were used as digital switches and connected in parallel to the
manual switches on the device’s circuit board. In total, 8 output pins were used to control
the 3M Bair Hugger switches. Preliminary tests indicated that a press time of 150 ms is a
reliable time for detection by the manufacturer’s logic board.
Given these hardware interfaces to the current device state by processing the LEDs and
the ability to control the 3M switches, the next step consisted of connecting the individual
components to a microcontroller for processing and communication.
For this task an Atmel AVR Mega8A [200] (Microchip Technology Inc.) microcontroller
was used, as it provided the required number of input and output pins for reading the device
states, controlling the switches, and a serial interface for information exchange. Software
development was performed C using Atmel Studio 6 with GCC. By using timer interrupts,
the current state of the 3M Bair Hugger’s LEDs, connected to input pins via the TLC 374
comparators, is processed once a second and sent to the serial interface. Furthermore, re-
ceived serial control commands are applied by simulating manual key presses using the
HFC 4066 ICs connected in parallel to the actual 3M Bair Hugger’s switches. The integra-
tion of the developed add-on board into the 3M Bair Hugger unit and the schematic circuit
are shown in Figure 12.1.
12.2.1 Communication protocol
Communication is performed using a serial RS232 interface with a speed of 9600 Baud.
Therefore, a matched Quartz crystal with 15.7456 MHz as the operation frequency of the
microcontroller is used. The device state and settings are transmitted once a second in
alphanumerical ASCII format and framed with a start and end character: 0x02 (STX) and
0x03 (ETX), respectively. The LED states are sent as numerical string of 0s and 1s. For
remote control of the switches, a simple ASCII message of the format S:X, where X is the
number of the Switch (1-8) that should be pressed for the pre-set time, can be transmitted.
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Figure 12.1: Opened 3M Bair Hugger 755 device with add-on board. (left, colors of original
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12.3 Control algorithm
The proposed algorithm [198] for temperature control uses three parameters: an evaluation
interval for the adaption ct , a target temperature Ttar, and a scaling factor cs for the power
of adaption. Aggregation of individual measurements is performed during the defined in-
terval ct and upon evaluation the arithmetic mean of the collected measurements is used.
This is performed using the current point in time t, the fixed interval ct in seconds, target
temperature Ttar, and the current body temperature Tt at time t:
Tt =
1
ct
·
t
∑
i=t−ct
Ti
Given this averaged observation, in a next step the difference between the current observed
measurement Tt and the target temperature is calculated:
∆t = Tt −Ttar
Based on this absolute change, a state st ∈ [−1,1] at time t is calculated using the desired
target ∆t and the scaling factor cs. This state variable st represents the action to be applied to
the 3M Bair Hugger and is limited within the interval [−1,1]. Within this notation s =−1
stands for maximal cooling and s = +1 means maximal heating. At the initial step t = 0
the state variable is set to zero (s0 = 0).
st =

1 if ∆t · cs ≥ 1
∆t · cs if −1 < st < 1
−1 if ∆t · cs ≤−1
Given this abstract representation st of the action to be performed, the final step consists
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of a mapping to the device settings. The possible device settings are a tuple consisting of
speed and heat setting xt = (speed,heat) with speed ∈ {standby,slow, f ast} and heat ∈
{21 ◦C,32 ◦C,28 ◦C,43 ◦C}. The setting for ambient temperature is denoted as 21 ◦C, as this
was the room temperature within the used experimental setting during the VNA studies.
Beside those 3 speed settings, the 3M Bair Huggger has an additional standby setting. This
is not used for the control, as this would deflate the forced-air blanket, which was considered
impractical as it would influence the continuous monitoring of patient weight.
xt =

(21 ◦C, f ast) if st = −1
(21 ◦C,slow) if −1 < st ≤ −0.5
(32 ◦C,slow) if 0.5 < st ≤ 0
(38 ◦C,slow) if 0 < st ≤ 0.5
(43 ◦C,slow) if 0.5 < st ≤ 1
(43 ◦C, f ast) if st = 1
As this tuple xt is a direct representation of the 3M Bair Hugger’s state, application can be
performed with the developed interface board.
12.4 Evaluation
The evaluation of the proposed closed-loop algorithm and system for temperature man-
agement was performed in the experimental setting for two animal subjects of the VNA
study. The 3M Bair Hugger 755 with forced-air blankets was connected via the developed
hardware interface to the developed and described medical communication framework.
For integration into the medical software framework, the serial COM-plugin was used
and an APP-plugin was developed. This application sends the current device state to the
framework and applies control commands. A second application was used to implement the
proposed control algorithm. It received the patient temperature and sends control messages.
Patient blood temperature readings were obtained with a temperature sensor within an arte-
rial PiCCO catheter. This sensor was connected to Philips IntelliVue MP 50 patient monitor.
Using the developed patient monitor connection, vital data, including temperature readings,
was processed by the framework and provided to the proposed temperature control algo-
rithm. Assessment of the performance was done by comparison of two trials with no control
(N), two manually controlled trials (M) and two automated trials (A). The uncontrolled ref-
erence (N) was obtained during the vna001 and vna002 trials. Manual control (M) was
performed for vna003 and vna004. The automated algorithmic control (A) was performed
for vna007 and vna008. The desired target temperature was set to 38 ◦C for both manual
controlled (M) and automated (A) trials as this is a normothermic porcine temperature. For
the uncontrolled trials (N), no active temperature management was performed. The used
measurement setup and interaction of the devices is shown in Figure 12.2. Evaluation was
performed in terms of how well the temperature could be kept at 38±1 ◦C for the entire
duration of observation.
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Figure 12.2: Experimental closed-loop TTM setup with 3M Bair Hugger and forced-air blankets
for temperature management based on temperature observations obtained from a
Philips IntelliVue MP50 patient monitor.
12.5 Results
Using the developed circuit, a 3M Bair Hugger 755 device was successfully extended
by monitoring capabilities and remote control. The developed hardware interface was
successfully integrated into the developed medical software framework and tested in the
performed study. The results for the uncontrolled (N) and manual (M) reference animal
subjects as well as the results for two automatically controlled animal subjects (A) of
the VNA study are shown in Table 12.1. Whereas in the uncontrolled animal subjects,
temperature raised and was only within the desired range of 38±1 ◦C for about 26% of the
time in N1 (vna001) and 71% in N2 (vna002). For the manually controlled animal subjects
M (vna003, vna004), an average performance of 96.4% was achieved. Using the developed
control algorithm for animal subjects A (vna007, vna008), the temperature could be kept
within the desired range at all times.
Table 12.1: Performance for the individual animal subjects regarding the time exceeding the
target temperature ±1 ◦C in seconds and the overall performance within the target
range [198]. N = uncontrolled, M = manual, A=automated.
trial: N1 N2 M1 M2 A1 A2
outside [s] 243583 55522 579 23538 0 0
total [s] 330060 192168 333490 333020 330960 329270
within [%] 26.20 71.11 99.83 92.93 100.00 100.00
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An overview of the temperatures during the entire observation time for all animal subjects
is shown in Figure 12.3. For the manually controlled animal subjects (M1, M2), infrequent
temperature adaptions can be observed. For the automatically controlled animal subject (A1,
A2), the tight temperature control with its frequent adaption steps can clearly be observed.
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Figure 12.3: Temperature measurements for the two animal subjects of each group: uncontrolled
(N), manually controlled (M), closed-loop controlled (A) in columns from left to
right [198].
12.6 Discussion
Using a developed hardware interface, remote control and monitoring capabilities were
successfully added to a 3M Bair Hugger 755 forced-air patient warming device. Integration
to the medical software framework and a developed closed-loop algorithm for temperature
control allowed a tight TTM. Using the automated system, temperature could be kept within
the desired target temperature range of 38±1◦C at all times. Whereas manual control could
achieve similar good results in the performed study, continuous human observation leading
to a high workload was required.
For the two animal subjects without temperature management, large variations and durations
outside the desired range could be observed. As trial N2 was cut short due to medical com-
plications, further potential temperature increase could not be observed. Yet, it is expected
to have been risen in a similar fashion as observed for animal subject N1. Thus, resulting
in an equally decreased accuracy. As all animal subjects were observed in the same study
conditions and the hyperthermia was observed in both uncontrolled as well as other pre-
viously studies animal subjects, this temperature increase was expected for the controlled
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subjects as well. Thus, by keeping the temperature at the desired target level, successful
application of temperature management for the automated and manual observations could
be shown. By maintaining normothermia, the effects of body temperature changes in the
managed animal subjects could be limited, thus minimizing potential temperature effects
on the biochemical processes and improving the desired management of homeostasis.
The used algorithm provided a dynamic adaption to the animal subject’s requirements as
it does not rely on fixed temperature or speed settings, but performed an annealing to the
desired target. Fixed settings or look-up table approaches would not suffice those individual
needs as warm air, sufficient in one case, might be not enough to keep temperature level
stable in another and lead to chilling. Hence, the only predefined setting is the desired target
temperature level as suggested for TTM [22].
12.6.1 Outlook
Using automated temperature control, human workload and error potential can be reduced
and temperature management may even be performed in settings where no human
supervision is present at all times. Additionally, an automated system with closed-loop
feedback from a patient monitor can provide more dynamic and faster adaptions, as it is
only monitoring a single patient and no frequent human observation and interaction is
needed.
As temperature management is an important aspect for keeping the body in a steady and
stable state and improve patient outcome [30–35] but still not applied in all ORs [23],
such an automated system may lead to a more widespread temperature management. For
clinical application of course, further improvements and security measures are needed.
Especially the serial communication and interface to the device was kept simple for this
proof-of-concept approach. For clinical application, an enhanced protocol with redundancy,
validation and check-sums should be used. However, such features could easily be
integrated by the device manufactures and not be provided as aftermarket additions.
An improved algorithm may use further patient monitoring information to adapt to the
patient need. For example, multiple sensors of different types, like placed on the skin or
integrated in catheters [24, 25] may be used and combined to account for the different
variable factors of heat loss [25] and include factors like body mass that may influence the
response to heating and chilling.
109

13 Management based on fuzzy logic
13.1 Motivation
Besides anticoagulation management and temperature control to improve hemo- and home-
ostasis management and automate manual tasks with high workload and human error po-
tential, the ability to achieve closed-loop control of individual physiological parameters for
further improved management was an important aspect for the design and implementation
of a fuzzy control system.
As shown throughout this thesis, homeostasis management is a crucial aspect of critical
care, including various vital parameters, other factors, and environmental conditions to be
kept within desired ranges by a manifold of used therapeutic protocols and drugs. Whereas
many model-based and specialized approaches for the management of individual parameters
exist, combining different and independently developed control systems, often with fixed
settings and parameters, is difficult. To evaluate the interactions and to achieve the desired
management, a more universal solution for usage in the experimental setting is therefore
needed. A further complication to be considered is the high variability and dynamics of
critical care settings as the ensemble of used medical devices and administered drugs is
highly depending on the individual needs of each patient. Thus, a fixed system with limited
and static closed loops would not suffice to provide enough flexibility outside of an isolated
setting. For studying a broad variety of clinical research questions and conditions, mainly
two important aspects needed to be considered:
First, a system should be flexible enough to accept arbitrary numerical inputs of vital param-
eters and provide outputs for the adaption of infusion rates or ventilator setting according
to targets set by physicians. And second, manual therapeutic interactions and interferences
have to be considered and must be tolerated by the system.
Regarding the first problem, the system needed to be designed in such a way, that the control
function can be described by relevant measures including target level, critical physiological
boundaries, and temporal aspects familiar to caregivers. As therapeutic guidelines often are
designed as linguistic if . . . then rules of fuzzy nature [7], a general goal-directed system
using the concept of fuzzy logic, as introduced in the background of this thesis, allowed for
adaption by physicians and caregivers prior to and during therapy.
To solve the second problem, closed-loop control had to be performed in a way such that
human interaction was not prohibited. Given a calculated action to be applied, human
interference with the system must be considered at any time, especially in critical conditions
where infusion rates or ventilator settings may be adapted manually. Thus, no internal state
or absolute values could be used, as they may become void at any time. Instead, an adaptive
system based on relative output factors was considered and implemented, allowing an
annealing to the desired parameter instead of setting absolute targets.
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13.2 Fuzzy logic controller
The developed fuzzy controller used the general principle described in the background of
this thesis. Numerical input values are fuzzified, processed by a set of rules, and defuzzified
to provide a numerical output. However, before any fuzzy control can be performed, the
fuzzy system itself needs to be configured. These individual steps should now be highlighted
in detail for the specific implementation within the clinical context. As rapid changes in
patient conditions with immediate need for action may occur, the dynamic response of
the system and the ability for manual interferences and adaptions were essential consid-
erations. A controller based on absolute values and targets would not allow for manual
interactions and prohibit the physician from performing changes and interactions in critical,
life-threatening situations.
13.2.1 Overview
The used controller concept was implemented for single input and output relations but can
be expanded to multiple inputs. The controlled variable can be any vital value or processed
parameter. This controller input is processed by a fuzzy function and the first derivative is
calculated to obtain a second fuzzy function, representing the change of the input parameter
between the current and last obtained measurement value. As for a first measurement no
previous measurement is available, a slope of zero is defined for this step. Depending on
the frequency of data acquisition, adaptions for every single new measurement may be too
frequent, e.g., for data collected from the ventilator once a second. Thus, values can be
aggregated within the controller and an averaged value is considered for a single control
step when a user-definable period of time has passed. On contrary, for infrequent or event-
based parameters like those obtained from BGA, the system may be set up to perform
adaption for any new measurement. The output of the controller is modeled as a relative
factor to adapt the current setting or state of an actuator like infusion pumps or ventilator.
In clinical applications, manual therapeutic interactions or other automated measurements
may be performed and interference with the control algorithm. To avoid such disruptions,
e.g., during therapeutic maneuvers or respiratory hold, the fuzzy controller can be locked
by a special message. Within this locked state, no measurements are calculated and no
adaptions are performed. As the proposed fuzzy controller is a general-purpose application
for arbitrary vital parameters, the relation between the measured and controlled parameter
may be inverse. Given a high glucose level, the infusion rate should be reduced, whereas
given a high etCO2 reading, RR should increase uni-directionally. Thus, this relation is an
additional parameter for a specific fuzzy controller. Further user-definable parameters are
the type and parameter of an input message and the output to be controlled. An in-dept
description of those individual parameters is given in subsequent sections. In short, the input
and output may be any message with the key-value based MDT format or direct control
command for ventilation device or pumps. Furthermore, a target value ct with critical upper
and lower boundaries (ccl ,cch) and the operation mode (interval or event-based) need to be
set. For considering the input parameter’s slope, a weighting factor w∆ is used. Additionally,
time frames, defining lower temporal boundaries for a parameter to reach one of the critical
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boundaries (tlc,thc) from the desired target level, need to be set. For adaption of the output
strength, a scaling factor a is used. This general pipeline with the used parameters and steps
is illustrated in Figure 13.1.
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Figure 13.1: Illustration of the implemented general purpose fuzzy logic controller utilizing
relative output factors. Input is provided by message objects and processed
according to user-defined target levels and boundaries. The relative output can
directly be sent to infusion pumps and ventilator or provided as a message object. To
avoid undesired adaptions, the controller can be locked and unlocked with a special
message at any time.
13.2.2 Modeling of the controller
Modeling of the fuzzy logic controller of Mandani type is performed using two input vari-
ables and one output variable. Each variable consists of five member-functions representing
critical low, low, normal, high, and critical high states. To provide a smooth control be-
havior with a relatively flat slope around the target value, Gaussian and sigmoid curves are
used for modeling of the fuzzy member functions. For the set operations of the different
processing steps within the fuzzy controller the following operators are used: set union –
max; intersection – min; implication – min; accumulation – prod; defuzzification – centroid.
As already motivated, the input for this controller and the fuzzy sets should be limited to
parameters that can easily be defined by physicians. Therefore, only a desired target (ct),
critical upper and lower bounds (ccl , cch), time constants (tlc,thc), and a weight factor w∆
are required as user-input. All other parameters like the individual membership functions
of the fuzzy functions are automatically calculated based on those settings.
13.2.2.1 Symmetry and scaling considerations
As the developed fuzzy controller is using an output factor instead of a defined range, this
factor needs to be calculated and processed by the fuzzy logic controller. For factorial
output, 1 refers to no change of the target parameter, whereas 2 results in a doubling,
and 0.5 in a bisection. In more general terms, increment of factor x is equal to the same
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decrement with a factor 1x . This reciprocal relationship must be mapped to the fuzzy set to
provide a symmetric response. Simply using the fractions results in a skewed distribution
of the member functions and numerical inaccuracies due to rounding. Especially for small
fractions, this effect needs to be considered for technical implementation. To overcome
this problem, the numerical ranges for increasing and decreasing factors should be equal:
An increment of x should correspond to its equal decrement with −x, therefore resulting
in equal numerical ranges at all times for possible parameter inputs. This is achieved by
mapping the factor into exponential space using 10x (x : abs(x)> 1) as the representation
within the fuzzy set. Given an exemplary factor of x = 2 using 10x, 102 = 100 equals
100 times more, whereas 10−2 = 0.01 equals 100 times less. Figure 13.2 illustrates the
behaviors and differences in the resulting numerical ranges for normal and exponential
scaling of the output factor calculation. To allow for scaling of the individual fuzzy sets
in the implementation, an additional scaling factor a is introduced. The fuzzy set for the
output factor therefore is represented as 10ax within the proposed controller.
1 2 4½¼
×2 ×4×0.5×0.25
… … z→∞z→0
×0.0...1 ×10....0
x→0 x→∞
Rate:
Factor:
1 2 4½¼… … z→∞z→0
×1010....0×10 0.301×10-0.301×10-0.602 ×10 0.602×10-10...0
-x→∞ x→∞
Rate:
Factor:
normal
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1
1
Figure 13.2: Illustration of the advantage of the exponential factor used within the fuzzy logic
calculation. The numeric ranges for large and small changes are equal in the
exponential modeling, resulting in a unscrewed fuzzy set.
13.2.2.2 Time to criticality
As already highlighted, the developed fuzzy controller uses a weighted combination of
absolute value and slope for the calculation of the output factor. Yet, establishing values for
slopes that reflect clinical knowledge and guidelines is difficult and the question to be asked
for configuration of the fuzzy controller is: How can physicians assess critical slopes if the
numerical value for such a parameter change is neither common knowledge nor a practical
clinical measure? However, given clinical practice, time spans are more natural concept
and often well known. This allows for a more practical approach by defining time periods
in which the parameter should not become critical, like a shift of 8 hours, after which the
next routine measurement may be performed. Thus, instead of defining a critical slope, a
measure for the time it takes for an observed value to reach one of the critical boundaries
from the desired target level is introduced and denoted as time to criticality (TTC). It
combines the physiological limits set by the physician with the temporal domain and, given
asymmetric risks, different lower and upper TTC may be required. For usage within the
fuzzy controller, the remaining step is to convert those times to critical slopes s regarding
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to the input parameter. Calculation of the critical slopes slhc for the lower and sthc for upper
bounds are based on the target value ct , the critical boundaries clc, chc and the TTC for
both boundaries, tlc and thc.
stlc =
clc− ct
tlc
sthc =
chc− ct
thc
A visual illustration of this process for slope calculations using the use-defined critical times
is shown in Figure 13.3.
t
x chc
t0
tlc
sthc
stlc
thc
ct
clc
Figure 13.3: Illustration of the time to criticality (TTC) calculation as the slope for reaching the
critical boundaries in a defined duration of time.
13.2.2.3 Input and output variables
The fuzzy sets of the developed proportional fuzzy logic controller consist of 5 membership
functions for each variable. The arrangement of the membership functions for the individ-
ual sets was designed to provide a scalable distribution for changing parameter ranges as
the fuzzy set will be applied to various parameter ranges, often unknown in advance and
therefore cannot be scaled or normalized.
For the implemented fuzzy controller, only two types of membership functions m are used:
Sigmoid and Gaussian, denoted as sigm(c,s), with center c and slope s, and gaus(c,sd),
with center c and standard deviation sd, respectively.
The first input variable FTARGET consists of 5 membership functions and is used for pro-
cessing the measurement input and requires the user-defined inputs for target ct and the two
critical boundaries clc and chc. The calculation is illustrated in Figure 13.4 and defined as
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follows:
fTARGET = {µLC,µL,µN ,µH ,µHC}
with : µLC = sigm
(
ct − (ct − clc) ·0.8,−100 · (ct − clc)−1.5
)
µL = gaus(ct − (ct − clc) ·0.5,(ct − clc) ·0.15)
µN = gaus
(
ct ,
(ct − clc)+(chc− ct)
2
·0.2
)
µH = gaus(ct +(chc− ct) ·0.5,(chc− ct) ·0.15)
µHC = sigm
(
ct +(chc− ct) ·0.8,100 · (ct − clc)−1.5
)
ctclc chcct-clc chc-ct
0.50.8 0.5 0.8
Figure 13.4: Illustration of the calculation for the generation of the fuzzy sets with their
membership functions from the small set of input variables.
The second input variable FDELTA consists of 5 membership functions and is used for pro-
cessing the slope of the measured input. For the first measurement, a slope of zero is used.
For definition of the fuzzy set, the input parameters for target ct and the two critical bound-
aries clc and chc as well as the two TTCs tlc and tlc are used and the input fuzzy function is
defined as follows:
fDELTA = {µDLC,µDL,µDN ,µDH ,µDHC}
with : µDLC = sigm
(
stlc,s−1.5tlc
)
µDL = gaus(stlc ·0.5,stlc ·0.2)
µDN = gaus
(
0,
stlc+ sthc
2
·0.2
)
µDH = gaus(sthc ·0.5,sthc ·0.2)
µDHC = sigm
(
sthc,s−1.5thc
)
The output function fFACTOR for the output factor consists of 5 membership functions with
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a constant definition:
fFACTOR = {µDECH ,µDEC,µKEEP,µINC,µINCH}
with : µDECH = sigm(−0.7,−15)
µDEC = gaus(−0.4,0.2)
µKEEP = gaus(0.0,0.2)
µINC = gaus(0.4,0.2)
µINCH = sigm(0.7,15)
13.2.2.4 Rule base for implication
The two input variables for absolute value (Target) and slope (Delta) are evaluated to ob-
tain the output factor (Factor) of the proportional fuzzy logic controller using the fuzzy
logic concept of simple if-then rules. Rules for absolute value and slope are defined inde-
pendently with the user-definable weight factor w∆ for balancing the influence of absolute
value (Target) and relative change (Delta). As all rules are evaluated by the fuzzy controller
and already combined in the aggregation step, no combinations of both input variables were
explicitly implemented in an extended set of rules. Dependent on the variable to be con-
trolled and the action to be performed, one of two rule sets can be selected by the user.
The first one is a unidirectional change of the input variable in relation to the output vari-
able. An increment of the measured value thus results in an increment of the output factor.
On contrary, the second set of rules implements an inverse relation. Increase of the input
results in a decrease of the output factor. This second relation is of clinical relevance for
many parameters, where the infusion rate should be reduced if the corresponding measure-
ment is increasing. This inverted rule base for the developed fuzzy controller is shown in
Figure 13.5. For the non-inverted rule base, the roles of INCH/DECH and INC/DEC are
exchanged, respectively.
If Target is LOWCRIT then Factor is INCH with 1−w∆
If Target is LOW then Factor is INC with 1−w∆
If Target is NORM then Factor is KEEP with 1−w∆
If Target is HIGH then Factor is DEC with 1−w∆
If Target is HIGHCRIT then Factor is DECH with 1−w∆
If Delta is DELTALOWCRIT then Factor is INCH with w∆
If Delta is DELTALOW then Factor is INC with w∆
If Delta is DELTANORM then Factor is KEEP with w∆
If Delta is DELTAHIGH then Factor is DEC with w∆
If Delta is DELTAHIGHCRIT then Factor is DECH with w∆
Figure 13.5: Used set of rules of the fuzzy logic controller with inverted output relation.
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13.2.3 Implementation
The fuzzy controller was implemented in C++ as an APP-plugin within the TICoMS frame-
work using the Fuzzylite library [201]. Each used controller is defined within the appli-
cation’s XML-based configuration file. The input parameter to be used are defined by a
unique message and parameter name. The numerical output can either be set to a specific
infusion pump or ventilation device parameter, or also be a defined parameter of a message
in general MDT format. Configuration of the fuzzy controller is performed within the XML
file by defining a desired target level tar ∈R and lower clow ∈R and upper chigh ∈R critical
bounds. If calculation should not be performed for every measurement but averaged, the
interval teval ∈ N must be set in seconds. For definition of the slope, the weight of the slope
w∆ ∈ [0,1] relative to the absolute value must be set. The critical boundaries for this slope
are set as times to criticality tlc,thc in seconds for lower and upper bounds, respectively.
For easy adaption of the regulatory power, a scaling factor fa ∈ (0,1] for the calculated
output needs to be set. Finally, the general relation between the input and output parameter
is defined with a flag to indicate if the relation between two factors follows an inverse rule.
If this flag is set, an increase of the input variable results in a reduction of the output factor.
13.2.4 Evaluation
For evaluation of the proposed fuzzy controller, parameters using event- and interval-based
controls were implemented and tested during the two conducted studies. For the former
operation mode, respiratory management was performed. The latter, event-based mode was
applied to BGA measurements for homeostasis control using the infusion pumps. Parameter
selection was based on the requirements during the studies and implemented for those
examples.
To prohibit interference of various maneuvers and manipulations during the conducted
studies, the fuzzy sets were automatically or manually locked during those interactions to
prohibit calculations based on falsified or artificial readings.
For the animal subjects of the AP study, a first version of the controller, not yet implementing
the 10ax concept and TTC was used. For the animal subjects of the VNA study, those
improvements were used for glucose management. The following sections present those
individual applications and their respective results, concluding with a general discussion of
the closed-loop management based on the proposed fuzzy logic controller.
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13.3 Respiratory management
As highlighted in the medical background, management of homeostasis is an uttermost
important aspect in critical care. Within this process, patient’s respiration has a significant
influence to achieving this goal, thus making respiratory management an essential factor for
prevention of conditions like respiratory acidosis or alkalosis. In the context of medical stud-
ies, respiratory management additionally plays an important role to allow for measurement
of other vital parameters in well-defined conditions.
The importance of ventilation management can be seen in Figure 13.6 for animal subject
ap004. Given a relatively constant RR due to mechanical ventilation under GA and changing
metabolic conditions, the body is not able to adapt the RR on its own. Thus, the CO2 level
in the exhaled air is highly variable and rising throughout the observation time. As the
expiratory CO2 is related to the intravascular levels and the acid-base balance, it has a
significant influence on homeostasis. Therefore, by keeping the etCO2 level stable, a more
natural response in breathing and homeostasis management can be performed. Using this
relationship between the RR and the measured CO2 levels, automated management with
the developed fuzzy logic was realized.
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Figure 13.6: Example for uncontrolled etCO2, often reaching levels outside the desired
physiological range of 40–45 mmHg in animal subject ap004 with a relatively
constant RR.
13.3.1 Setup
The used setup for automated management of etCO2 consisted of the used mechanical ven-
tilation device (Dräger Evita XL) with remote control capability and a bedside computer
system integrated into the TICoMS framework. The ventilator was connected to an embed-
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ded PC via serial connection for reading the measurement results and settings about once a
second, and sending control commands to the device using a framework APP-plugin. The
obtained measurements were sent via TICoMS as messages to the fuzzy controller applica-
tion and collected for a defined interval I. After this predefined period has passed, the mean
was calculated and evaluation of the measured etCO2 level was performed. The resulting
adaption factor for the RR was sent as control commands to the ventilator application and
automatically applied. An illustration of this measurement and control setup is shown in
Figure 13.7. This adaption of etCO2 levels was performed for both studies, starting with
animal subject ap005. For the AP study, an interval I = 240s was used. This interval was
reduced to I = 120s in the VNA study to provide a faster response time. The desired etCO2
target level t was set to a physiological level of 40 mmHg.
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Figure 13.7: Schematic illustration of the fuzzy-controlled closed-loop setup for etCO2
management by adaption of the respiratory rate.
13.3.2 Results
The automation setup was successfully implemented and tested during the performed stud-
ies. However, for three animal subjects (ap005, ap007, vna003) medical conditions, unre-
lated to the application of the closed-loop system, forced an adaption of the target etCO2
level to 45 mmHg. Yet, management was still hardly possible. For animal subject ap010
unreliable measurements of the ventilator’s etCO2 sensor prohibited the closed-loop ap-
plication. Thus, manual control and correction was performed by monitoring of oxygen
saturation and arterial pCO2 levels from BGA. This problem occurred repeatedly during
the observation of another animal subject (vna002), whereupon the sensor was replaced.
The results of the closed-loop control are visualized in Figure 13.8. For better visual presen-
tation and reduction of measurement artifacts, the charts are plotted using mean averaged
blocks of 120 seconds. Data falling within periods of manual intervention, e.g., respiratory
maneuvers in the VNA study, is excluded and the last known value is imputed for visualiza-
tion. For the boxplots, raw measurements are used. Whiskers are placed at the outermost
values falling below or exceeding the interquartile range of Q1 to Q3 by 1.5 times, respec-
tively. Numerical results for the individual animal subjects, like detailed statistics of the
information within the figure’s boxplots, targets, and deviations thereof, are provided in
Table 13.8. Automated control could be performed for total duration of over 1066 hours
and measurements within a range of ±3 mmHg related to the set target could be observed
in over 95% of the total observation and management time. Broken down into the two
performed studies, management was successfully performed in 91% of the time for the AP
study and the desired target range was maintained in 97% of the time within the VNA study.
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Table 13.1: Configuration and results of respiratory management for the individual animal
subjects with defined target etCO2 level t, control interval I, and duration d.
ct I d t±3 rel. dev. IQR MAD
[mmHg] [s] [h] [%] [%] [mmHg] [mmHg]
ap005 45 240 37.3 0.85 1.72 1.78 1.23
ap006 40 240 32.4 0.65 3.30 4.82 2.01
ap007 45 240 56.0 0.90 0.83 0.73 0.53
ap008 40 240 72.0 0.98 -0.22 1.03 0.76
ap009 40 240 70.4 0.99 0.04 0.87 0.59
vna001 40 120 93.1 0.96 0.00 1.10 0.88
vna002 40 120 33.1 0.66 -21.61 12.68 1.48
vna003 45 120 94.1 0.96 -0.42 1.17 0.86
vna004 40 120 94.1 1.00 -0.51 0.90 0.80
vna005 40 120 93.7 0.95 -0.24 1.53 1.23
vna006 40 120 61.0 0.96 -0.21 1.22 1.01
vna007 40 120 93.4 1.00 -0.92 1.23 1.18
vna008 40 120 93.3 1.00 -0.74 1.27 1.06
vna009 40 120 93.3 1.00 -0.70 1.12 0.99
vna010 40 120 47.1 0.97 0.23 1.15 0.86
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Figure 13.8: Observed etCO2 levels (top) and RRs (bottom) for the individual animal subjects as
time-series and boxplots for both used intervals (240s left, 120s right).
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13.4 Glucose and electrolyte management
Besides respiratory management, maintaining glucose and electrolyte levels is another
important aspect to preserve homeostasis and prevent conditions like hypoglycemia or
metabolic conditions like alkalosis or acidosis. As treatment of the animal subjects is per-
formed according to medical standards and required to obtain reliable results, management
has initially been performed manually. To reduce workload and provide more stable con-
ditions for collection of research data, management of different metabolic parameters was
automated using BGA results to control infusion pumps with selected electrolyte and glu-
cose solutions. Due to the prolonged observation of the animal subjects for several days,
nutrition supplement by administering glucose and management of base excess were the
most important parameters. Other parameters like calcium and potassium were evaluated
only in a limited number of animal subjects if individual clinical indication was given. As
the proposed fuzzy logic controller was used for all those automated therapies, first, the
general setup and individual configurations for those parameters are presented.
13.4.1 Setup
For automated management of metabolic parameters, the BGA results were obtained from
the Radiometer ABL 800 Flex analyzer using an APP-plugin within the developed frame-
work. After validation by a caregiver to catch potential measurement errors, the collected
results were automatically sent as message objects via TICoMS to the individual fuzzy
controller application. After evaluation, the output factor was sent as a message to control
application for the B.Braun Space infusion pumps. A schematic illustration of this control
setup is given in Figure 13.9. The individual configuration of the evaluated fuzzy logic
controllers is presented in Table 13.2. For glucose management, an improved version of
the fuzzy controller with consideration of slope and criticality times was introduced for the
VNA study, whereas in the AP study only the absolute measurement was used. All imple-
mented controllers were event-based and triggered by new BGA measurements, without any
aggregation and averaging. The controlled pumps were glucose (G20, 20%), NaBic (8.4%;
1000 mmol/ml), KCl (1 mmol/ml) and CaCl (5.5%; Ca2+ 0.5 mmol/ml, Cl- 1 mmol/ml).
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Figure 13.9: Schematic illustration of the fuzzy-controlled closed-loop setup for homeostasis
management by adaption of infusion pumps based on BGA measurements.
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Table 13.2: Configuration of the fuzzy logic controller for the evaluated parameters. Target
parameters are arterial BGA measurements. Targets for glucose in mg/dL, potassium
and base excess in mmol/L.
name tar. pump ct ccl cch wδ tlc thc a inverse?
Glu AP Glu G20 100 50 200 0 – – 0.3 yes
Glu VNA Glu G20 100 50 200 0.3 12 h 1 h 0.3 yes
Base excess BE NaBic 0 -4 4 0 – – 0.3 yes
Potassium K+ KCl 4 3 5 0 – – 0.3 yes
Calcium Ca2+ CaCl 1 -0.8 1.2 0 – – 0.3 yes
13.4.2 Results
The measurement for all metabolic parameters were based on arterial BGA measurements.
In the AP study, BGAs were performed regularly in two-hour intervals whereas in the
VNA study, measurements were performed event based for each change of 200 gBW. This
resulted in a variable measurement frequency. Glucose management was automated for all
animal subjects where supplementation was needed (ap005-009, vna001-010). Base excess
and potassium were controlled, if clinical indication for supplementation was given. Only
then, the corresponding electrolyte solutions were connected and the closed-loop controllers
were started. Calcium was only managed during the AP study.
13.4.2.1 Glucose
The proposed fuzzy-controller was successfully implemented and tested in the performed
studies with 15 animal subjects. For the AP study, a symmetric control a with target arte-
rial glucose level t =100 mg/dL was used and the slope was not considered. For the VNA
study, asymmetric risk with lower and upper critical levels of 50 mg/dL and 200 mg/dL,
respectively, were used with the same target level t. The slope was considered with asym-
metric TTC for lower and upper bounds (tlc =12 h, tlc =1 h). Thus, the lower critical level
of 50 mg/dL should not be reached within 12 hours, starting at the desired target level of
100 mg/dL.
An overview of the results is given in Table 13.3. Glucose levels could be kept within a
physiological range of 86–150 mg/dL in 85 % (SEM 3.6 %) of the measurements with a
total duration of 1142 hours. Regarding the individual settings, this goal could be kept in
83 % (SEM 7.8 %) and 86 % (SEM 4.0 %) of the time for AP and VNA study, respectively.
Additional visualization of the measured levels and pump rates for all animal subjects is
provided in Figure 13.11.
In two animal subjects (ap006, vna010) with short observations, management was only suc-
cessful in 55 % of the time, whereas successfully performed in over 80 % for the remaining
13 animal subjects. Hypoglycemia was only present in 9 of 1141 hours for 5 animal subjects
at the beginning of the observation. An example for the variable and individual need and
successful glucose control by the enhanced controller is shown in Figure 13.10 for animal
subject vna003, maintaining the physiological range in 98 % of the time.
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Table 13.3: Results of glucose management for individual animal subjects with a target of
100 mg/dL
glucose ranges [mg/dl]
within
(85,150]≤70 [71,85] (85,120] (120,150] >150 hours
ap005 1 14 39 11 0 65 0.77
ap006 2 12 11 6 0 31 0.55
ap007 0 0 70 1 0 71 1.00
ap008 0 6 67 0 0 73 0.92
ap009 0 7 62 0 0 69 0.90
vna001 0 14 61 14 3 92 0.82
vna002 2 10 23 19 0 54 0.78
vna003 0 2 84 6 0 92 0.98
vna004 0 6 68 19 0 93 0.94
vna005 1 10 61 21 0 93 0.88
vna006 0 2 74 12 4 92 0.92
vna007 0 6 82 1 0 89 0.93
vna008 3 1 87 2 0 93 0.96
vna009 0 13 66 7 4 90 0.81
vna010 0 17 18 6 3 44 0.55
total 9 120 873 125 14 1141 0.87
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Figure 13.10: Example for successful glucose management for animal subject vna003. Shown are
the measured glucose level (cGlu), the relative change (∆cGlu) and the G20
infusion rate. The reaction of the controller to slope and absolute changes can
clearly be observed.
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Figure 13.11: Overview of one hour means of the measured glucose levels (mg/dL) for all
automated trials. If no measurement was performed, the last known measurement is
carried forward.
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13.4.2.2 Other controlled parameters
In addition to the glucose management, limited evaluations for the other parameters have
been performed, if they were required for the individual animal subjects.
13.4.2.2.1 Base excess Management of base excess by adaption of a sodium bicarbon-
ate (NaBic) infusion pump was performed for 5 animal subjects. The results of this man-
agement are shown in Table 13.4. Base excess could be kept within a physiological range
of −2–2 mmol/L in 53 % of the 289 observed hours. Measurements <−4 mmol/L were
observed for 62 hours and significantly increased levels >4 mmol/L for 6 hours. A sig-
nificant deviation from the average performance can be seen for animal subject vna003,
where the desired range could only be kept for 8% of the observation time. An overview
of the measured levels and pump rates for all animal subjects is shown in Figure 13.13.
Additionally, an example for the dynamic adaption of the infusion rate performed by the
fuzzy logic controller for management of base excess in animal subject ap009 is shown in
Figure 13.12.
Table 13.4: Results for control of base excess with a target of 0 mmol/L.
base excess ranges [mmol/l]
within
(−2,2]≤−4 (−4,−2] (−2,2] (2,4] >4 hours
ap007 0 1 60 4 6 71 0.85
ap008 0 1 57 15 0 73 0.78
ap009 11 7 39 12 0 69 0.57
vna003 33 53 7 0 0 93 0.08
vna004 18 19 44 2 0 83 0.59
total 62 81 207 33 6 389 0.53
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Figure 13.12: Example for NaBic control depending on base-excess level for subject ap009.
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Figure 13.13: Base excess: Overview of one hour means of the measured levels for all automated
trials. If no measurement was performed, the last known measurement is carried
forward.
13.4.2.2.2 Potassium Further evaluation of the fuzzy controller was performed by imple-
menting management of potassium levels by adaption of a potassium chloride (KCl) pump
for 7 animal subjects of the VNA study. The achieved performance of this management is
shown in Table 13.5 and Figure 13.14. During the observation time of 567 hours, physio-
logical levels (3.5–4.5 mmol/L) could be maintained for only 44 % of the time. Yet, severe
hypo- and hyperkalemia were not observed in any animal subject.
Table 13.5: Results for potassium management with a target level of 1 mmol/L.
potassium ranges [mmol/l]
within
(3.5,4.5]≤2 (2, 3.5] (3.5,4.5] (4.5,6] >6 hours
vna003 0 58 34 0 0 92 0.37
vna004 0 47 41 3 0 91 0.45
vna005 0 56 31 6 0 93 0.33
vna006 0 18 62 13 0 93 0.67
vna007 0 1 18 5 0 24 0.75
vna008 0 61 26 6 0 93 0.28
vna009 0 33 42 15 0 90 0.47
total 0 274 254 48 0 576 0.44
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Figure 13.14: Potassium: Overview of one hour means of the measured levels for all animal
subjects. If no measurement was performed, the last known measurement is carried
forward.
13.4.2.2.3 Calcium Calcium management was performed in 5 animal subjects of the AP
study. The results of this management are shown in Table 13.6. A physiological level within
0.8–1.2 mmol/L could be maintained for 213 of 313 observed hours (68 %). Hypocalcemia
with levels ≤0.6 mmol/L was observed for 4 hours. Significant hypercalcemia was not
observed at any time. An overview of the measurement results and pump rates is shown in
Figure 13.15.
Table 13.6: Results for calcium management with a target level of 4 mmol/L.
calcium ranges [mmol/l]
within
(0.8,1.2]≤0.6 (0.6,0.8] (0.8,1.2] (1.2,1.6] >1.6 hours
ap005 0 23 41 2 0 66 0.62
ap006 3 11 18 0 0 32 0.56
ap007 1 16 47 7 0 71 0.66
ap008 0 9 64 1 0 74 0.86
ap009 0 20 43 7 0 70 0.61
total 4 79 213 17 0 313 0.68
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13.5 Discussion
For application of closed-loops in medical decision making and the used experimental study
setting, a closed-loop system based on a fuzzy-logic controller was developed and applied.
By using fuzzy logic controllers, clinical expertise can easily be integrated as it can use
linguistic descriptions and be derived from therapeutic protocols which are often of fuzzy
nature without sharp numerical boundaries [7]. Thus, fuzzy logic is a concept successfully
applied to various different tasks in medical decision making [116, 137–140, 174, 179].
Using the proposed controller, inputs and outputs can easily be configured to be any
parameter transmitted via message objects within the TICoMS. This allows for rapid
evaluation of novel concepts as well as easy adaption and expansion of existing controllers.
In comparison to other fuzzy-logic based approaches, the proposed fuzzy-logic controller
uses only relative output factors to control the medical devices. By usage of such a factor, no
adaption of the output function to the individual numeric ranges of the controlled variable
needs to be performed. Instead, the output can directly be applied to a variety of tasks. Due
to these relative adaptions of the current setting, a goal-directed therapy by annealing to
a desired target level is performed. Manual therapeutic interaction and adaptions of the
current settings are possible at any time. After such manual interventions, the target levels
can be adapted, otherwise the controller will just start a stepwise return to the previously
set goal. Furthermore, the controller can be started and stopped at any point in time, as the
only internal and absolute state are the most recent measurements for slope calculation and
averaging in the next processing step. Those can simply be omitted in a first processing
step after (re-)start. Using those relative factors together with the message-based output, a
decoupling from a specific controlled device is achieved as the output is simply a message,
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distributed by the server to any application with matching filter rules. For example, if an
infusion pump has a malfunction, caregivers can easily remove the defective pump and set
up another pump with the appropriate drug and an approximately matched infusion rate.
The system will then continue the goal-directed therapy by applying the rate changes to
this replacement pump. Apart from such a failure scenario, this interchangeability and the
possibility of intervention at any given state may be important features in inter- or intra-
hospital transfer, where patients may arrive with already running infusion pumps that need
to be integrated in the control system without any further change of pumps or configurations.
Evaluation of the proposed goal-directed closed-loop fuzzy-logic controller was suc-
cessfully performed during the AP and VNA study in the used porcine ICU setting
for management of etCO2, glucose, base excess, potassium, and calcium to maintain
homeostasis and provide stable conditions for the observations. Further parameters were
only evaluated briefly for several hours or individual animal subjects and not included in
this evaluation as no reliable evaluation can be performed on the limited data base. For the
developed and presented closed-loop controls, the individual needs of the animal subjects
can clearly be observed with the collected measurements and resulting infusion rates.
The proposed closed-loop control for RR was successfully applied to maintain a constant
etCO2 level. Due to the relationship between exhaled CO2 and the CO2 concentration in the
blood, the acid-base balance could be stabilized as an essential step for maintaining general
homeostasis. For almost all animal subjects, the desired CO2 level could be achieved. In
three animal subjects (ap005, ap007, vna003), an increased target level (45 mmHg) was
used as medical conditions or sensor offsets required an adaption. For one animal subject,
a problem with etCO2 sensor of the ventilator arose, resulting in a measurement offset.
Therefore, the fuzzy set had to be adapted for compensation of the wrong measurement.
This was easily performed by adaption of the desired target level and shows the importance
of a flexible system that can be adapted by the caregiver at any time to counter technical
problems and provide adequate care if medical conditions indicate adapted target levels
during therapy.
For respiratory management, the implemented locking function for the fuzzy set proved
to be a vitally important feature during the performed medical procedures and maneuvers
by freezing the current state and prohibiting changes during those measurement episodes.
Especially during the VNA evaluation, where the RR is purposely set to 0 for a short
period of time as a respiratory hold, aggregation of measurements would have been
significantly skewed. Regarding the aggregation time itself, the shorter time frame used in
the VNA study allowed for a tighter control with better results. Admittedly, the prolonged
post-operative observation time with more stable conditions and the study protocol with
less common interruptions as well as the larger sample size, might contribute to this bias.
Glucose management was successfully performed using the proposed controller. Due bed-
ding times of up to 96 hours in the VNA trials without other means of nutrition, the G20
infusion was an essential energy source and thus the most important application of the de-
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veloped fuzzy logic controller. Hypoglycemic events below 70 mg/dL were only observed
in post-operative animal subjects at the beginning of the observation and not caused by the
control algorithm. On contrary, hyperglycemia was present for some post-operative animal
subjects. As no insulin was administered, no direct intervention could be performed and it
took some time for the animal subjects’ blood glucose levels to descend to nominal levels.
Once this range was reached, management was successfully applied. Other approaches
as proposed by Thompson et al. observed severe hypoglycemic events in 1.42 percent of
the 12.886 performed glucose measurements [150], a single hypoglycemia event with a
measured glucose level below 40 mg/dL was observed by Pachler et al. [152] during their
study with 60 patients observed for 72 hours each. The observations by Kulnik et al. [154]
included 10 patients with an average observation time of 66 hours where glucose levels
between 80 mg/dL–110 mg/dL could be achieved in 47 % of the observation time. In
comparison to these results, the developed control system showed a comparable or better
performance and provided a fully automated solution. Of course, for direct comparison
between the results, all study conditions would need to be identical and differences in the
patient demographic, their nutrition, illness and other factors influencing the glucose levels
would need to be known and considered.
Management of base excess by intravenous infusion of buffering NaBic solution was
successfully evaluated for 5 animal subjects. Yet, a significantly decreased performance
was observed for animal subject vna003. Since ventilation was difficult for this animal
subject, the target etCO2 level was increased from 40 mmHg to 45 mmHg. Of course, this
increase influenced the gas exchange and intravascular CO2 concentration. Such increased
levels lead to an acidification of the blood, which is most likely reflected in the decreased
base excess. By excluding this animal subject with the previous reasoning, successful
management could be performed in 68% of the time for the remaining 4 animal subjects.
The next managed parameter, potassium, could only be kept within the desired range in
44% of the total observation time and significant differences regarding the performance,
ranging from 28% to 75% for the individual animal subjects, are observed. Since the
fuzzy control for potassium was only evaluated for the VNA study, no comparison to more
stable conditions in the AP study can be performed. However, given the aim of this study,
investigating the volume state of the animal subjects, different defined states of volume
deficit and excess were evaluated by administering of diuretics and supplementary volume,
respectively. This caused significant changes in intravascular fluid content, as a result of
which the dilution of the solved potassium cations varied. Additionally, the different usage
of diuretics for the individual animal subjects may have further contributed to the observed
variations. Because of these dependencies, factors such as infusion rates and diuresis
should be included in the fuzzy controller for further evaluation.
Calcium management by the proposed fuzzy controller was performed for 5 animal subjects
of the AP study. Levels were kept within the desired target range for 68% of the total obser-
vation time. Whereas this application showed the successful implementation of the fuzzy
controller, the need for this control was not indicated for further animal subjects. Retrospec-
tive analysis of the obtained BGAs of the VNA study showed that only 5 hypocalcemic
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events occurred in a total of 932 observed hours and the nominal level could be maintained
without closed-loop control for around 70% of the time. This leads to the conclusion that
the proposed controller does not have a significant impact on the calcium levels, which
are successfully regulated by the body’s internal closed-loops under the given study condi-
tions. Further studies where this buffering ability of the body may be impaired, e.g., kidney
failures or alkalosis, would be required to perform an assessment of benefits for such an
automated calcium management.
Of course, this general fuzzy controller required simplifications compared to other more
specific and model-based approaches. Yet, for clinical application and easy configuration,
a simple input is required and no system with more parameters that need to be decided on
by the physician can be put to practical use. Additionally, model-based approaches require
large sets of training data or expertise and are tailored to a single, specific parameter. As the
developed approach was specifically designed for the experimental research environment
where the easy application and evaluation of novel closed-loops was desired, no such prior
knowledge and models should be required.
Regarding the measurement frequency, BGAs were performed every few hours to achieve
a tight control. This high frequency is required for a dynamic system and remains a
major drawback and is not limited to the proposed controller but a general problem
of related closed-loop systems, requiring measurements to be obtained nearly every
hour [147, 152]. The benefit of high measurement frequencies could clearly be shown for
the controller applied to management of etCO2, where such a high data frequency was
available. Another complication is the manual process of blood withdrawal for BGA. A
subsequent measurement might be carried out in half an hour or not within the next 8 hours.
Further complications are measurement inaccuracies and waiting times for the analysis to
be performed as processing of other samples or regularly executed maintenance programs
on the blood gas analyzer may delay the sample processing. Therefore, the regulatory
closed-loop is fully dependent on this manual task and a mere dependency on blood gases
should be avoided if possible. Novel sensors for continuous glucose monitoring (CGM)
may provide a reliable and high data rate, yet available sensors are expensive or still
in an experimental state and mostly tailored for long-term implantation during diabetes
management [148, 157]. Thus, not applicable in critical care as a disposable product. For
this reason, currently further indicators and surrogate parameters should be considered.
A further comparison to closed-loop systems used in clinical trials shows that such ap-
proaches are always based on individual laptops or integrated in isolated devices with no
direct access to other measurements and patient data. Thus, the measured glucose levels
and other parameters are required to be entered manually. On contrary, the developed fuzzy
logic controller integrated in the unified TICoMS is able to obtain the required measure-
ments automatically, reducing workload and human error potential. In addition, the required
changes are directly applied to the infusion pumps, providing further reduction of workload
and allowing a faster response. Of course, given the current legal framework, the control part
can only be carried out in an experimental research setting, as automated therapy guidance
in clinical trials is very restricted and requires manual confirmations by the caregivers.
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Considering further safety aspects, it is important to care about various safety features in
automated systems to prohibit decisions that may cause patient harm. Therefore, as shown
for the implemented pump and fuzzy logic controllers, as a final step before applying
changes to medical devices, limiting checks for maximum rates and settings should always
be performed. Given the evaluated examples, conditions like low respiration rates causing
oxygen depletion or excessive infusion of possibly lethal drugs, like KCl, were avoided
by those limitations. Furthermore, manual interaction should remain possible at any time
and have immediate effect, as complicated overriding procedures may cause or prolong
life-threatening conditions.
13.5.1 Outlook
With the current implementation as a proof of concept for using a fuzzy logic controller
within the developed software framework, further steps may include the improvement and
expansion of the current system.
Whereas the implemented fuzzy sets were used as test cases for the controller and the devel-
oped framework, the complexity of those closed-loops was still limited. More complicated
interaction of different parameters, e.g., total infused volume in relation to the dilution of
the administered medications may be included to provide a more adaptive and precise sys-
tem. Given the current consistent rule base, expansion to multiple parameters can easily be
performed. Additional fuzzy functions for pairs of absolute values and slope of a second pa-
rameter could be integrated to reflect further interactions and dependencies for a controlled
parameter. The used weighting between absolute value and slope could be expanded to an
additional weighting between the multiple input parameters and their slopes.
Regarding the data collection and control of the devices, the most important aspect would be
an improved connection to the infusion pumps. Due to the limited and experimental remote-
control interface provided by the manufacturer, data rate and collected information were
still limited. Especially for highly sensitive and critical infusions like Arterenol, infusion
pumps with a faster response time and more information about current pump state, including
the remaining infusion fluid for administering a bolus, would be required. Given the current
implementation, pumps could no longer be controlled if they entered a warning state, e.g.,
when the amount of infusion fluid gets low and syringes need to be replaced, which may
lead to critical situations if not recognized.
For scenarios with very asymmetrical risks, the distribution of the member functions within
the fuzzy sets might not be optimal, as proportional factors derived from the three used
input values (target, lower citical, and upper critical levels) are used. Extremely skewed
settings thus might cause member functions to overlap to a high or low degree, impairing
the control algorithm. Hence, such extreme scenarios may need to be evaluated to improve
the performance of the controller.
For respiratory management, sensor offsets and measurement inaccuracies may influence
control. Automatic recalibration of the target value based on BGA may be considered, as
in some cases an offset was present and in one case (vna003) the target had to be artifi-
cially increased until sensor recalibration and replacement could be performed. Of course,
such offsets may not only be of technical nature, as some medical conditions can disturb
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the correlation between blood and expiratory CO2 levels. Yet, such technical difficulties
showed the single point of failure. To prohibit such problems and sole dependencies, sur-
rogate parameters or redundancy by sensor fusion with additional sensors for improved
reliability would be useful. Additionally, further control of metabolic processes and con-
sideration of additional parameters like temperature and cardiac parameters might improve
CO2 management.
Beside specific improvements for individual control applications, the controller itself
might be improved by a more general and variable description. Recently, a standardized
fuzzy makeup language was proposed as the IEEE standard 1855-2016 for modeling
of fuzzy systems [202]. Modeling of the controller according to this novel standard
could provide an additional abstraction layer between the controller, integrated into
the medical framework, and the control logic. Thus, implementation and evaluation of
different controllers with varying complexities and enhancements may be performed
more easily and by definition in an additional configuration file. This might allow for dy-
namic adaptions of the controller during run-time by utilizing machine-learning approaches.
Yet another important aspect for clinical application is the need for a more adaptive and
interactive configuration of the fuzzy sets by the physician as shown for sensor offsets or
clinical conditions that required adaptions of the therapeutic goals. Whereas the used XML-
based configuration files provide all necessary settings, adaptions can only be performed
by a quick edit of this configuration file once the fuzzy controller is stopped. An enhanced
version may utilize the central patient monitor and the touchscreen interface to perform
such adaptions during run-time. This may include the assignment of new fuzzy sets and
adaption of existing ones using a GUI. Moreover, it may provide warnings to the caregiver
if critical conditions are observed. A concept for such an integral fuzzy control system is
shown in Figure 13.16.
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Figure 13.16: Design draft for a fuzzy GUI integrated in the control touchscreen for overview and
control of multiple vital parameters.
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Part V
Out of the Loop: Data Analysis and
Prediction
Prediction is very difficult, especially about the future.
old Danish proverb
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14.1 Motivation
Using the developed framework with the implemented closed-loop systems, clinical data
has been collected in a homogenous database for further analysis. Within the clinical setting
and the given study conditions, specific devices and configurations have varied between
individual subjects or were not used for intermediate time frames depending on the thera-
peutic needs. Furthermore, given the experimental research setting, the configuration of the
devices was changed several times in the course of the studies and occasional hot-fixes as
well as updates sometimes led to short down times during data collection.
Thus, as many machine learning approaches rely on a fixed vector of input parameters, a
first assessment regarding the availability and quality of the over 300 collected parameters
in the raw data base had to be made prior to further processing.
This assessment must not be limited to the availability of data, because even if a measure-
ment result is collected, it might be artificial or erroneous. Such an observation can have
various causes, including inaccurate internal calculations by the medical devices or manual
interventions interfering with the correct measurement. An example for the first case are
irregularities or intermediate heart beats due to a bad signal to noise ratio and measurement
artifacts due to breathing. Regarding to the second cause, pressure readings and other sen-
sors might be impaired by accidental touching and disturbance of the setup or intentional
therapeutic actions.
Therefore, prior to any further analysis and application of machine learning approaches, a
general overview of the hundreds of collected parameters should be obtained. This offers
important information on data availability, frequencies, and characteristic patterns that may
facilitate further analysis by distinguishing reliable results from data that should be excluded
from further steps or used only for tasks other than such an analysis.
14.2 Method
Using the developed export pipeline with the created HDF5 files for each animal subject,
the collected data was imported to Matlab for further analysis. Since this analysis should be
applicable for all collected parameters, a general approach, not requiring specific models
and knowledge for over 300 individual parameters, was chosen. Such an enhanced and
in-dept processing may only be performed for selected parameters in further steps. In
order to obtain additional information beyond mere availability, an automatic classification
of each data point was performed. This classification provided information on available,
measurement delays, changes in measurement frequency, and mean deviation.
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Analysis is carried out independently for each individual parameter and animal subject.
Given the complete measurement series, a sliding window approach with window size ct
is used to evaluate each point depending on the previous measurements. This subset is the
analysis vector v = (xt0−ct , . . . ,xt0), containing the current data point v(ct) and the chosen
subset of previous observations.
With this data frame, evaluation of the current observation is performed in several steps
regarding three different scopes: the absolute relation of the current value in comparison
to the earlier observations, its relative change, and changes in the frequency of obtained
measurements.
In a first step, general statistics, including mean vˆ, median v˜, standard deviation s, and two
quantile boundaries q1 and q2 are calculated for the observation vector v. Based on those
boundaries, a nominal data range [vˆ− s, vˆ+ s] is defined.
For the next steps, a filtered time series vnom, containing only measurements within [vˆ−s, vˆ+
s] is used to reduce the effect of outliers. Given enough data points (|vnom|> obsmin), a robust
regression using iteratively reweighed least squares with a bi-square weighting function is
performed to obtain an estimator v′nom for the observations within vnom. For computation in
Matlab the implemented robustfit with default bi-square settings is used. This function
utilizes a tuned calculation of the regression factors for handling large residuals with adapted
standard deviation s = MAD/0.6745 and a tuning factor f = 4.685 for the calculation of
the residuals r = rprior/( f · s ·
√
(1−h)).
Once this regression is calculated, the quality is assessed by calculation of the absolute
error err = abs(vnom− v′nom). This estimator for the goodness of fit is used with and addi-
tional slack variable cslack to define a numerical reference range rangenom = err · cslack for
classification of nominal values.
Next, the temporal dimension is analyzed. This is conducted by calculating the time differ-
ences tdi f f between each two successive measurements within v and estimating the median
data rate t˜di f f . Additionally, utilizing the calculated time differences between successive
observations from the previous step, the slopes are calculated. Those are averaged to obtain
a median relative rate of change ∆˜ for comparison to the current observation.
Given those statistical measures for the vector v with the length ct in the numerical and
temporal domain, the last step consists of the classification of the current observation x =
v(ct) with respect to those metrics, resulting in a binary vector containing flags for: (1) data
available; (2) absolute thresholds exceeded (x /∈ [v˜− rangenom, v˜− rangenom]) ; (3) data late
((tdi f f (vt)− tdi f f (i))> clate · t˜di f f , where i is the previous available measurement in v); and
(4) relative rate change greater than threshold (∆vt ,vt−1 > ∆˜).
An overview of this processing pipeline is shown in Figure 14.1. Analysis is repeated for
all parameters and successive time points with a shifted observation vector v.
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Figure 14.1: Schematic overview of the general analysis pipeline for all observed parameters.
Different binary flags for the characteristics of the currently observed data point at t0
are calculated by using a vector of previous observations.
14.3 Application to collected study data
For application of this classification pipeline to the collected study data, an observation time
ct = 3600 with a window size of one hour was used. Regression analysis was performed if
more than 20 measurements were present (obsmin = 20), otherwise only a comparison to the
median observation was performed. Quantile boundaries q1 = 0.2 and q2 = 0.8 were used
and the nominal data range was defined using cslack = 1.1. For classification within the time
domain, a delay tolerance of clate = 1.5 was used. A special analysis case was the processing
of the obtained BGA measurements. Since most of the time only one measurement was
available in the observation window ct , just the availability flags could be calculated.
14.4 Results
Using the described analysis pipeline, automated classification for each observation of
the studies was performed to obtain an overview of the data distribution and availability.
Examples for the classification for different parameters and periods of time are shown in
Figure 14.2. Successful classification of missing data points and deviations can clearly be
observed in all examples. Since analysis was performed for all parameters and time points,
it was possible to generate overview graphics including all parameters of the animal subject
using R. Such a summary is shown in Figure 14.3 for animal subject ap010. The analysis
results are presented as one-minute averages of the availability flags. Devices like ventilator
and scales with the highest resolution of 1 Hz are shown in black. Lower data rates are
colored gray. The different start times of the medical devices can clearly be recognized by
the individual start of the recording. Outages are displayed in red and, depending on the
cause, occurred for individual parameters, single devices, or device groups. At the end of
the study, the shutdown of the devices can clearly be observed. Apart from this retrospective
analysis, the classifier was successfully evaluated as a real-time application with a data rate
of 1 Hz.
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Figure 14.2: Examples for point analysis and classification or detection of outliers and absolute
and temporal changes with different analyzed and plotted timeframes for blood
temperature during injection of cold fluid (top), mean arterial pressure with artifacts
(middle) and heart rate (bottom). The flags, represented with colored symbols, show
the nominal states and if a deviation is detected by exceeding the dynamically
calculated threshold, change rate, or maximal timeframe between measurements.
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Figure 14.3: Overview of the point analysis for all parameters of animal subject ap010 as one
minute averages. Missing data is shown in red and shades of gray indicate the
average data frequency.
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14.5 Discussion
The presented method is an intermediate step to gain a first insight to the collected data. The
algorithm uses a sliding window to calculate nominal ranges for each observation to detect
outliers and provide a dynamic, but robust reference for the quality of each observation.
This provides additional information for the collected data that can be used in further
processing steps, including but not limited to the detection of outliers. By using the sliding
window, considering the most recent observations, dynamic adaption of the boundaries in
the course of time is performed. To account for the uncertainty of the performed regression,
the goodness of fit is evaluated and used as a slack factor for the classification. Whereas
mainly used retrospectively for processing of the collected data, a real-time version was
tested as well and might be used to provide a general overview of the various parameters
with a fast detection of potential problems in real-time.
The used approach was especially designed for general application to all parameters with
different numerical ranges and characteristics to detect significant events like sensor drop-
offs, bad pressure reading, or other errors in a dynamic ensemble of medical devices and
therapeutic interactions. Such events should be detected in collected data to reduce or elimi-
nate the influence of artificial observations in further analysis. As only an intermediate step
to guide additional processing and analysis, no further evaluation of the performance and
comparison to other methods was conducted. Using output flags as supplementary informa-
tion, differentiation between errors in individual sensors, entire devices, or the framework
for data collection itself may be performed. In comparison, most other methods are designed
for data imputation and do not calculate additional flags, that might be processed further.
Such further analysis may include the detection of different states, as parameters might
be NMAR if they share a common cause. Especially the combination of different parame-
ters and specific patterns of outages or delays may be useful if it originates from specific
therapeutic procedures. One such application may be an automated segmentation of the
observations into different phases during operation or critical care. Once given a general
overview regarding specific problems and requirements for individual parameters, further
analysis pipelines and processing may then be used to develop more specific and improved
models for individual parameter sets. In anticipation of the next chapter, such characteristic
patterns could be observed in the overviews of the analyzed animal subjects for the arterial
pressure curves during blood withdrawals. This observation, a combination of artificial
pressures and data NMAR, was then used as a detection algorithm for those events.
On the other hand, device malfunctions, accidental disconnects, or other events may cause
data to be MCAR without specific patterns or patterns that show individual devices as
malfunctioning. This can beneficial for the development of smart alarms and notification of
caregivers. Yet, given the current implementation, the dynamic adaption of the uncertainty
range may not be optimal for this problem as large uncertainties without fixed boundaries
can limit the detection of outliers. For the main goal, obtaining an overview of the collected
data prior to further processing, this dynamic adaption provided no problems.
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As shown in results for the closed-loop applications, limited temporal resolution and avail-
ability of BGA results was a major obstacle and uncertainty factor for automated control and
management of homeostasis. Thus, the ability to interpolate or predict BGA measurements
for intermediate control or guidance to achieve shorter adaption intervals was found to be
the most important aspect for improvement of the developed closed-loop system. Given the
general overview of the collected data presented in the previous chapter, the next steps to
approach this goal were obtaining matched training datasets of BGA- and surrogate param-
eters and a first evaluation of the performance for such a prediction. As processing of blood
samples can induce a significant and variable delay of several minutes between monitoring
and sample data, determination of the withdrawal timepoint was essential for this task and
of general interest in clinical practice.
15.1 Detection of blood withdrawals and other manipulations
15.1.1 Motivation
As BGA is a laboratory measurement involving manual processing steps and possible
delays, further analysis for developing a prediction model and subsequent application for
automated predictions and recalibration may only be performed if the blood sample can
be matched to other collected parameters. Therefore, an automated detection of blood
withdrawals and other manipulations is an essential step to provide the required data and
detect measurement artifacts.
Additionally, detection of withdrawals is of clinical relevance as blood sampling is one of
the essential tasks in critical care, which has to be carried out manually every few hours or,
if clinically indicated, even more often. One of the most common errors during handling of
blood samples is patient misidentification [203]. Various precautions such as checklists and
bar-codes are used to ensure proper sample dating and patient identification as critical and
significant steps for an adequate patient care [203–205]. Yet, errors, observed in up to 1 per
1000 samplings [206–208], may have life-threatening consequences if critical conditions
are not recognized or assigned to the wrong patient. However, those steps still require
manual work and may even provide additional workload, which means that noncompliance
with these guidelines continues to pose a major problem [203, 209, 210]. It is therefore a
purposeful and forward-looking strategy to solve this problems with technical methods that
ensure reliable identification [211, 212].
To perform this crucial task, a detection algorithm was developed and published [213]. The
concept of this approach will be presented in the following with an extended evaluation for
additional animal subjects.
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15.1.2 Blood sampling process
In order to develop a technical solution for withdrawal detection, it is important to under-
stand the sampling process and how it affects patient monitoring. Blood withdrawal from
an arterial line with established arterial pressure monitoring is in general performed by
an interruption of pressure monitoring to obtain access. This procedure is illustrated in
Figure 15.1. Such interventions cause unavoidable artifacts and characteristic patterns, e.g.,
artificial blood pressure and no pulsation, in the monitoring data that provide difficulties for
further processing and need to be filtered for further analysis [130, 214]. Such patterns were
also found in the general analysis of the recorded data and formed the starting point for
recognition. An example for such a typical withdrawal pattern is shown in Figure 15.2. The
observed mean arterial pressure (ABPm) reaches an artificial high level, whereas systolic
(ABPs) and diastolic (ABPd) pressures cannot be calculated due to the lack of pressure
variation and thus are not transmitted by the patient monitor.
While these artifacts pose problems for the further processing of the data, they can be used
for the detection of blood withdrawals and for validation of blood samples with recently
detected withdrawals from a specific patient. In addition, it provides an essential tool for
matching blood samples to other data aiding further analysis and machine learning.
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Figure 15.1: Schematic illustration of the arterial pressure measurement setup and interruption
during arterial blood withdrawal. During measurement (1) a standing fluid pillar is
detecting pressure changes. For withdrawal, arterial blood is aspirated (2) and
withdrawn with a syringe (3). To continue measurement, the aspirated arterial blood
is re-injected through the arterial access (4) and pressure measurement is continued.
15.1.3 Detection algorithm
With the help of the basic observations regarding patterns in the monitoring data during
blood sampling, a detection algorithm for blood withdrawals was developed [213]. This
algorithm uses available and missing information derived from the classification of the
arterial pressure monitoring data to detect the exact time of blood withdrawal. However,
detection is not limited to those specific case but can be used for general detection of events
based on a variable number of input parameters and calculated flags. Thus, first a general
description is given and then applied to the concrete withdrawal detection problem.
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Figure 15.2: Example observation of arterial pressure (ABP) readings from the patient monitor
during a blood withdrawal for animal subject ap006. Significant variation of the
arterial mean pressure and lack of calculations (highlighted with boxes) for systolic
and diastolic calculations by the patient monitor can clearly be observed.
In a first step, individual binary scores si ∈ [0,1] for the defined input parameters are cal-
culated. These scores are based on the various available flags of the data classification
which were described in the previous section. Additionally, each parameter is associated
with a individual weight wi for contribution to a total score S. To calculate the individual
scores, the obtained measurement of a parameter i is processed once a second to obtain an
individual score si for this parameter. If multiple observations were detected within a single
second, the most recent measurement is used for further processing.
For the individual scores (s1, . . .sn), the total score S = ∑ni=1 wi · si with ∑ni=1 wi = 1, result-
ing in a normalized scoring function within the interval [0,1], is calculated. The interval
boundaries of the scoring function s = 1 and s = 0 indicate that either all indicators for a
blood withdrawal are present or no indication for such an event was given, respectively.
Based on this score s, a simple threshold ST h is used to determine if a blood withdrawal
event was present when S > ST h. To obtain a more robust result and avoid false detections
for cases where only a single point in time exceeds the threshold, a series of Sn successive
points in time must reach the threshold ST h to qualify as a blood withdrawal event.
15.1.3.1 Detection of manipulations at the arterial access
Detection of manipulations and withdrawal events at the arterial access with the described
algorithm is performed by utilizing the ABPm, ABPs and ABPd pressure readings for
calculation of the scoring function. For ABPm, the score sABPm is based on the detection
of deviations from the mean observation of the last 10 minutes, ignoring missing data. If
a deviation is more than 10 mmHg from the mean the individual score s1 is 1, otherwise 0.
For ABPs and ABPd, binary flags for data availability are used (si = 1 if a measurement is
present).
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Based on the individual scoring functions for ABPm, ABPs, and ABPd, the combined score
as a weighted combination is used as an indicator for withdrawal events. The total score S is
calculated from the weighted average (w1 = w2 = w3) of the individual scores for all three
parameters. The threshold for the scoring function is set to ST h = 0.7 and manipulation
events are reported if this threshold is exceeded for 10 successive seconds (Sn = 10).
15.1.4 Evaluation
Evaluation of the proposed algorithm was performed as a retrospective analysis for all ani-
mal subjects of the performed AP and VNA studies where data collection from the patient
monitor was available. Due to the short observation time and various required therapeutic
interventions influencing the pressure measurement, animal subject ap010 was excluded
from this analysis. The arterial pressure information was obtained from the Philips MP50
patient monitor with TICoMS during the studies and stored in the central database. With-
drawals were performed by physicians, scientists, medical students, and lab technicians,
thus providing a broad variety of individuals and skill levels. For retrospective analysis, the
collected information was extracted from the study database and each point in time was
processed in successive order, simulating the online behavior of the algorithm.
Each detected event was automatically plotted using a MATLAB script to provide a graphic
chart covering a 10-minute window. This was used to perform a visual inspection and
validation of the variables and the scoring function for each event. As the used blood gas
analyzer (Radiometer ABL800 FLEX) was connected to the developed system as well,
the analysis results and processing times were stored with the monitoring information in
the central database. For evaluation of the withdrawals, those events were exported and
processed in the same manner as the automated detected events to be used as a reference.
Each automatically detected event then was matched to the reference analysis times if
an assignment was possible and counted as hits or misses, respectively. For additionally
detected events, manual visual inspection and classification of legitimate withdrawals or
flushing events with clearly visible artificial pressure levels (as others) and false positive
detections (as FP) was performed. Finally, using this classification of all detected and
known withdrawal events, performance of the detection was evaluated in terms of sensitivity,
precision, and F1 score.
In addition to the retrospective analysis, a proof of feasibility for the real-time version of
the algorithm was performed for two animal subjects. As a reference, blood withdrawals
were observed manually and the resulting deviations in ABPm, ABPd, and ABPs on the
IntelliVue MP50 monitor were compared to the automatic detection by the proposed algo-
rithm.
15.1.5 Results
Using the proposed evaluation method, the performed BGAs were matched to the detected
withdrawal events. All additional events were evaluated and classified using the generated
plots. A detailed example of such a detected event with the plotted measurements and
scoring function is shown in Figure 15.3. Using this analysis for all detected events, the
algorithmic performance for each animal subject and as a whole was evaluated and is pre-
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sented in Table 15.1. A total number of 886 BGAs was carried out during the performed
studies. The proposed algorithm detected 1198 events of which 866 were the performed
BGAs. Thus, BGAs could be successfully detected in 866 of 886 cases (97.74%). In ad-
dition, 268 further events, including blood withdrawal for laboratory and ACT analysis,
or flushings of the arterial lines, were correctly detected. In 47 cases, the algorithm per-
formed a false positive event detection, which, easily recognizable by visual inspection of
the plotted data, was based solely on fluctuations in the pressure curve. Overall, a sensi-
tivity of 0.98, a precision of 0.96, and an F1 score of 0.97 were achieved. An overview of
all detected of the individual animal subjects matched to the performed BGAs is shown
in Figure 15.4. As observable in this figure, nearly all BGAs (97.3 %) were successfully
detected in the AP study with regular withdrawal patterns and the number of additionally
detected events was very small (2.9%). For the VNA study, most BGAs were successfully
matched as well. However, numerous additional detection events (30%) can be observed.
In this study, BGAs were performed at defined changes in the total body volume, resulting
in dynamic and variable sampling intervals that can clearly be observed.
A real-time version of the algorithm was successfully integrated in the developed software
framework and was able to successfully detect blood withdrawals and manipulations from
the arterial catheter in real-time for two animal subjects.
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Figure 15.3: Detection example with the proposed scoring for the same event as in the motivation
for animal subject ap006.
15.1.6 Discussion
The detection of blood withdrawals using pressure monitoring was tailored to a usual
blood withdrawal process from an arterial access. Whereas those events lead to unavoidable
artifacts in pressure measurements that need to be filtered for further analytical processing
of the pressure curve [130, 214], they provide essential markers for automated detection
of blood withdrawals and interactions. Weighting and combining individual parameters as
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Figure 15.4: Overview of all detected events (red) and the BGA references (black) for all
analyzed animal subjects. During the AP study, stable conditions with fixed BGA
intervals were maintained. The VNA study was performed with purposeful states of
volume deficits, causing difficulties maintaining arterial access which required
aspirations and flushings that can be observed as additional interaction events.
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Table 15.1: Performance for the individual animal subjects. Presented are the number of
performed BGAs, the number of detected events, the number of correctly identified
BGAs (hits), not detected BGAs (misses), other withdrawals and flushings (other),
false positives (errors) and applicable scores. (Extended from [213])
VNA
1 2 3 4 5 6 7 8 9 10
#BGAs 66 40 74 73 60 67 62 54 42 17
#manip. 78 57 109 108 94 89 119 77 88 40
hits 66 38 73 68 59 65 62 54 42 17
misses 0 2 1 5 1 2 0 0 0 0
other 8 15 15 35 30 22 47 20 44 22
errors 4 4 4 5 5 2 10 3 2 1
sen. 1.00 0.96 0.99 0.95 0.99 0.98 1.00 1.00 1.00 1.00
prec. 0.95 0.93 0.96 0.95 0.95 0.98 0.92 0.96 0.98 0.98
F1 0.97 0.95 0.97 0.95 0.97 0.98 0.96 0.98 0.99 0.99
AP AP & VNA
5 6 7 8 9 Summary
#BGAs 72 34 75 77 73 #BGAs Σ 886
#manip. 77 36 74 79 73 #manip. Σ 1198
hits 69 33 73 77 70 hits Σ 866
misses 3 1 2 0 3 misses Σ 20
other 5 2 1 1 1 other Σ 268
errors 3 1 0 1 2 errors Σ 47
sen. 0.96 0.97 0.97 1.00 0.96 sen. 0.98
prec. 0.96 0.97 1.00 0.99 0.97 prec. 0.96
F1 0.96 0.97 0.99 0.99 0.97 F1 0.97
algorithmic input allows an easy adaption and expansion of the algorithm depending on
the available data and needs. For example, the blood temperature could easily be added to
detect flushing events. However, since arterial temperature measurement using a PiCCO
catheter system is not always available, this additional indicator was omitted for general
application and during the performed evaluation.
In this evaluation, a maximum permissible time between sample collection and analysis
had to be assumed, as the detected events had to be matched to the performed analysis. If
a BGA was not detected within the chosen 10-minute window, it was counted as a miss.
This scenario may have happened in some cases where required medical interactions or
cleaning programs of the blood gas analyzer delayed processing of the blood sample. Thus,
no interactions could be observed within the pressure curves for the reported analysis time
but only more than 10 minutes prior. Accounting for those events, further improvement of
performance may be achieved, as the presented values may be seen as a lower boundary.
For the AP study, with animal subjects observed in a stable condition with fixed BGA inter-
vals of 2 hours, a one to one matching of manipulations and BGA events could be achieved
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in most cases. On contrary, in the VNA study, evaluating different volume states that in-
cluded severe volume deficit, multiple additional events were detected. Such extreme states
made management of the arterial access more difficult, frequently requiring aspirations and
flushings of the arterial access to maintain monitoring. Those therapeutic interactions were
of course detected as well and different volume states may even be classified by the changes
in the frequency of manipulation during the course of observation.
In order to be used as a detection algorithm for withdrawals and validation of blood samples,
it is important to recognize each performed withdrawal as undetected events cannot be dated
and compared. Thus, the sensitivity of the algorithm is more important than specificity.
Whereas other events and manipulations, as seen in VNA study, may lead to false positives,
the number of such additional events is still limited and did not cause problems for the
matching of individual BGAs.
Another important aspect is variability in the blood withdrawal process as it requires several
steps to be performed manually, possibly interfering with the algorithms performance. Dur-
ing the performed studies with the animal subjects, interactions and blood withdrawals were
performed by a broad variety of caregivers with different levels of professional experience
and backgrounds. This resulted in variations of the blood withdrawal process, including the
individual steps and required amount of time. The developed algorithm was able to success-
fully detect those events for all caregivers, showing feasibility for general application in a
clinical environment and allowing a precise dating of blood samples by correcting the time
offset added by sample collection and analysis.
15.1.6.1 Outlook
As patient misidentification [203] is one of the most common errors in handling blood
samples, detected withdrawal events and times may be used as a reference for validating
blood samples originating from a specific patient. This may provide an improvement for
blood gas analyzers, as the patient selection can be limited to patients where a manipulation
was recently detected. As correct dating and matching of blood samples is essential for ade-
quate patient care [203–205], such an automated solution can increase safety as it becomes
effective automatically in the pre-analytical phase [212], whereas guidelines and other
approaches still rely on the human compliance [203, 209, 210] to avoid life-threatening situ-
ations due to mix-ups [211]. Even further enhancement of patient safety may be performed
with automated validation of the BGA results with other vital parameters.
Regarding the detection method of the algorithm, further improvement may be achieved
by including additional parameters or a more specific scoring flags like duration of the
spikes or the numerical sign of the changes to further differentiate between flushing and
withdrawals. If a large enough training data set is available, this might be performed as a
supervised or unsupervised classification task utilizing machine-learning approaches.
Despite the evaluation with different caregivers and critical states of volume deficit, further
evaluation regarding to various patient conditions would still be necessary. Since the algo-
rithm was evaluated on animal subjects under general anesthesia, no voluntary movement
and other artifacts were present in the collected data. For clinical application, especially
patient movement may cause interruptions and significantly decrease performance and thus
should be considered and evaluated.
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15.2 BGA prediction with surrogate parameters
15.2.1 Motivation
As BGA may only be performed irregularly every few hours, difficulties for closed-loop
control due to the low data frequency can arise. Additionally, BGAs are invasive measure-
ments associated with infection risk, cost of disposables, and high manual workload for
the caregivers during sample collection and processing. Thus, finding surrogate parameter
with a higher temporal resolution can be a helpful solution and will aid the development
of predictive models for BGA parameters, allowing to establish tighter closed-loop control
and better homeostasis management. And even if this goal of an accurate prediction cannot
fully be achieved, a detection of significant changes observed in the surrogate parameters
will still be very beneficial to indicate the imminent need of a BGA to the caregiver.
Another important aspect, as described in the previous section, is the matching of blood
samples to the correct patient for patient safety. Because check-lists and other approaches
to avoid sample mix-ups still have an associated human risk, technical solutions becoming
effective in the pre-analytical phase may be beneficial for patient identification and
avoidance of sampling mix-ups [211, 212]. If blood gases can be derived from other vital
parameters, this prediction may be used for validation of the blood sample.
Independently of the goal to be achieved, the most important aspect for any analysis was to
obtain matched pairs of monitored vital signs and BGA results. Unfortunately, the process of
blood sampling requires some time for the withdrawal process itself, sample transportation,
and analysis. It may even further be delayed if the blood gas analyzer is busy or not ready for
processing of the sample. This can easily result in varying delays of several minutes during
which vital parameters that can be correlated to the blood sample may change. Whereas for
simple correlations between closed-loop systems and the measured parameters, an offset
of a few minutes may be neglected, for machine learning, using a vector of many, even a
few hundred, input parameters, the relations between those values and the BGA results are
important. Especially, when considering the experimental setting with different analytical
maneuvers, a stable state is disturbed with those interactions and various changes as part of
the analytical protocol may be required. For example, in the VNA study, the respiratory hold
maneuver and Trendelenburg leg-raise test were performed directly after blood withdrawal
and could drastically change various vital parameters, resulting in a significant mismatch
to BGA results.
Given the developed method for automatic detection of withdrawal events described in
the previous section, BGA results can be matched to withdrawal events and thus to other
observed vital signs, solving the delay problem as additionally illustrated in Figure 15.5.
Using this essential foundation of a matched dataset, surrogate parameters that are readily
available from patient monitoring may now be used to improve the closed-loops or patient
identification. Yet, for finding such surrogate parameters and a first evaluation, several
steps still had to be performed. Given the raw, matched dataset, the first required step
was generating a training dataset that can be used for further processing and machine
learning. Then, using the obtained dataset, prediction of blood gas parameters with different
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approaches and evaluation of the achieved performance could be conducted. In what follows,
those steps will be presented.
t
t0
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actual vectors of observations
for predictive parameters
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Figure 15.5: Visualization of parameter offset resulting from withdrawal and analysis delay.
Predictive values are obtained from various points in time after the withdrawal if no
correct dating of the withdrawal is performed.
15.2.2 Methods
15.2.2.1 Creation and evaluation of the training dataset
In a first step for machine-learning-based predictions of blood gas surrogate parameters, a
training dataset had to be generated. Using the automated detection of blood withdrawal
events to get the specific withdrawal times, a raw dataset containing the BGA results and
matched monitoring data without a measurement offset for each performed BGA of the
VNA study (animal subjects vna001 – vna010) was obtained. Within this dataset, containing
the union of all parameters observed during the study, missing observations for individual
measurements or parameters in individual animal subjects were still included. Yet, for
further processing with machine-learning approaches, a complete training dataset without
such gaps was required. To obtain this dataset, a subset had to be calculated. Therefore, a
tradeoff between the removal of entire unreliable parameters and incomplete observations
had to be found. This was performed by solving the maximization problem for remaining
data points in relation to a variation of the threshold for removal of an entire parameter.
After finding this threshold and reduction of the dataset, a subset of parameters relevant to
the BGA prediction task was chosen, excluding alarm limits and other technical parameters.
15.2.2.2 Prediction of blood gas parameters
Using the calculated training dataset, prediction of surrogate parameters could be performed
with a broad variety of machine learning approaches that require complete input vectors.
Yet, due to different numerical ranges of the vital parameters, a scaling of the training data
was needed to avoid a prediction bias toward larger numerical parameters. This problem
was solved by scaling each parameter by the 90% quantile of its absolute values.
For analysis of this now scaled dataset with 14 different blood gas parameters, three re-
gression methods were tested. First, ridge regression was used to provide a base-line for
regression performance. As parameter reduction was a desired goal, lasso regression with
these capabilities was tested as well. To gain an insight how parameter reduction influences
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the result, a third analysis using elastic-net regression, a weighted combination of the L1
and L2 norms used by lasso and ridge, was evaluated for the entire range of α weighting
factors. For each regression method, models for each of the 14 parameters were trained
and evaluated using leave-one-out (n-1) cross-fold validation. Training was performed on
9 animal subjects of the VNA study and performance was tested on the remaining one in
each step.
The λ parameter for each of the 14 models within this 10-fold cross-validation was automat-
ically selected by using another nested 10-fold cross-validation on the training dataset. The
optimal value for λ within each cross-fold then was selected from a geometric sequence of
100 values, with the largest just sufficient to produce β = 0. Performance of each regression
model was assessed by calculation of MSE, NRMSD, and R2 for the test subject of each
cross-fold, excluded from training. The overall performance was then calculated as the
average performance for all cross-folds.
For the third performed analysis using elastic-net regression, 100 different α values between
0 and 1 for steps of 0.01 were evaluated in the same way. In fact, as ridge and lasso are
only edge cases of elastic-net regression with α= 0 and α= 1, respectively, those two edge
cases were already covered. To assess the influence, the results for all α parameters were
collected. The average performance for each value of α was calculated as the average of
the models obtained from the 10 cross-folds. The best α for each BGA parameter was then
chosen as the one yielding the smallest average MSE.
Given the best α value, the achieved parameter reduction was observed. To provide an
estimate how many parameters have a significant influence and if parameter reduction is
reasonable for the evaluated BGA parameter, the average number parameters required to
contribute to 50 percent of the regression coefficients was calculated and is denoted as β50.
For this calculation, the regression coefficients were sorted in descending order by their
absolute value and the total contribution of the parameters was accumulated until a sum of
0.5 was exceeded.
Previously, only the MSE was used as a measure for the goodness of fit. Yet, often relative
changes and correlations are more important for parameters in the clinical field. To provide
an estimate of how the selection of an optimal α for the elastic-net regression influences this
performance, the previously described steps for selection of the best α were performed with
the goal of selecting the minimal coefficient of determination (R2) as well. A schematic
overview of the nested regression pipeline and selection of optimal α values for the evalu-
ated BGA parameters, based on the average model performance of the cross-fold validation,
is shown in Figure 15.6.
Finally, besides evaluation of elastic-net regression and assessment of optimal α parameters
for each of the examined BGA parameters, the results are briefly compared to SVR. This
evaluation was performed in a similar fashion, using the scaled input data and by performing
an n-1 cross-fold validation.
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Regression analysis pipeline for each BGA parameter
Figure 15.6: Schematic illustration of the processing pipeline. Elastic-net models were evaluated
for different α values using 10-fold cross-validation with nested cross-validation for
λ selection. Based on the best average performance in the trained models, α was
selected.
15.2.3 Results
15.2.3.1 Optimization of training dataset
In a first step, the raw dataset was preprocessed to obtain a reduced dataset suitable for
training. For the VNA study, an optimal threshold of 38 missing observations for exclusion
of a parameter was calculated and is visualized in Figure 15.7. Omitting technical parame-
ters and alarms, 498 BGA observations of 88 parameters from patient monitor, ventilator,
infusion pumps, Pulsion PulsioFlex, Osypka ICON, body, and diuresis scale remained.
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Figure 15.7: Optimization of the training dataset by maximizing remaining data points (top) and
the relation between remaining observations and parameters (bottom). If a parameter
was unavailable in more than 38 observations, it was excluded.
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15.2.3.2 Regression analysis
Using the training data set obtained in the previous step, scaling of each parameter was
carried out by its 90% quantile. In this way, training bias towards individual parameters
was avoided and possible outliers were taken into account, which would also have led to a
bias if normalization had been performed on the basis of the largest observed value.
Next, regression analysis was performed. The results for all performed regressions for the
evaluated range of α parameters, including ridge and lasso regression as edge cases, are
shown in Figure 15.8. For each BGA, the calculated MSE of each cross-fold, the average of
all, and the optimal alpha are visualized on top of the results regarding the r2 performance
below. The results of this evaluation are summarized in Table 15.2 for the three used
methods (ridge, lasso and elastic-net). For elastic-net regression, the best α, based on the
average MSE of the cross-fold models, is denoted. During the evaluation of the performed
lasso regression of cCa2+, no r2 could be calculated as the prediction yielded a constant
term with zero variance. For most evaluated BGA parameters, ridge regression or elastic-net
regression with small values of α achieved the best results. Yet, the influence of α for most
parameters, as observed in Figure 15.8, is very small. Parameter reduction yielded the best
performance for FCOHb (α= 0.98), FMetHb (α= 0.69), and temperature (α= 1.00).
By observation of the individual cross-fold models in Figure 15.8, similar performance,
with an exception for the models evaluated on animal subject vna002, can be seen for
most parameters. For this subject, only a limited set of test cases could be evaluated as the
observation time was cut short due to medical complications. For SBE and T , a significant
variation between the individual cross-fold models can be observed.
Using the chosen optimal α parameters for each examined BGA parameter, the true val-
ues for the test cases of each cross-fold can be plotted against the predictions as shown in
Figure 15.9. For visualization of the data distribution, hexplots with color-coded density
are used. It can be observed that a majority of obtained results could be predicted with a
high accuracy, except for COHb and MetHb, which show a bifurcation in two clusters of
observations for individual animal subjects. Yet, for the remaining parameters, the high ac-
curacy is mostly limited to a cluster around a single point with high density. With increased
distance from this center of the distribution, a decreasing accuracy is observed.
15.2.3.3 Selection regarding the best coefficient of determination
Additionally to the optimization of the α value in regard to a minimal MSE of the cross-
fold test cases, a model selection based on a maximized coefficient of determination R2
was performed to assess the influence of this goal regarding the choice of α. The model
selection regarding this goal is included in Figure 15.8 and shown below calculated MSE
of each parameter, respectively. The results of this optimization and the best α parameters
are presented in Table 15.3.
Comparison of the individual cross-folds, presented in Figure 15.8, show a similar perfor-
mance for most cross-folds. The chosen value of α does not have a significant influence on
the achieved performance, except for temperature T , where parameter reduction leads to a
significant increase.
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Table 15.2: Evaluation results for regression analyses and MSE optimizations (rounded to 3
digits). The average number of coefficients contributing to at least 50 percent of the β
coefficients is denoted as β50.
FCOHb cCa2+ cGlu cK+ cLac FMetHb cNa+
ridge MSE 2.416 0.037 314.527 0.440 2.238 1.020 176.718
α= 0 NRMSD -3.245 0.194 0.162 0.159 0.914 0.941 0.077
R2 0.056 0.037 0.079 0.110 0.261 0.051 0.190
lasso MSE 2.537 0.048 687.543 0.841 8.657 1.469 533.715
α= 1 NRMSD -5.008 0.213 0.229 0.207 1.758 1.030 0.120
R2 0.052 – 0.117 0.081 0.243 0.053 0.389
optimum α 0.98 0.01 0.02 0.00 0.00 0.69 0.00
elastic net MSE 2.352 0.036 293.691 0.440 2.238 0.901 176.718
NRMSD -4.951 0.192 0.159 0.159 0.914 0.885 0.077
R2 0.058 0.056 0.156 0.110 0.261 0.074 0.190
β50 2.3 7.4 19.4 14.8 18.1 2.1 14.2
FO2Hb SBE T pCO2T pHT pO2T ctHb
MSE 36.596 14.146 0.572 33.129 0.004 1192.076 1.175
α= 0 NRMSD 0.044 -0.756 0.018 0.120 0.008 0.236 0.106
R2 0.040 0.118 0.049 0.080 0.112 0.063 0.261
lasso MSE 43.441 10.994 0.397 59.069 0.010 4211.333 2.643
α= 1 NRMSD 0.054 -0.708 0.014 0.159 0.012 0.428 0.145
R2 0.048 0.116 0.610 0.079 0.053 0.283 0.242
optimum α 0.00 0.06 1.00 0.33 0.00 0.00 0.00
elastic net MSE 36.596 10.391 0.397 31.577 0.004 1192.076 1.175
NRMSD 0.044 -0.690 0.014 0.119 0.008 0.236 0.106
R2 0.040 0.105 0.610 0.088 0.112 0.063 0.261
β50 13.4 16.6 1 8.5 20.3 11.5 15.3
15.2.3.4 Optimal model parameters
Based on the optimized α values regarding MSE and R2, predictive parameters may be de-
rived from the influence of the individual regression coefficients. Therefore, the normalized
regression coefficients were sorted by their absolute weight in descending order. The weight
distribution of the individual regression coefficients for the optimal α for each predicted
BGA parameter are shown in Figure 15.10. The difference between the weights for optimal
MSE and R2 of each coefficient is highlighted with a thick bar on a smaller stem for each
parameter. Whereas for some parameters a broad distribution with small regression coef-
ficients for numerous parameters can be observed, especially for temperature T , FCOHb,
cCa2+, FMetHb, and pCO2T a small fraction of significantly contributing coefficients can
be recognized. This can be observed in Table 15.2 as well, where those parameters have a
large optimal α and a small β50 value. For BGA parameters with significant contributions
of individual regression coefficients, contributing parameters with their relative coefficient
weight are shown in Table 15.5. Comparing the two evaluated measures for the goodness of
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Table 15.3: Evaluation results for the regression analyses and optimizations regarding the
goodness of correlation based on R2 (rounded to 3 digits). The average number of
coefficients contributing to at least 50 percent of the β coefficients is denoted as β50.
FCOHb cCa2+ cGlu cK+ cLac FMetHb cNa+
optimum α 0.72 0.31 0.01 0.01 0.04 0.58 0.94
elastic net MSE 2.432 0.046 302.428 0.478 2.329 0.952 573.355
NRMSD -4.824 0.211 0.161 0.167 1.108 0.909 0.118
R2 0.063 0.110 0.159 0.111 0.322 0.076 0.467
β50 2.7 1.1 19.6 12.5 15.3 2.4 3.5
FO2Hb SBE T pCO2T pHT pO2T ctHb
optimum α 0.92 0.27 1.00 0.95 0.04 0.97 0.23
elastic net MSE 40.357 12.828 0.397 54.437 0.011 2311.109 2.958
NRMSD 0.049 -0.745 0.014 0.153 0.012 0.336 0.149
R2 0.049 0.154 0.610 0.112 0.164 0.289 0.311
β50 3.7 13.3 1 3.3 8.3 5.0 9.5
fit, MSE and R2, only small variations in the regression coefficients for the most significant
contributing parameters can be observed. The only notable exception is cCa2+, where 9
factors are contributing to 50% of the regression coefficients in MSE optimization, yet
regarding R2 the only significantly contributing factor is tissue perfusion.
15.2.3.5 Comparison to SVR
For comparison, an additional evaluation using SVR, using a linear kernel and similar
n-1 cross-fold validations for the 10 animal subjects of the VNA study, was performed.
Evaluation results of this model are presented in Table 15.4. Neither this linear kernel nor
additional tests with other kernels provided significantly better results for MSE and R2 than
the optimized elastic-net approach.
Table 15.4: Averaged results for the test cases of the 10-fold cross-validation using a SVR
approach.
FCOHb cCa2+ cGlu cK+ cLac FMetHb cNa+
SVR MSE 4.512 0.264 350.641 1.912 2.378 1.672 381.429
linear NRMSD -3.346 0.431 0.173 0.292 0.910 1.104 0.100
R2 0.025 0.067 0.175 0.084 0.302 0.039 0.385
FO2Hb SBE T pCO2T pHT pO2T ctHb
SVR MSE 50.978 12.939 1.074 54.303 0.010 1301.463 4.134
linear NRMSD 0.055 -0.774 0.023 0.154 0.012 0.260 0.175
R2 0.047 0.060 0.299 0.043 0.073 0.217 0.255
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Figure 15.8: Evaluation of the optimal α values for reduction of MSE (top) and r2 (below) for
each of the 14 BGA parameters. The results of the individual crossfolds for animal
subjects vna001–vna010 are shown in thin gray lines for each regression model, the
average performance is shown in thick red and blue lines for MSE and r2,
respectively. The optimal alpha is highlighted by a vertical black bar.
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Figure 15.9: True (x-axis) vs. predicted (y-axis) values, based on the best α with minimal MSE
for each parameter as hexagon binned density plots with a red reference line.
Optimal predictions would be along this line. For COHb and MetHb, two separate
clusters indicating distinct observed states can be observed.
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Figure 15.10: Visualization of the relative contributions of the regression coefficients for the
evaluated parameters of animal subjects vna001–vna010. Differences between the
mean MSE and mean r2 model are shown as thick line segments for each input
parameter.
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Table 15.5: Influence of the surrogate parameters for a subset of blood gas parameters based on
the relative contribution of the regression coefficients for MSE and R2 optimization
that are contributing to half of the weight of correlation coefficients.
Parameter rel. influence Predictive Parameter
MSE opt. r2 opt.
T 0.781 0.781 Philips MP50 IntelliVue blood temperature
0.219 0.219 remaining parameters
FMetHb 0.320 0.292 Pulsion PulsioFlex O2er
0.222 0.201 Osypka ICON str
– 0.126 Osypka ICON pep
0.458 0.381 remaining parameters
FCOHb 0.320 0.283 Pulsion PulsioFlex O2er
0.150 0.136 Osypka ICON str
0.132 0.131 Philips MP50 IntelliVue EVLW
0.398 0.450 remaining parameters
cCa2+ -0.161 -0.542 Philips MP50 IntelliVue Perf
0.068 – Jonosteril infusion rate
0.054 – Osypka ICON sqi
0.049 – Philips MP50 IntelliVue ABP dia
-0.044 – Osypka ICON vic
0.042 – Philips MP50 IntelliVue CFI
0.042 – Pulsion PulsioFlex dPmx
0.036 – Pulsion PulsioFlex PPV
-0.036 – Philips MP50 IntelliVue ITBV
0.467 0.458 remaining parameters
pCO2T -0.083 -0.092 Osypka ICON str
-0.074 -0.079 Osypka ICON pep
0.067 0.090 Dräger Evita XL Inspiratory O2
-0.059 -0.118 Pulsion PulsioFlex ScvO2
-0.057 – Philips MP50 IntelliVue EVLW
-0.056 – Philips MP50 IntelliVue Perf
0.041 – Osypka ICON ci-wt
0.038 – Osypka ICON icon
-0.037 -0.087 Dräger Evita XL minimal airway pressure
– -0.063 Dräger Evita XL PEEP airway pressure
0.488 0.471 remaining parameters
SBE 0.051 0.055 G20 infusion rate
-0.048 -0.056 Osypka ICON tfc
0.037 0.042 Dräger Evita XL respiratory rate
0.036 0.041 Osypka ICON vic
0.036 0.041 Dräger Evita XL minute-volume
-0.036 -0.035 Philips MP50 IntelliVue EVLW
-0.030 -0.035 Dräger Evita XL minimal airway pressure
-0.029 -0.032 Philips MP50 IntelliVue SVV
-0.028 -0.033 Dräger Evita XL PEEP airway pressure
-0.025 -0.029 Pulsion PulsioFlex HP-PR
-0.025 -0.029 Osypka ICON str
-0.024 -0.026 Philips MP50 IntelliVue dPmax
-0.023 -0.025 Pulsion PulsioFlex DO2I
-0.022 -0.027 Philips MP50 IntelliVue CFI
0.549 0.495 remaining parameters
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15.2.4 Discussion
Parameter estimation and prediction are important aspects for closed-loop control of param-
eters dependent on blood gas analysis. As those measurements are only performed infre-
quently, often with several hours in between the measurements, the dynamic behavior of
automated approaches is very restricted, limiting the achievable performance in homeosta-
sis management. A sufficient prediction model utilizing surrogate parameters with higher
temporal resolution may allow to bridge this gap by tighter control and faster feedback.
The first preliminary step for such predictions was the correct dating of the blood sample
as variable withdrawal and analysis delays cannot be avoided and were present in the
obtained measurements. As therapeutic interventions induced rapid changes in the vital
parameters during the VNA study, no fixed window, e.g., observing and averaging the last
10 minutes prior to measurements, could be used but a correct identification of withdrawal
times had to be performed with the developed detection algorithm to obtain a matched
dataset. Containing all measurements of the VNA study, the dataset was preprocessed to
remove unreliable parameters and incomplete measurement vectors.
To avoid an optimization bias toward individual parameters with large error potential or
larger numerical ranges, scaling was needed as for ridge and lasso regression each error term
is accounted equally. Looking forward to application within a real-time prediction system,
no retrospective normalization may be used. Furthermore, training data may still contain
significant outliers that may skew the scaling due to large differences in the numerical
range. By using the 90 percent quantile as a scaling factor, those outliers were considered
and a scaling to a nominal parameter range was achieved. This provided a more balanced
training input for regression. Given this scaled data set, regression analysis was used to
obtain estimates of the BGA parameters and evaluate the potential for parameter reduction.
Missing parameters are an important problem for any prediction as only complete input
vectors may be processed by a model, trained on those particular parameters. Thus, besides
allowing for better clinical interpretation of the regression coefficients, a limited set of input
parameters reduces the dependencies of regression models and allow for a more general
application. Additionally, specific pre-processing steps may be used for the most significant
and influential surrogate parameters regarding to the relative influence of their regression
coefficients. With this goal in mind, methods like lasso and elastic-net regressions are a
purposeful approach as the used L1 norm allows for these restrictions, whereas ridge cannot
achieve this by using the L2 norm.
Evaluation of the predictive performance and the potential for parameter reduction was
performed for the dataset obtained from the VNA study using elastic-net regression, in-
cluding the edge cases of ridge and lasso regression. The effect of parameter reduction
and potential relevant parameters to be pre-processed further was evaluated by variation of
α as a weighted combination between lasso and ridge regression. The calculated β50 pro-
vided a good estimation of this parameter restriction potential, as the number of regression
coefficients significantly contributing to the total regression vector can clearly be observed.
Yet, except for the temperature reading of the BGA, where a parameter reduction to a single
input parameter yielded the best performance, parameter reduction only showed significant
benefits regarding the predictive performance for FMetHb and pCO2T . For all other eval-
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uated parameters, maintaining non-zero regression coefficients for all parameters yielded
better results. This indicates that BGA parameters are dependent on a broader variety of
influences or hidden, not observed factors, correlating to several observed parameters.
Another important assessment for clinical applications may be the performance regarding
correlation and r2 as often not the absolute numerical values are most relevant but relative
changes and trends. Therefore, a model with good correlation would be more beneficial for
this task than a model with a minimal MSE. To assess the influence of the MSE optimiza-
tion regarding this goal, a comparison to the trained model with the best R2 was performed.
For most parameters, model selection yielded no significant differences for best α. Notable
exceptions are the regressions for Na+, Ca2+, O2Hb, and pCO2−T . Yet, for those param-
eters, achieved performance is almost equal for all values of α, thus selection was mostly
based on small fluctuations of the achieved performance and not due to significant benefits
of parameter reduction. This, limited by the achieved prediction accuracy, indicates that
models of high quality with regards to the MSE also exhibit good correlation and thus a
common model for both goals may be used.
Finally, a comparison to SVR with linear and Gaussian kernels was performed. The evalua-
tions did not provide significantly different results compared to the elastic-net regressions
and came with the disadvantage of interpretability. Whereas for linear regression methods
like ridge, lasso, and elastic-net, the contributions of each parameter can be observed by the
regression coefficients, such a direct evaluation of the contributing factors is not possible
for SVR. Especially in the medical sector, where reason and causal relations play an impor-
tant role for certification and approval, interpretability of the regression coefficients is an
important criterion. Additionally, the SVR approach does not allow for parameter reduction,
yet may be able to model non-linearity using Gaussian or polynomial kernels. Such more
complex and non-linear methods may be required to train better models regarding surrogate
parameters of blood gases. Yet, a significant increased performance would be required to
justify this step, which could not be observed in the performed evaluation.
Whereas the performed analysis provided several insights regarding the required process-
ing steps and achievable performance, some limiting factors and observations need to be
discussed. Considering the results and the density distribution of the training data, a bias
towards relatively constant observations is present. This effect becomes evident in the pre-
sented hexplots, where small, local clusters with a high density of similar measurements
can be observed. Furthermore, within the hexplots of COHb and MetHb, a bifurcation in
two clusters of observations for individual animal subjects is present. These effects may be
caused by the defined study conditions and the already successfully implemented closed-
loop management. But presumably also by the body’s own buffering abilities, stabilizing
the current condition using biochemical receptors, cascades, and closed loops in order to
maintain homeostasis. Thus, changes may only become visible if the body’s buffering
capabilities are exhausted. In addition, given only close to 500 training points, training
capabilities were limited, especially for machine learning approaches like ANNs and SVR.
To facilitate application of such methods, a much larger database with a greater number
of measurements, including critical conditions and deviations from the stable state, would
be required. This problem and the lack of data was probably aggravated by the required
pre-processing to create a training dataset by removal of unreliable parameters and incom-
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plete observations. As such observations may occur during critical clinical conditions, those
edge cases may have been removed, facilitating a bias to stable measurements. Further pro-
cessing by application of median filters to take account of measurement disruptions could
possibly have also led to an impairment of the observed correlations.
15.2.4.1 Interpretation of regression coefficients
Given the optimal prediction results for the elastic-net regression performed for each param-
eter, the average weight of each regression coefficient can be used for interpretation of the
performed regression. In what follows, this interpretation is performed for a few selected pa-
rameters where a significant contribution of individual regression coefficients was observed.
For those parameters, the potential causal biochemical and medical relations between the
regression coefficients and the parameters should briefly be discussed. If parameters with
significantly contributing regression coefficients have such plausible causal relationships,
this is a good sign for the feasibility of the model. However, if no such direct interpretation
can be made, this does not invalidate the model as the observed parameters may still be
influenced or correlated to the desired target parameter. Therefore, discarding a prediction
model just because no clear interpretation can be made is unjustified [215].
15.2.4.1.1 Blood temperature T The arterial blood temperature was continuously mea-
sured by the patient monitor using a temperature sensor included in the PiCCO catheter
system. This temperature was used for temperature calibration of the performed BGA by
observation of the current temperature and manual input to the blood gas analyzer. There-
fore, the blood temperature T provides a positive reference for the prediction method. Due
to the manual input, however, only a limited accuracy and correlation is achieved since
the temperature is roughly rounded to a maximum of one digit and therefore small fluctua-
tions are not taken into account. When evaluating the regression coefficients of the optimal
prediction, a dependence of about 78% can be observed for the individual measured temper-
ature parameter. This is the expected correlation and the remaining 22% may be attributed
to inaccuracies caused by manual processing.
15.2.4.1.2 FCOHb, FMetHb, FO2Hb, ctHb A set of parameters obtained by the BGA are
related to the hemoglobin (Hb) within the blood and used as indicators for different clin-
ical conditions related metabolism and gas exchange. Carboxyhemoglobin (FCOHb) is a
measure for CO bound to the red blood cells, Methemoglobin (FMetHb) is hemoglobin
consisting of Fe3+ instead of Fe2+, thus unable to bind oxygen. Oxyhemoglobin (FO2Hb)
is the relative fraction with bound oxygen. Furthermore, ctHb is the total hemoglobin con-
centration, thus a measure for oxygen transport capacity. Regression analysis and parameter
reduction yielded mostly similar regression coefficients related to a set of input parame-
ters. Those parameters are related to gas exchange, ventilation, and cardiac parameters.
The most significant regression coefficients related to hemoglobin were Pulsion PulsioFlex
oxygen saturation (O2er), Osypka ICON’s systolic time ratio (str), and the correlated pre-
ejection period (PEP) of the ECG. For the hemoglobin concentration ctHb, regression
coefficients suggest negative correlation to infusion volume. As ctHb is the relative amount
of hemoglobin within the blood sample, dilution of the blood by supplementary infusions
provides a causal relation.
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15.2.4.1.3 cCa2+ For the calcium levels in the BGA results, the most significant re-
gression factors were the perfusion index of the oxygen saturation monitoring (inversely
correlated) and the Jonosteril infusion rate. Further significantly contributing factors in-
clude different parameters for cardiac function like ABP, variation of contractility index
(vic), cardiac function index (CFI), and contractility index (dPmax). As Jonosteril contains
1.65 mmol/L Ca2+ [40], a causal relation to the infusion volume is obvious. Contributions
of cardiac regression factors seems plausible as relations of measured calcium levels to
cardiac work [216], ATP hydrolysis [217], or arterial pressure [218] have been reported.
Regarding the negative correlation to blood flow of peripheral vessels, improved tissue
perfusion has been correlated to inhibition of extracellular Ca2+ influx [219].
15.2.4.1.4 pCO2T The temperature-corrected partial CO2 obtained by BGA, is depen-
dent on the regression factors of systolic time ratio (str), central venous oxygen saturation
(ScvO2), index of contractility (ICON), weight corrected cardiac index (ci-wt), and respira-
tor settings. As respiratory parameters and cardiac work are related to CO2, a causal relation
of those regression coefficients to the measurement results is feasible.
15.2.4.1.5 SBE Regression coefficients of the optimal model for base-excess (SBE) are
dependent on the respirator settings (RR, minute volume, airway pressures) and cardiac
parameters. This suggests a relation to cardiac work and CO2 production, influencing the
base excess. Additionally, the thoracic fluid content (TFC) has a significant contribution to
the regression. As this is a measure for the fluid state, a plausible link between the buffering
capacity of the body and dilution related to a varying fluid content influencing the SBE is
present.
15.2.4.2 Conclusion
The presented evaluation is only a brief example and first insight to the possibilities for
prediction of blood gases using surrogate parameters, showing the benefit of a homogenous
data collection and processing framework with high temporal resolution of a large number
of vital parameters and settings.
Application of the presented regression pipeline with cross-fold validation for the task of
predicting blood gases and for evaluation of parameter reduction could successfully be
performed. Whereas the results only achieved a moderate goodness of fit regarding the
evaluation of MSE and r2, the positive reference for the observed blood temperature T
could successfully be detected. In this case, lasso regression (α = 1) provided the best
result, essentially reducing the parameters to the single temperature input used for manual
temperature correction of the BGA. Yet, only an r2 of 0.61 could be achieved. This may
be caused by inaccuracies in manual processing or time offsets and rounding the observed
parameter prior to entering it manually at the blood gas analyzer.
For other parameters, only moderate performance regarding MSE and R2 could be achieved.
For most parameters, elastic-net regressions with different α weights had only a moderate
effect on the performance and maintaining non-zero regression coefficients was beneficial.
As no limited set of input parameters with non-zero regression coefficients could be selected,
this indicates a complex dependency on the observed parameters or on unobserved ones,
correlating to the observations.
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Yet, for evaluated parameters where a restriction of the number of input parameters was
beneficial, causal relations of the input parameters to most contributing regression factors
can be made. Whereas the abundance of such interpretability cannot be used as an exclusion
criterion for the regression model, causal relations strengthen the general feasibility of the
approach for finding models based on surrogate parameters that can be used for closed-loop
application.
The comparison of the best R2 models to MSE models showed no significant divergence,
requiring different models for predictions regarding the relative change and the absolute
value. Yet, as the influence of α was small for most parameters and only moderate perfor-
mance was achieved, this should be re-evaluated with better models to draw a conclusion if
a general model for surrogate parameters covering relative changes and absolute numerical
predictions may be used.
15.2.4.3 Outlook
Automated matching of BGA parameters with surrogate parameters may allow for a
validation of each blood sample to deal with the problem of sample mix-ups [211, 212]
and to be used as an estimator for physiological changes that need to be recognized and
controlled more tightly to avoid life-threatening conditions. Surrogate parameters may
be used for development of a dynamic BGA scheduler, providing the caregiver with a
suggested timeframe for the next BGA depending on the current state and stability of the
observed parameters. If for example, blood gas parameters are predicted to be changing,
the suggested time for the next BGA could be reduced if those changes are of a significant
degree. Caregivers may be notified to perform a BGA immediately to verify the predictions
and provide adequate therapeutic measures to counter possible changes.
To achieve better performances in subsequent studies, effects within the time-domain and
individual delays of the observed parameters might be considered as different parameters
may have delayed influences on the blood gas parameters. Thus, not only the observations
at a fixed point in time, related to the blood withdrawal, but a defined range of observations
prior to blood withdrawal may be used. Additionally, the delays may be defined individually
for each parameter to account for different physiological relations and delays.
Another limiting factor was the restricted number of usable data points with less than 500
measurements. Whereas selection of training data was performed to obtain the largest
possible data set, individual parameters and measurements were excluded. This number of
limited measurements and parameters paired with often only small measurement variations,
e.g., for parameters like partial oxygen saturation, were limiting factors for the regression
model. Thus, using a more extended data set with various different study conditions may
lead to better results. Of course, limitation of the measurement observation variation is
facilitated due to the already used closed-loops for homeostasis management.
Regarding the used regression method, novel and more robust versions of elastic-net
regression (e.g., using Tukey’s biweight criterion [220]) may be used to evaluate if a
better and more reliable prediction based on the raw data stream from the medical devices
can be achieved. Alternatively, more complex, non-linear models may be used. Whereas
comparison to linear SVR models yielded similar results and short supplementary tests
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with polynomial kernels could not lead to better results, different machine learning
approaches like artificial neural network (ANN)s may be able to achieve this. Yet, such
approaches need a significantly larger data base. This however, closes the loop regarding
the initially stated problem of insufficient availability of medical data and often comes
with the additional problem of being a black box solution, not allowing the assessment of
causal relationships for the trained model. On contrary, by using regression-based analysis,
the coefficients can yield a subset of influential parameters. Further research may then
be focused on better and more robust filtering and sensor fusion to obtain more robust
observations for those most relevant parameters.
Unfortunately, whereas more advanced methods may be able to reveal additional informa-
tion contained within the observed data, or sensor fusion can achieve more reliable results,
no method may be able to generate a surrogate model if the observed parameters may not
contain enough information of the parameter to be estimated. This would require the de-
sired parameter to be measured directly with novel and additional sensors. But even then,
given the body’s own closed-loop systems with most often excellent buffering capabilities,
significant changes may still not be observable until a critical threshold, exceeding those
buffering capabilities, is reached.
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16 Summary of the thesis
In Chapter 1 a first introduction was given, highlighting the current issues regarding
interconnection of medical devices with various protocols and the opportunities of
automation in the context of clinical understaffing and an aging population.
In Part I with Chapter 2, the backgrounds for the relevant aspects of medicine and computer
science were provided. For the medical background, this included the various medical
devices, different aspects of patient management, the used medications, and the relevant
aspects for animal studies as a surrogate model. Subsequently, the IT background provided
a brief overview and introduction to the relevant topics of software design and networking.
Finally, a brief introduction to fuzzy logic controllers was given and the relevant statistical
and analytical aspects used for evaluation and regression analysis were presented.
In Chapter 3, the current state of the art with related work was presented. This included
various examples for partial automation of individual devices, automated therapy manage-
ment, and general concepts for medical device interconnection frameworks.
After those general introductions, the following parts of the thesis covered the performed
studies, implementations, analyses, and results:
In Part II (Chapter 4) an overview of the conducted clinical studies with a porcine animal
model was given to provide a general frame and reference for the implementation and
results of the subsequent chapters.
In Part III the theoretical concept, the implementation, and the evaluation of the proposed
framework for interconnection of medical devices and data collection in an experimental
setting was presented. This framework uses a client-server architecture with various plugins
for expanding the basic functions and a message-based approach for information transport.
It was successfully evaluated during the two performed studies and able to collect over
1300 hours of scientific research data in a central database.
In Part IV, various applications based on the developed framework for management of
hemo- and homeostasis to reduce variance in the study conditions and workload were
presented:
In Chapter 11, the development and evaluation of automated anti-coagulation management
was shown. It uses a modified measurement device and automated processing of the results
to adjust a heparin infusion pump. This allowed for successful and automated management
of the required heparin levels based on a state-of-the art look-up table for adaption during
the performed studies.
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In Chapter 12 another application, automated temperature management, was presented
and evaluated. Using a modified forced-air warming device to allow for remote-control
by communication with the developed framework, TTM based on the body temperature
was implemented. Evaluation showed that the desired nominal body temperature could be
maintained at any time, drawing level with the performance achievable by constant human
supervision and frequent manual adaption to reduce thermal effects on homeostasis.
In Chapter 13, the proposed adaptive and multi-purpose fuzzy-logic controller was
presented. It uses a relative output factor for adaption, allowing a dynamic response and
tolerating human interference. Evaluation of the controller was performed during the
studies by automating the management of etCO2, glucose, and electrolytes to improve
homeostasis. For the frequently adaptable RR for management of etCO2, target levels
could be maintained in over 95% of the total observation time. Glucose could be kept in
a nominal range in over 85% of the time. For the electrolytes, evaluation was limited to
individual animal subjects with an average performance.
In Part V, retrospective analysis based on the collected data with a focus on the problem of
infrequently obtainable BGA results was shown:
In Chapter 14, a brief overview of the data collection and the general approach to gain a
first insight into the collected data was presented. This was especially relevant, as it allowed
for pre-processing and detecting patterns and characteristics relevant in further processing
steps.
In Chapter 15, one example for such a characteristic pattern within the obtained data was
shown and used for the automated detection of blood withdrawal events to allow for an
automated and improved sample dating. For the 886 BGAs performed during the studies,
a F1-score of 0.97 could be achieved. Those detected events could then be used to solve
the problem of matching the obtained blood samples to other vital parameters. Given the
observed problem of closed-loop management with sparse adaption intervals due to the
limited number of blood samples from BGA, a regression analysis to assess the potential
of surrogate parameters for blood parameters, utilizing the calculated withdrawal times,
was performed. This initial analysis showed a limited performance on the available dataset,
suggesting a restricted predictability and the requirement for an increased and more com-
prehended training data set with more diverse physiological conditions.
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Research in the scope of clinical decision making and automation is a constantly evolving
field with a steadily increasing number of publications in recent years. Whereas progress in
clinical techniques and equipment allow for treatment of more complex and life-threatening
conditions [1], technological advantages and automation are still mostly limited to patient
management and guidance systems [3]. For potential improvements in automation tech-
nology, better interconnection of medical devices is an essential step towards solving the
fundamental problem of clinical decision making: the availability of data.
Since clinical decision support systems often have none or limited access to the displayed
data, information cannot be collected and processed [179]. Thus, possible knowledge from
clinical practice is still lost forever on a daily basis [9] and most knowledge and insights
for decision-making need to rely on empirical research [2]. When solutions for clinical
information systems and automation are proposed, they are often limited to theoretical con-
cepts and the evaluation is limited to the few publicly accessible collections of clinical data,
often only containing short time frames and a limited number of parameters, or performed
entirely on simulated data.
For bridging this data gap, a unified system for interconnection and automation of medical
devices, which was previously only a theoretical concept, has now been evaluated in the
research environment for porcine studies at the UKT and was used to collect significant
amounts of research data. During the studies presented in the context of this work, funda-
mental solutions and concepts for an ICU software framework for medical devices were
developed and evaluated as the initial and most important step, providing the main focus of
this thesis.
Automation and closed-loop systems, which were defined and guided by the clinical ques-
tions and practical requirements in the used experimental porcine ICU, were implemented
and have been evaluated successfully in this real setting based on the developed framework.
A central concept for the implemented automation was the usage of a fuzzy logic-based
controller. Fuzzy logic was selected as the method of choice, as it is a well-established
concept and empirical clinical decision making is often based on linguistic descriptions that
are intuitive to physicians. Such descriptions include the often fuzzy range of commonly
acceptable physiological values, which need to be assessed individually to obtain optimal
settings [3].
Whereas other approaches utilizing fuzzy logic for clinical decision making use absolute
relations for the membership functions, the developed fuzzy controller is based on relative
factors applied to the current setting of various medical devices. Since the factors used are
relative, automated therapy can be started and adjusted at any time and in any condition.
In addition, this used approach is able to tolerate human interactions and reconfigurations,
which are an important aspect during therapy, repeatedly observed in the carried-out studies.
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The feasibility of this adaption method and the system in general could be demonstrated
with the successful implementation of adaptive fuzzy-logic controllers for management of
expiratory CO2, glucose, and several electrolytes. They provide an initial proof of concept
and may form the basis for further improvements and studies in this ICU setting with more
adaptive algorithms, considering further interactions.
Whereas many specific solutions for medical devices or features exist, such research and
development is mainly focused on and limited to individual components and aspects, specif-
ically tailored for individual devices or manufacturers. Therefore, no such general concept
is required and application is most often limited to individual laptops or the scope of the
individual medical device. Furthermore, most available systems can only be used for col-
lection of clinical data in a unidirectional way. Of course, given that such systems are in
general medical products, this necessitates legal and functional limitations of scope and
performance for their respective tasks and mostly prohibits direct control capabilities.
For automation and control, however, it is not sufficient to simply collect data, but systems
that provide a return channel for the general control of connected devices are required.
Aside from specific implementations for individual tasks, only some approaches for general
medical frameworks have been postulated over the recent years. Yet, published literature
is mostly limited to theoretical concepts or assessments of the emerging demand for such
systems. Additionally, none of the proposed system is specifically tailored to the needs of
academic research.
During development of the software framework, the closed-loop systems and the practical
implementation of such a fully-functional system in a research environment as a bridge
between theoretical concepts and clinical application, various difficulties that have not been
covered by the various theoretical concepts became noticeable. Maybe the most important
of those aspects was the physical implementation regarding required hardware, network
structure, and storage that is required in an experimental or clinical setting.
Whereas clinical application of such a system and the developed solutions are ultimately
the long-term goal, the necessary legal framework restricts the development and evaluation
of such systems. For clinical research in animal studies, such legal limitations are
not as strict as those for human participants, thus allowing for a more comprehensive
evaluation under human supervision. As this was the available experimental context for
this research, a novel, easily expandable experimental framework, aimed at overcoming
those limitations and providing functional implementation for evaluation and further
academic research, could be developed. It is specifically tailored for medical applications
with its very heterogeneous landscape of devices and able to collect a broad variety of
data from different sources. The message-based system allows for arbitrary bidirectional
communication between connected devices. This facilitates easy expansion and evaluation
of novel sensors, methods, closed-loop systems, and collecting data on various interactions
in changing study conditions. Which might provide insights and help developing concepts
for the future of critical care as already shown successfully for various automated tasks
during the performed studies. Yet, besides evaluation of algorithmic solutions, the physical
implementation of such a system was an important step to investigate interactions with
caregivers and how such a system can be integrated into the medical work flows as an
assistive technology.
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As the body is a very complex manifold system with highly sophisticated interactions,
this need is further enhanced as simple therapeutic protocols can hardly be developed and
only provide a limited quality of care [3]. Especially in critical conditions, optimal levels
cannot be defined in general but must be assessed individually with as much information
as possible [3]. Moreover, patient care is highly dynamic and clinical decision making
is time sensitive [179]. Automated systems may rapidly interact with the patient and be
able to better assess complex situations and recognize changes in patient condition earlier,
allowing for faster and more proactive interventions [3, 179]. Additionally, such systems
can reduce therapeutic variances between patients, if two or more medically acceptable
solutions exist for a single condition [2]. This may be especially beneficial, if no continuous
therapy would have been provided by switching the goals in an ongoing therapy, e.g., due
to shifting medical staff.
Independently of the individual goals regarding improved care, personalized medicine,
smarter alarms, and automation using machine learning, the fundamental requirement
for clinical research leading to better, personalized medicine is a large and sufficient
high-quality data foundation. Unfortunately, such data is rarely available and most often
limited to short periods or few parameters. Using the developed framework and database,
this kind of data could be collected in the used experimental setting. It provided a research
foundation containing over 1000 hours of observations for 300 synchronized parameters in
a single unified database format, exceeding any other available data source.
Yet, even when fundamental problems for interconnection and data processing are solved as
it is the case for the developed solutions presented within this thesis, still no continuous data
stream for several parameters can easily be established. An example for this scenario are
measurements of blood gases, which could only be obtained with a limited frequency. For
the fuzzy logic-based glucose controller, short intervals are needed and the limitation pro-
vides a general problem in glucose management [147]. With this dependency on infrequent
and manually performed measurements, there is an imminent need for finding alternative
methods to estimate such parameters and interpolate the time between measurements, al-
lowing to detect critical situations. Additional challenges regarding the availability and
quality of data can be demonstrated by using this example as well. Not only is it difficult
to collect information from various medical devices to be used as surrogate parameters and
matching them in the time domain to get a complete measurement vector of the current
state, but finding the correct time point for prediction provides an additional challenge. As
there is no specific parameter for blood withdrawals events that can easily be established
without the need for manual interaction, it had to be derived automatically from the given
parameters as shown with the proposed detection for withdrawal events. Only then further
analysis like the evaluation of surrogate parameters with a correctly matched input vector
can be performed.
However, even with the usage of surrogate parameters and predictive models, automated
systems are dependent on sufficient data input. If a sensor fails, controls can be restricted
or become impossible. An example is the respiratory management during the conducted
studies, where the developed fuzzy closed-loop controller is solely dependent on the
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ventilators etCO2 sensor input. During the observation of two animal subjects, problems
with the sensor caused disruptions and measurement errors, forcing the automated system
to be stopped to prevent possible health risks. Thus, this example of a relatively simple
closed-loop system already illustrates the importance of sensor fusion with redundant
parameters in control algorithms.
Beside improvement of future critical care with personalized medicine, another important
aspect and motivation for automation is the rising demand for critical care in an aging
population with a limited number of caregivers and thus, increased workload [3, 4]. By using
advanced technologies with an increasing number of devices, observed parameters, and POC
tests, clinical decision making can be improved. However, such tools and their protocols may
become more and more complicated and difficult instead of being part of clinical routine [1].
This complexity will increase workload, lead to more errors, and reduced compliance [3].
Automation may have a significant impact in dampening this effect as there are still many
repetitive and manual tasks where workload and complexity could be improved to boost
compliance and significantly reduce the risk of human errors [212]. An examples for such
a task is automated processing of BGA measurements for anti-coagulation management,
using the ACT device presented within this thesis. Automating the protocol-based manual
approach for adaption of the heparin pump with a closed-loop application embedded in the
developed framework, reduction of workload and error potential during the calculations
could be achieved.
Another concern regarding the increasing number of different devices and monitors is the
risk of missing crucial information as human observers might get overwhelmed by the
amount and variation of the presented information. Whereas IT and automated systems in
principle should ease this burden, compartmentalization and limitations of the individual
devices lead to increased workload [3]. As this is a problem concerning the medical envi-
ronment as a whole, automation of individual aspects of care within their respective devices
and monitors cannot lead to a reduction of workload as parameters, and now additional
settings, still need to be observed and controlled at their associated interfaces.
Therefore, general concepts including data aggregation and presentation are required. Only
systems that can interact with many devices and collect data from different sources to gain
a detailed insight into the patient’s condition and allow adaptations can achieve this goal.
Such central interfaces, where all information about the patient is gathered and therapeutic
measures can be carried out, will become even more important as the amount of data contin-
ues to grow. For the presented experimental research system, such a central observation and
control monitor was already an essential aspect of the treatment. By using a touch-screen
with a freely implementable GUI, interaction with the system and the different interface
types for monitoring and control of medical devices, therapeutic protocols, and closed-loop
systems by caregivers was possible and could be evaluated.
One advantage of automated systems is not requiring continuous observation once a
therapeutic goal has been set. As in many settings and scenarios supervision by caregivers
cannot be assured at all times, this advantage may be particularly beneficial as various
therapies may be extended to settings where the required observation is not currently
available. An example would be non-invasive closed-loop temperature management within
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ICUs, where unsupervised application may cause patient harm. Evaluation of such a task
was performed for closed-loop temperature management using a forced-air warming
system. By adding a monitoring and control interface and developing a closed-loop system
for automated temperature management, the workload for temperature management has
been significantly reduced and even better performance than with manual management has
been achieved to improve homeostasis maintenance.
Yet, whereas providing many advantages and, above all, having the potential to reduce the
amount of work, automation carries some risks. As automated systems perform therapeutic
measures independently, physicians and caregivers may no longer take notice of develop-
ing and occurring physiological changes. This might limit evidence-based research and
advances in medicine, as the ability and motivation to detect and understand pathophys-
iological changes could vanish [3]. Thus, possibly inappropriate therapies carried out by
automated systems might go unnoticed for a prolonged period of time. Besides the need for
maintaining interaction and awareness of the caregivers by providing automated systems as
tools for an improved goal-directed and personalized care, this clearly shows the need for a
concurrent development of smarter alarms to detect such systems and alert caregivers.
In general, automation should not be a competition to caregivers, but be developed and
seen as a form of displacement, instead of considering it as a replacement, allowing
caregivers to focusing on therapy guidance and other tasks where human experts are more
flexible and can exceed the capabilities of algorithms. Above all, caregivers should not be
forced to accept decisions that contradict their expertise and critical thinking [1], as this
reduces acceptance and, if implemented in this way, could significantly limit interaction
and awareness with regard to automated decision-making.
Besides all technical and psychological difficulties, there is still a third important obstacle
as a limiting factor for automation in the medical field. Certification of medical devices
is already a lengthy and expensive process. Considering decision-making in closed-loop
and full-automated systems, many questions regarding the certification process and liability
remain unanswered. In the near future, applications may still be limited to suggestion- and
open-loop systems. However, manual processing or entering of data from different devices
might finally be replaced by automated processing, just requiring human verification. How-
ever, these verification tasks can be error-prone or even become more problematic unless
adequate observation and critical decision making is ensured, especially if it becomes rou-
tine to accept the proposed results of the automated system. Thus, human verification for
each automated action in comparison to a straightforward implementation of a fully auto-
mated solution with sufficient auto-validation of the results may not always be preferable.
Given this uncertainty about changes in medical regulatory frameworks and liability
issues, healthcare insurers who already cover the cost of treatment and, in the future, may
even cover treatment errors by automated systems could play a key role. Watching the
developments in other industrial sectors, such as the automotive one, with car insurers as
an equivalent type of a public insurer dealing with questions of assisted or autonomous
driving could play a guiding role for dealing with automation issues in the medical sector.
Yet, the scenario of autonomous driving is only a conditionally fitting example as drivers
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strive to focus on other tasks instead of monitoring the car, whereas in other areas with
automation, for example pilots or also caregivers are employed to ensure safety and, if
necessary, intervene in order to prevent and deal with critical situations. Moreover, if such
automated systems are considered as assistive systems, physicians will continue to set
therapeutic goals and be responsible for supervising the therapy.
17.1 Outlook
Given the developed framework and the evaluation of first closed-loop systems for auto-
mated intensive care medicine, further research may focus on various different aspects,
enhancing the performance and scope of this first, fundamental implementation and evalu-
ation. The development and implementation of physical systems for interconnection is an
essential aspect and will become even more important with an increasing number of med-
ical devices and therefore should be a research focus in this fundamental stage of clinical
automation. Hence, requiring to elaborate and evaluate solutions regarding the scalability
of medical frameworks and their application to multiple hospital wards. This will require
considerations regarding redundancy, sufficient data storage, and all other practical aspects
for the implementation in every day clinical practice. Otherwise, although there may be
elaborated concepts for decision making within a legal framework, the practical implemen-
tation and management of those systems within the clinical environment will still remain
an unsolved problem for a prolonged time.
Another important research aspect might be the reduction of caregivers’ workload and fur-
ther (semi-) automation of the various manual tasks in intensive care settings. The provided
example for automated processing of ACT measurement results using an existing therapeu-
tic protocol was just a proof of concept and a first step for further research towards more
advanced therapeutic strategies and for other POC and laboratory devices. Likewise, the
automated detection of blood withdrawals is not only an important first step for analysis and
automation, but it can also facilitate easier patient selection by caregivers and the detection
of sample mix-ups. This may include the better integration to BGA devices by providing
reduced and sorted patient lists, dependent on the detected blood withdrawals, to improve
patient safety and reduce workload at the same time.
Based on the data collected with the developed framework during the conducted studies,
in-depth analysis regarding the clinical research questions of the studies, e.g., the analysis
of patient’s volume state based on the collected monitoring data, may be performed. Be-
sides monitoring data collected once per second, real time curves with up to 500 Hz have
been collected from patient monitor and ventilation device. This data may be utilized and
allow for ECG and respiration pattern analysis using different approaches like wavelets
and machine learning to segment the data stream and develop detection and classification
algorithms for different physiological states. Applied to the detection of critical conditions
and complications, this may lead to refinements of study protocols, significantly reducing
the risk of errors and possible harm to the study animals. Combined with the developed au-
tomated solutions for stabilizing the animal subjects and standardizing the study conditions,
this could lead to a reduction of the number of animal subjects required to obtain significant
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study results. Obtained results may then lead to improvements of guidelines and therapies
in clinical practice.
Furthermore, given the growing collection of high resolution data for various conditions,
development of better models, predictions, and simulation may be performed. Additionally,
using an extended database, research questions might be retrospectively answered to an
increasing degree based on the collected observations. Even regarding parameters that were
unrelated to the initially performed study but possible by collecting all available information
and preserving it for such a potential future use. This might provide a useful tool as a
replacement for studies to actually be carried out on animals. Obtained research results may
also be directly applicable to humans and could lead to improved care during the current
research phase, where the technical and legal frameworks still need to be established to
allow more advanced automation in clinical settings.
Additionally, given the extensive set of collected parameters in the used experimental ICU
setting, research might focus on the aspect of sensor fusion for parameters from different
devices. Given an ensemble of medical devices, several parameters like HR and others are
measured by different systems and methods. Thus, sensor fusion might be used to generate a
more reliable parameter from the raw data stream for further processing and analysis. Within
this context, the development and integration of additional sensors and information sources
to facilitate sensor fusion might be relevant, too. This includes better sensing technology
for different aspects like continuous glucose monitoring (CGM), which is still experimental
or too expensive for a disposable product in clinical practice, and may provide alternatives
to the indirect estimation of BGA¸ parameters based on patient monitoring data.
However, even if such training data is available for development of better models and
algorithms, its application as a tool for personalized medicine will still be mainly dependent
on a continuous and comprehensive stream of monitoring information from the individual
patient to provide optimal decision-making and aiding caregivers as the body itself is a
regulatory closed-loop system that is able buffer and compensate numerous conditions.
Besides the already variable therapeutic settings for each patient, a trend for further compart-
mentalization into specific care units, with their respective set of devices, can be observed
with the increasing number of specific systems and therapies. Even with the best possi-
ble device interconnection, such restrictions in clinical settings, providing only a subset of
parameters, should be considered regarding the choice of models and the required input
parameters as it will provide additional problems and require further research for automa-
tion and decision-support systems. Yet, such restrictions are even to be considered from
a clinical standpoint, as they should be avoided because patients may develop the same
critical conditions independently of the assigned special unit [3].
Another important aspect of automation and integrated systems in the medical field will
be the need for better data presentation on a single screen, as the rising number of devices
and monitors make keeping an overview more and more difficult. Additional research is
required to find practical and intuitive ways for interaction with automated control systems,
like the fuzzy controller, to allow caregivers to easily set goals and parameters for the desired
therapy. The importance of this aspect became clear during implementation and evaluation
of the rate of change as an additional fuzzy function for calculation of the adaption factor.
Whereas the slope could of course have been used, it is not a common unit of measurement
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in the clinical environment compared to time spans. Those are a more natural measure for
physicians in clinical practice. The search for such measures of configurable parameters,
which can be assessed by physicians through empirical knowledge or practical need, is
therefore an important aspect that should be taken into account in every implementation
and further developments. Furthermore, additional research needs to consider and evaluate
human interactions, interface design in the context of large amounts of information. This
will require smart filtering of information for context-aware presentation of the currently
most relevant and important information to caregivers and physicians in order to reduce
information density but still allow a fast assessment of the current patient state.
17.2 Conclusion
Given those various open questions, sparsity of data, and technical limitations, automated
clinical care is still a long way off. The developed experimental framework and evaluations
for different closed-loop and data collection solutions may provide essential steps for further
research regarding automation and surrogate parameters. Yet, including consideration of
the current legal limitations and potential risks, much additional research and a better legal
foundation is required.
Maybe the most suitable area of application for automation and closed-loop strategies at
this time are remote locations where telemedicine used, e.g., on offshore structures or other
isolated locations where no qualified physicians are in reach [3, 221]. Once more, the most
important aspect for this task is the availability of all collected data to the physician. By
providing automated therapy where expertise or staffing is otherwise not sufficient, qualified
physicians may be able to remotely guide an automatically performed goal-directed therapy.
Yet, besides any long-term goals, possible clinical application areas, and remaining
questions, the development and implementation of the proposed system provides an
imminent improvement for further research regarding animal studies in the established
experimental setting at the UKT and is the foundation for several medical doctoral theses
and research papers. Additionally, as all available information is collected and infor-
mation loss is minimized, retrospective analysis based on all observations can be performed.
Finally, it is time to close the loop and return to the introductory question — Would you
entrust your life to a computer while staying critically ill in a hospital? — Given the current
state of the art and the research presented within this thesis, this fundamental question is
still mostly hypothetical as many aspects and difficulties regarding clinical application of
automation and machine learning remain to be addressed. Yet, machine-learning and au-
tomation are already beginning to find applications in various medical devices. Considering
the rising demand for an aging population and the progress in medical technology for better
treatments and patient outcome, it will just be a matter of time until advanced systems with
better interconnection will become part of everyday clinical practice. This will most likely
be a continuous process with more and more assistive technologies. Thus, within the next
decades, the hypothetical question may just turn into a rhetorical one, as everybody may
get used to physicians and caregivers piloting the journey to recovery.
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